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“EPIGENETIC CONSEQUENCES OF PRE-CONCEPTIONAL EXPOSURES IN HUMAN” 
This chapter was adapted in part from the following publication: 
Estill MS, Krawetz SA. (2016) “The Epigenetic Consequences of Paternal Exposure to 
Environmental Contaminants and Reproductive Toxicants.” Current Environmental Health 
Reports 3(3):202-13. doi: 10.1007/s40572-016-0101-4. 
 
i. Summary 
The Developmental Origins of Health and Disease (DOHaD) hypothesis proposes that 
periconceptional environment influences offspring phenotype, partially through epigenetic 
mechanisms [1-3]. Both maternal and paternal peri-conceptional environments are now 
believed to contribute to offspring phenotype. Assisted reproductive technologies, such as in 
vitro fertilization, alter the pre- and post-fertilization environment of the human embryo. 
Manipulation of the early embryo for treating human infertility is suspected of contributing to 
offspring abnormalities through epigenetic mechanisms. While the causal paternal 
components of DOHaD are insufficiently understood, particularly in human, the pre-
conceptional environment of the father may influence several components of the male 
germline. In addition to the haploid paternal DNA, spermatozoa carry RNA, proteins and 
chromatin marks to the embryo. Murine and limited human studies suggest that epigenetic 
marks in the mature spermatozoa may be modified by the paternal environment, including 
common endocrine disruptor exposures. Frequent human exposures to endocrine disruptors, 
exogenous chemicals that can mimic or alter hormonal responses, make it imperative to fully 
define the affected epigenetic marks in human sperm. 
ii. Background 
The Developmental Origins of Health and Disease (DOHaD) theory proposes that 





Maternal health is a critical component of DOHaD, as maternal stressors, diet, and chemical 
exposures can directly affect both the oocyte and the growing fetus across gestation. Maternal 
psychological stress during gestation, often measured by self-reporting, is often correlated 
with autism symptom severity [4] and toddler cognition and temperament [5, 6]. Maternal diet 
is well documented to be associated with offspring health [7, 8]. Certain chemical exposures 
during human gestation are well known to be detrimental to fetal development. For example, 
gestational thalidomide use, prescribed as an antiemetic to counter morning sickness, leads 
to limb and organ deformation [9]. However, more subtle effects, in the absence of a gross 
fetal morphological phenotype, may occur with gestational exposure to exogenous chemicals. 
For example, diethylstilbestrol (DES), a synthetic estrogen, was once prescribed under the 
assumption that DES would prevent adverse pregnancy outcomes, such as pre-term birth and 
miscarriages. However, gestational exposure to DES has since been associated with 
reproductive system cancers and reproductive tract problems in the exposed offspring [10].  
With the majority of DOHaD studies focus on the maternal contribution to fetal health, 
the paternal aspect of DOHaD remains largely unexplored. However, there is evidence for the 
non-genetic transfer of paternal environmental information to the embryo and subsequent 
fetus (Figure 1.1). Murine experiments on paternal exposure to chemicals, extreme diets, 
exercise or adverse psychological events suggest that the paternal experience is passed 
along to the offspring, presenting an offspring phenotype. For example, male mice fed a 
Western-like diet produce offspring with metabolic dysfunction, an effect which is suggested 
to be mediated by spermatozoal RNAs [11]. The intergenerational effects of paternal diet also 
extend to simpler organisms, with a drosophila model showing that acute paternal dietary 
sugar reprograms offspring metabolism [12]. Stressful events in both neonatal and adult male 
mouse are capable of modifying phenotype, such as fear and anxiety responses, in 






Figure 1.1. DOHaD maternal and paternal contributions. Maternal and paternal germlines 
may be influenced by their environments and stimuli, such as chemical exposures and food 
availability. On the maternal side, the uterine condition can also be affected by the maternal 
environment. Environmental insults to parental reproductive tissues and the developing fetus 
can influence the phenotype (e.g. health) of the offspring during childhood and into adulthood. 
 
Accordingly, environmental perturbations in the human may also affect offspring. 
While the long-term observations are required to demonstrate the isolated/specific paternal 
contribution in humans to the offspring and subsequent generations, historical records of 
isolated communities do suggest that parental nutrition influences the disease risk of 
subsequent generations [16]. Observations of a Swedish parish, Överkalix, suggest that 
dramatic shifts in pre-pubertal food availability of paternal grandmothers increases the risk for 
cardiovascular mortality in female grandchildren, via the F1 sons, suggesting a sperm-
mediated mechanism. Subsequent work on the Uppsala Birth Cohort Multigeneration Study 
further suggested that abundant access to food during the slow-growth period (pre-pubertal 
period) of paternal grandfathers is associated with elevated mortality in grandsons, also 





caused by a German blockade of the Western Netherlands during World War II, yielded a 
cohort of individuals who experienced gestational undernutrition. Maternal undernutrition 
during gestation of male offspring (F1 generation) resulted in the grandchildren (F2 
generation) being prone to obesity [18].  
To understand the impact of human paternal environment, it is critical to thoroughly 
characterize the components of the male gamete, as well as the mechanisms by which 
common environmental exposures may alter spermatozoal contents. Human populations are 
exposed to a wide spectrum of environmental contaminants, some of which are considered 
reproductive toxins [19]. Certain exposures are intentional, such as the case of 
chemotherapeutic treatments, intended to kill fast-growing cells, including the target cancer 
cells. However, chemotherapy often has negative repercussions on the reproductive system, 
up to and including infertility. Other such reproductive toxins include certain heavy metals, 
such as lead, and endocrine disruptors, such as bis-phenol A (BPA), which can disrupt 
gametogenesis and reproductive functions [20]. Epidemiological studies have examined the 
effect of such toxins on the human male reproductive system. However, the basic tenant of 
epidemiological studies in the male human is to infer how one or more substances alter the 
hormonal profile, seminal characteristics, or both. Unfortunately, except in extreme cases of 
sperm parameter abnormalities, such as azoospermia or globozoospermia, the clinical utility 
of traditional seminal characteristics at predicting fertility is limited [21, 22]. The contribution 
of subtle epigenetic alterations, such as DNA methylation and histone marks, to reproductive 
phenotypes and fertility potential has, until recently, received little attention. 
The mechanisms underlying phenotypic changes in DOHaD are largely proposed to 
be epigenetic. Although genotype and consequent gene-environment interactions certainly 
account for a portion of a response, controlled murine experiments indicate a long-lasting 
effect that perpetuates a phenotype across an individual’s lifetime, and possibly to the 





epigenetic marks across an individuals’ lifetime [26-28]. Epigenetics is broadly defined as the 
non-permanent alteration of DNA structure. Common epigenetic alterations are DNA 
methylation, histone modifications, and chromatin states (euchromatin/heterochromatin). 
DNA methylation, the addition of methyl groups to individual bases, occurs primarily in the 
context of methylated cytosines. In mammals, 5-methylcytosine (5-mC) is thought to be the 
primary type of methylated cytosine [29]. Other epigenetic alterations, while being more 
transitory in nature, also can alter DNA structure, such as regulatory RNA and TF binding. 
The involvement of the epigenome in Assisted Reproductive Technologies and the male 
germline is explored below.  
iii. Epigenetics in embryonic development 
Human infertility is a common condition, with approximately 12% of couples of 
childbearing age in the United States experiencing a prolonged time to conception or the 
inability to conceive [30]. Assisted reproductive technology (ART) therapies to address 
infertility range from non-invasive to invasive. Non-invasive therapies include Timed 
Intercourse (TIC) (having intercourse during the predicted window of ovulation), and Intra-
Uterine Insemination (IUI) (manual placement of sperm inside a woman's uterus to facilitate 
fertilization). Invasive therapies include Gamete Intrafallopian Tube Transfer (GIFT) (external 
mixing of sperm and oocyte, followed by immediate transfer to the fallopian tube), In Vitro 
Fertilization (IVF) (in vitro oocyte fertilization, followed by transfer to recipient uterus), and 
Intra-Cytoplasmic Sperm Injection (ICSI) (IVF, with manual fertilization via direct micro-
injection of sperm into the egg. Controlled ovarian hyperstimulation, commonly known as 
superovulation, is the administration of exogenous gonadotropins to promote the release of 
multiple oocytes in a single cycle. Superovulation is often used in conjunction with IVF and 
ICSI, in order to obtain viable embryos and increase chances of pregnancy. 
With regards to offspring health, IVF is considered a safe procedure and is now 





since the first IVF child was born approximately 36 years ago. Despite the positive impact of 
ART, this technology presents an atypical nutritional, biochemical, and hormonal environment 
to the developing embryo. Whether this has an effect on the long-term health of the conceptus 
and the magnitude of effect remains to be resolved in humans. 
The “natural” ovulation cycle involves sequential hormone peaks, that result in follicle 
recruitment, maturation, and release at ovulation. Concurrently, the uterine endometrium 
undergoes proliferation and vascularization, to yield a thick endometrial layer capable of 
supporting embryo implantation and growth [32]. Intercourse (or IUI) around the time of 
ovulation, when successful, fertilizes the oocyte within the fallopian tubes. The resulting 
embryo then continues its journey to the uterus, where implantation takes place.  
While each part of the “natural” fertilization process is designed for optimal oocyte 
selection, fertilization, and embryonic development, the focus of IVF is the production of 
sufficient numbers of high-quality oocytes for subsequent fertilization. Over the years, IVF 
procedures have been refined to optimize production of high-quality embryos [33]. However, 
the superovulation procedures, in addition to the psychological and physical stresses of the 
female patient [34], neglect the endometrial health and implantation capacity. In the context 
of DoHAD, the periconceptional environment of a child born through IVF is comprised of the 
oocyte milieu (superovulation, oocyte retrieval, and gamete storage), fertilization, and the 
environment surrounding early embryonic development (in vitro growth and uterine 
environment). Modification of this pre-implantation environment by assisted reproductive 
technologies may have unintended consequences on embryo growth and resulting health of 
the child. Additionally, the growing use of oocyte/embryo cryopreservation may further modify 
the embryonic environment. Overall, the use of ART procedures, particularly IVF and ICSI, 
may unduly alter the epigenome of the fetus. This concept is explored in Chapter 2. 





The male gamete, spermatozoa, serves to deliver the paternal DNA and other cargo 
to the oocyte [35]. Sperm are produced in the seminiferous tubules of the testis through a 
series of pre-meiotic, meiotic and post-meiotic processes known as spermatogenesis 
(reviewed in [36]). Within the seminiferous tubule, post-meiotic processes require the 
transformation of a round spermatid (with typical cellular structure) into the unusual 
spermatozoal structure, containing a flagellum, highly condensed nucleus, mitochondrial 
midpiece, and very little cytoplasm. After sperm differentiation within the testis, the sperm 
enter the epididymis and undergo additional maturation during the approximately two weeks 
of epididymal transit [37]. This epididymal maturation potentiates the sperm’s fertilizing ability 
and motility [38].  
In the past, spermatozoa were perceived to merely be a vessel for the paternal DNA. 
However, sperm were subsequently shown to not only contain DNA, but transmit RNA, 
proteins and chromatin marks to the embryo [35]. Mature spermatozoa are known to be 
transcriptionally and translationally inert. However, labeled probes, microarrays and 
eventually, RNA-sequencing, have identified a wide range of RNAs present in sperm, both in 
mammals and other organisms [35]. The majority (~85%-96%) of sperm DNA is packaged in 
the specialized proteins called protamines, which provide a compact chromatin structure ~10 
fold more compact than the nucleosome structure generated by histones [39-41]. However, 
sperm still contain some histones, which are known to preferentially localize at promoters of 
developmental transcription and signaling factors [39, 42]. In addition to proteins directly 
involved in chromatin structure, other proteins with diverse roles are also delivered to the 
embryo [43]. This additional cargo, which is delivered to the oocyte, may then influence 
fertilization and subsequent fetal health. Recent work on the mammalian epididymis has 
shown that epididymal exosomes (epididysomes), which contain proteins, RNAs and other 
molecules, are integrated into sperm during epididymal transit [44, 45]. The RNA profiles 





which includes both RNAs generated in preparation and those acquired during epididymal 
maturation for transmission to the future embryo.  
Recent work in humans currently indicate that sperm epigenetic marks and RNAs can 
be modified by paternal environment [46]. Comparison of obese males to lean controls 
suggested differential profiles of non-coding RNAs and DNA methylation. Additionally, in a 
cohort of obese men undergoing bariatric surgery, longitudinal observations of sperm DNA 
methylation show shifts in methylation at several genomic loci, including loci involved in 
appetite regulation [Donkin cell metabolism 2016]. In a human trial of endurance training, 6 
weeks of endurance training was sufficient to remodel both sperm RNA levels and DNA 
methylation [47]. While DoHAD studies in human have primarily focused on the maternal 
contributions, the preconceptional environment of the male gamete may also play a role in 
intergenerational offspring health in human [16, 17].  
v. Endocrine disruptors on male reproduction 
Like the female reproductive system, the male reproductive system is under the control 
of the endocrine system. In humans, the hypothalamic–pituitary–gonadal axis (HPG axis) is a 
primary modulator of reproductive function. As shown in Figure 1.2, the hypothalamus 
produces Gonadotropin-releasing hormone (GnRH), which influences the adjacent pituitary 
gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH) into the 
bloodstream. LH subsequently enters the Leydig cells and promotes testosterone production. 
Concurrently, FSH promotes the release of androgen-binding protein (ABP), allowing the 
binding of testosterone by the Sertoli cells [48]. Androgens, particularly testosterone, are 
critical to maintaining spermatocytes and completion of meiosis. Although FSH is not required 
for spermatogenesis, the targeted uptake of androgens by Sertoli cells optimizes 
spermatogenesis. While testosterone serves as a negative regulator of the hypothalamus and 
pituitary gland, thus producing a negative feedback loop in the HPG axis, the contrasting 





maintaining spermatogenesis [49]. Among the many functions, activin is a growth factor that 
can stimulate the pituitary gland to secrete FSH. In contrast, inhibin, which is produced in 
reproductive tissues (as well as other tissues), can suppress pituitary FSH production [50, 51]. 
Disruption of the HPG axis in males, by environmental factors, age, or genetic mutations, can 
result in altered spermatogenesis or hypogonadism [52-54].  
 
Figure 1.2. Hypothalamic–pituitary–gonadal axis in the adult human male. The 
hypothalamus within the brain, whose location is approximated by a black dot, secretes 
Gonadotropin-releasing hormone (GnRH). GnRH stimulates the adjacent pituitary gland to 
secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH) into the bloodstream. 
FSH and LH then enter the testis, promoting the production of androgens, particularly 
testosterone, and inhibin. Testosterone acts in a paracrine manner to create a negative 
feedback loop, suppressing GnRH secretion by the hypothalamus, and also suppressing FSH 
and LH production at the level of the pituitary gland. Concurrently, inhibin produced the Sertoli 






Endocrine disruptors, exogenous chemicals that can mimic or alter hormonal 
responses, are a prevalent feature in urban environments [19]. A heterogeneous collection of 
natural and synthetic chemicals have been identified as likely EDs, including several well-
publicized pesticides, such as dichlorodiphenyltrichloroethane (DDT), and plastic 
components, such as bisphenol A (BPA) and phthalate esters [55]. Phthalates, suspected 
endocrine disruptors, are commonly used as solvents and plasticizers in consumer products, 
such as polyvinyl chloride. They have also been incorporated into coatings used in 
medications [56, 57]. Phthalates have been noted to act on peroxisome proliferator‐activated 
receptors (PPAR) [58, 59]. Additionally, different phthalate species, including phthalate 
metabolites, have different capacities for modifying an endocrine response [58-60]. Although 
considerable literature suggests that gestational and neo-natal phthalate exposure is 
detrimental to reproductive function [61], the health effects of phthalates at environmentally 
relevant doses in adult humans is still uncertain, particularly in the adult male, although 
existing human studies are described below. Interestingly, chronic in vivo exposure of rats to 
the tolerable daily intake (TDI) of BPA altered protein expression and histone acetylation [62, 
63]. While rats and mice cannot replace pertinent observations in humans, such model 
organisms do suggest that humans may also be subject to subtle reproductive changes when 
challenged with endocrine disruptors.  
Epidemiological studies on adult phthalate exposures and semen parameters have 
associated elevated phthalate levels with abnormal sperm morphology [64], sperm 
concentration [65, 66], oxidative stress [67], and DNA damage [68]. Among IVF couples, 
phthalate levels in the male partner are inversely correlated with high-quality blastocysts [67]. 
While a controlled study of adult human males exposed to a low, chronic dose of phthalates 
[69, 70] indicates hypothalamo-pituitary-testis axis dysregulation and declining sperm motility, 
the mechanisms directly underlying the spermatozoal modifications in such individuals are yet 





exposures in the adult human male remains unknown. However, animal models, and limited 
data in human, suggests that paternal experiences, such as diet or stress, can have 
phenotypic consequences in the offspring. Such intergenerational effects are expected to be 
mediated through epigenetic mechanisms, such as chromatin structure or RNAs delivered by 
the spermatozoon at fertilization [17, 71-73].  
vi. Overview 
The contribution of the male gamete and pre-implantation environment to offspring 
health, while important, is relatively understudied. ART procedures, such as IVF and ICSI, 
can alter the pre-implantation environment of the oocyte, growing embryo, and uterus. Despite 
the manipulations involved in ART, offspring derived from ART procedures are generally 
healthy [74]. However, such offspring may exhibit subtle epigenetic effects, exemplified by the 
small, but elevated, risk of congenital defects due to imprinting disorders, such as Beckwith-
Wiedemann and Prader-Willi syndromes [75]. In Chapter 2, I explore the role of IVF/ICSI 
protocols in the DNA methylation of infants. The study presents DNA methylation changes in 
infants conceived through the use of Fresh Embryo Transfer (ET), Frozen Embryo Transfer 
(FET), or Intrauterine Insemination (IUI). The relative similarity between FET and IUI indicates 
that the fetus’s DNA methylation is either unchanged by, or altered in an inconsistent manner, 
by FET. This is likely due to improved uterine receptivity in FET and IUI conceptions compared 
to ET. Overall, this study supports the use of FET in IVF/ICSI procedures [76]. 
During fertilization, the male gamete contributes DNA, RNA, and epigenetic marks. 
Spermatozoal RNA can also provide an epigenetic mechanism. Chapter 3 explores the RNAs 
present in the male germline and early embryo. This analysis indicates that, in addition to 
annotated transcripts, numerous intergenic and intronic RNAs are present in human 
spermatozoa. These novel RNAs were identified using a pipeline for discovering intergenic 
RNAs from standard read alignments. Implementation of the RNA Element Discovery 





novel RNAs and exonic RNAs in each tissue [77]. Spermatozoa contain many more novel 
RNAs than somatic (e.g. liver) tissue, suggesting that transcription of intergenic and intronic 
RNAs may be important for spermatogenesis. Notably, genomic repeats exhibit a shifting 
transcriptional enrichment pattern across spermatogenesis and early embryogenesis.  
Using the spermatozoal RNAs identified by the REDa approach, Chapter 4 examines 
the impact of phthalate exposure on male reproduction. The Mesalamine and Reproductive 
Health Study (MARS) (NCT01331551) was initiated (https://clinicaltrials.gov/) to directly 
address the physiological effect of in vivo di-butyl phthalate (DBP) exposure on male 
reproduction. Within the MARS study, subjects with Inflammatory Bowel Disease (IBD) were 
exposed to longitudinally alternating DBP exposures. Using a cross-over design and 
longitudinal data structure, each subject acts as their own control, thus mitigating genetic 
variation and environmental variation (e.g. lifestyle and exposome) that often complicates 
causal assessment in epidemiology. The results of longitudinal modeling suggest that 
exposure to, or removal of, high DBP produces transcriptomic effects that require longer than 
one spermatogenic cycle to resolve, if at all. While the two study arms exhibit enrichment of 
different biological pathways, the H1BH2 arm, which initiates the study on high DBP, displayed 
activation of oxidative stress and DNA damage response pathways. Network analysis of small 
RNAs and genomic repeats also suggest that transcription of small RNAs and genomic 
repeats contribute to spermatid development. Together, this work provided insight into both 








“THE IMPACT OF ASSISTED REPRODUCTIVE TECHNOLOGY ON THE EPIGENETIC 
PROFILE OF NEWBORNS” 
This chapter was adapted from the following publication: 
Molly S. Estill, Jay M. Bolnick, Robert A. Waterland, Alan D. Bolnick, Michael P. Diamond, 
and Stephen A. Krawetz. (2016) “Assisted reproductive technology alters deoxyribonucleic 
acid methylation profiles in bloodspots of newborn infants.” Fertility and Sterility, Volume 106, 
Issue 3. Pages 629-639.e10, https://doi.org/10.1016/j.fertnstert.2016.05.006. 
i. Summary 
Little is known of the genome-wide effect of assisted reproductive technologies (ART), 
on the genome and epigenome of the conceptus. To address this shortfall, I have examined 
the DNA methylation profile of newborns conceived naturally, or through the use of intrauterine 
insemination (IUI), or in vitro fertilization (IVF) using Fresh or Cryopreserved (Frozen) embryo 
transfer. Newborn methylation levels of these four different conception types, stratified by 
gender, were compared using the HumanMethylation 450k platform. Perturbation of probe 
clusters within genes and enhancers suggests that the newborns born from ART possess a 
dramatically different methylation profile compared to those naturally conceived. Intriguingly, 
there was a striking similarity of the methylation profile of IUI and IVF-Frozen embryo transfer 
infants, but not IVF-Fresh. This suggests a possible reduction of epigenetic aberrations in the 
IVF conceptions using cryopreservation and implicates that a resetting mechanism is acting 
upon cryopreserved embryos. These results are in accord with the observed reduction in birth 
defects using those protocols that employ cryopreserved embryos. Periconceptual nutrition is 
known to alter epigenomes of offspring at specific loci termed metastable epialleles (MEs). 
IVF culture conditions can mimic various nutritional conditions experienced by the early 
embryo. With this consideration, analysis of the ART methylation changes in MEs was 





culture conditions and parental infertility showed consistently altered methylation at certain 
MEs. This is the first study to reveal an impact of ART or fertility status on MEs and suggests 
a lasting epigenetic effect of IVF nutrition on the developing embryo. 
ii. Introduction 
The DoHAD hypothesis [78] suggests that environment during the periconceptional 
period, as well as later stages of embryonic, fetal, and postnatal growth, can persistently 
impact health. Epigenetic modifications, including histone modifications and DNA methylation, 
are suspected to be one of the mechanisms by which prenatal environment influences 
offspring health. Accordingly, nutritional status at the time of conception in rural Gambian 
women altered the DNA methylation profile at metastable epiallele (ME) loci in the children. 
This effect was modulated, at least in part, by methyl donor availability in the food sources 
available at the time of conception [79, 80]. 
Assisted reproductive technology (ART) provides infertile couples several treatment 
options, including ovulation induction followed by intrauterine insemination (IUI), in vitro 
fertilization (IVF), and intracytoplasmic sperm injection (ICSI). Despite the positive impact of 
ART on fertility outcomes, these procedures present an atypical nutritional, biochemical, and 
hormonal environment to the developing embryo. Murine studies suggest that the transient 
stresses that IVF places on the growing embryo can result in a considerable change in gene 
expression, metabolism, and growth trajectory [81-83], which can persist into adulthood [84-
87]. Although there are likely several underlying mechanisms for these effects of IVF, one 
such mechanism that has been proposed is the increased incidence of random epigenetic 
errors, including changes in imprinted genes [83, 88]. 
ART procedures are generally accepted as safe for the mother and conceptus in 
humans. However, there is an elevated risk of birth defects, neurologic disorders, and 
imprinting disorders in conceptions generated through IVF and ICSI [89, 90]. In addition to the 





comparing the metabolic and cardiovascular health of children conceived by ART with those 
conceived naturally indicate a trend toward impaired glucose metabolism and cardiovascular 
function [92-94]. Such health risks observed in ART-conceived children may result from 
underlying epigenetic aberrations presented by parental infertility or ART itself. However, it is 
important to note that evidence for concerted epigenetic changes in the ART population [95-
100] is countered by a number of studies asserting that the epigenome of ART-conceived 
offspring is essentially unchanged [101-104].  
Studies investigating the effect of ART on the human epigenome often observe a 
limited number of genomic loci, which are usually regions of known interest associated with 
imprinting syndromes. However, two studies recently expanded the number of genomic 
regions examined in ART studies. One described DNA methylation in the promoter regions of 
736 select genes, which were primarily associated with imprinting and growth regulation, from 
10 IVF and 13 in vivo–conceived children [95]. The second used an Illumina Infinium Human 
Methylation27 Beadchip array, identifying 733 CpG sites of differential methylation when 
comparing the cord blood of 8 IVF and 10 naturally conceived children [98]. However, these 
two studies did not address the impact of infertility, which is the primary reason why ART is 
prescribed, nor did they provide a genome-wide assessment. By employing the Illumina 
Infinium HumanMethylation450k BeadChip on newborn blood samples, we began to fill in 
these gaps, revealing that a larger span of genomic sites may be impacted by parental 
infertility and ART than previously appreciated. A targeted investigation of children born after 
transfer of cryopreserved or fresh ICSI embryos further delineated the epigenetic impact of 
these two different ART protocols, while suggesting that embryo cryopreservation may 
indirectly improve epigenetic outcome. 
iii. Materials and Methods 





Newborn residual bloodspots, which were collected from Michigan newborns between 
24 and 36 hours after birth for metabolic screening, were obtained from the Michigan Neonatal 
Biobank (www.mnbb.org/). After Michigan Department of Community Health (approval 
#037913MP4X), Wayne State University, and Biotrust institutional review board approval, 120 
women (40 per group) were selected who conceived after one of three types of infertility 
treatments (IUI, ICSI with fresh embryo transfer [FH], or ICSI with frozen embryo transfer 
groups [FZ]). Sample requests were then given to the Michigan Biotrust for Health, and 
bloodspots were subsequently requested from the newborn of each of the women in the 
different categories through the Michigan Neonatal Biobank using storage codes only (all data 
were deidentified). For the three procedure categories, a total of 18 IUI, 38 FH, and 38 FZ 
bloodspots were obtained for calculation of DNA methylation, as detailed in Figure 2.1A. 
While the clinical parameters of the newborn and mother for the samples analyzed in this 
study were not known, the majority of bloodspot samples represent individuals born in the 
Detroit and metro Detroit regions. As a naturally conceived control, 16 male and 27 female 
bloodspots were also examined. Intensity Data (IDAT) files from the 450k assay of naturally 
conceived (NAT) newborn bloodspots were graciously provided by Dr. Douglas Ruden, 
Wayne State University [105]. The NAT samples were also previously obtained from the 
Michigan Neonatal Biobank. In total, 137 individuals were utilized in methylation comparisons. 








Figure 2.1. Samples and conception group comparisons subject to differential 
methylation analysis. (A) Number of individuals analyzed in this study, according to 
conception type and gender. (B) Directional arrows indicate that the conception group at the 
source of the arrow is the methylation dataset (control) against which that at the termination 
of the arrow (case) is being compared. (C) Pipeline provided by ChAMP was used to filter, 
normalize, and apply batch correction, to obtain corrected methylation values. Aclust was then 
implemented to calculate methylation changes in probe clusters, followed by downstream 
analyses. Concurrently, the same corrected methylation values were analyzed using a linear 
model to calculate differential methylation of individual probes and verify the results obtained 
from Aclust. 
 
Study Design and Data Processing 
To assess the effects of infertility treatments (specifically ICSI and cryopreservation) 
on genome-wide DNA methylation profiles of newborns, a case–control design was 
implemented (Figure 2.1B). Neonatal bloodspots from newborns conceived through 
unassisted (NAT) and IUI conceptions provided controls from fertile and infertile backgrounds, 
respectively. In this case–control design, a given conception group considered as a “case,” 
such as ICSI fresh embryo transfer, was matched to a “control,” such as IUI. The unassisted 
conception control, NAT, served as a control for the IUI, FH, and FZ conception groups. The 





using the Illumina Infinium HumanMethylation450 BeadChip array. The Chip Analysis 
Methylation Pipeline (ChAMP) pipeline was utilized for processing the datasets into 
methylation profile (as measured by β-values) (Figure 2.1C). 
Each conception comparison, outlined in Figure 2.1B, addressed a specific query. 
Comparison of either FH or FZ with IUI was undertaken to identify ICSI-associated changes 
within the group of parents requiring artificial insemination to conceive. Within the ICSI (FH 
and FZ) group, differences between FH and FZ were assessed to discern the effects of fresh 
embryo transfer and cryopreserved embryo transfer. Subsequent comparison of IUI, FH, or 
FZ with NAT identified differences between children born to parents undergoing infertility 
treatment and those born to fertile parents. Methylation changes between males and females 
within the same conception group were undertaken to examine how the epigenome might 
differ between genders [106-108]. 
The ChAMP pipeline was used to analyze the 450k signals, normalize the methylation 
values to produce β-values (the proportion of methylated CpG sites) and identify the 
differentially methylated probes [109]. Blood cell distributions of each sample were estimated 
using the estimatecellcount function in minfi. The single value decomposition function of 
ChAMP provided the relative influence of plate, assay characteristics, and blood cell 
proportions on sample methylation. In an effort to minimize technical variation, all multiply-
mapped probes, as well as probes containing single-nucleotide polymorphisms in either the 
target CpG or the 10 bases of probe closest to the target CpG site [110, 111], were removed 
from differential methylation analysis. This excluded 91,058 probes from analysis, leaving 
394,454 probes prior to calculating differential methylation. All sample comparisons were 
subjected to batch correction using ComBat, in order to eliminate the effects of array batch. 
To eliminate the risk of identifying false positives due to gender imbalances, I implemented a 





increased the confidence in assigning genes and other genomic loci as differentially 
methylated, while removing gender as a confounding variable. 
Batch-corrected β-values from the ChAMP pipeline were used in the A-clustering 
algorithm [112]. The algorithm generates clusters of correlated autosomal probes, followed by 
general estimating equation (geepack) estimation of the differentially methylated autosomal 
clusters. Differentially methylated clusters were as having a minimum absolute average effect 
size (methylation) change of 2.5% and Benjamini-Hochberg adjusted P value of <.05. 
Calculating Differential Methylation Using Limma 
The β-mixture quantile dilation (BMIQ)-normalized, batch-corrected β-values of all 
reliable probes produced by the ChAMP pipeline were applied to limma, which calculated 
differential methylation of individual probes [113]. Differentially methylated probes were 
defined as having a minimum absolute methylation change of 2.5% and Benjamini-Hochberg 
adjusted P value of <.05. Limma yielded similar proportions of hypermethylated and 
hypomethylated probes, when contrasted to clusters of probes, and generally supported the 
trends in counts of differentially methylated regions between the conception types. 
Calculating Differential Methylation of Promoters and Gene Bodies 
The locations of all RefSeq genes were obtained from Ensembl, build hg19/GRCh37. 
Promoters of genes were defined as 1 kb upstream of the unified gene start site. The 
identification of clusters and probes within gene bodies or genomic loci was performed using 
a series of bedtools utilities and custom R scripts. For a given comparison, all differentially 
methylated clusters (filtered for a methylation change of 2.5% and Benjamini-Hochberg 
corrected P value of <.05) with at least 75% of the cluster intersecting a gene body or promoter 
were assigned to that particular gene. Because of the potential for numerous non-differential 
clusters to reduce average gene body methylation below the threshold of 2.5% methylation 
change, only differentially methylated clusters were considered in the calculations for gene 





the average of all effect size (methylation) changes of all differentially methylated clusters 
assigned to that gene. Gene bodies were then further filtered for a minimum absolute average 
effect size (methylation) change of 2.5%. Differentially methylated genes, as calculated using 
Aclust clusters, are referred to as hypermethylated or hypomethylated according to an effect 
size (methylation) change of greater than 0.025 or less than −0.025, respectively. 
Regulatory/enhancer Regions 
Human regulatory regions and putative human enhancers (indicated here as 
“regulators”), were obtained from Andersson et al. [114]. Clusters were intersected with the 
set of 43,011 permissive regulators to identify the clusters overlapping the regulators. The 
change in regulator methylation was calculated as the average of all differentially methylated 
clusters located in the given regulator. To avoid spurious associations of methylation changes, 
all differentially methylated regulators were required to have a minimum absolute average 
methylation change of 2.5%. 
Genome Annotation and Relative Enrichment 
Annotation of significant clusters with respect to promoters, introns, exons, and 
intergenic regions was calculated with the “Annotation & Statistics” function of Genomatix 
(July 2014 build), using the December 2013 Eldorado annotation of the hg19 genome. 
 
iv. Results 
Study Sample Characteristics 
As the cohort was composed entirely of newborns, the postnatal environment was 
expected to have minimal effect on DNA methylation. While cellular composition of blood 
samples can affect methylation profiles, the estimated cellular composition of each sample 
did not significantly impact the methylation status in the cohort. The general differences 
among the samples were small, as determined by pairwise comparison of all autosomal probe 





suggest that the global pattern of methylation of prepubertal children is not affected by ART 
[101, 103]. Supporting the previous observation, I found that principle component analysis 
(unsupervised clustering) did not effectively cluster the NAT, IUI, and ICSI groups. This 
recapitulated previous observations that methylation profiles of ART and control individuals 
do not segregate in clustering analysis [95]. 
Differential Methylation of Probe Clusters 
As outlined in Figure 2.1B, the conception groups were compared to identify 
differentially methylated probes and clusters. Aclust was used to identify each cluster of two 
or more correlated probes and calculate differential methylation at each cluster [112]. While 
numerous previous studies have listed differential methylation at individual CpG sites, the 
biological impact of a single CpG is questionable. Therefore, the Aclust approach was used 
to identify methylation changes across multiple adjacent CpG sites, given that methylation 
differences that extend over multiple CpG sites can be viewed as confirmatory and are likely 
to have a biological impact. To avoid spurious associations of methylation change, regions of 
interest were required to contain multiple differentially methylated probes, as well as exhibit a 
minimum absolute average methylation change of 2.5% [112]. As summarized in Figure 
2.2A,B and Figure 2.3A, several interesting differential methylation patterns emerged. The 
naturally conceived group exhibited considerable differential methylation when compared to 
all three assisted conception groups. Hypomethylated clusters were observed more frequently 
within the ART groups (Figure 2.2B), concordant with a similar result in a non-ICSI sample 
group [98]. Within each conception group, differentially methylated clusters in females 
(compared with the male control) were more frequently hypermethylated than hypomethylated 
(Figure 2.3A). Comparisons between three assisted conception groups revealed 
considerable differences between FH and IUI or FH and FZ, while, in contrast, there were 
comparatively fewer differences between IUI and FZ. It should be noted that the A-clustering 





[112]. Therefore, the possibility that the A-clustering algorithm was responsible for the 
unexpected patterns in methylation changes between assisted conception types was 
considered. In order to verify the A-clustering results with a different method, a commonly 
used linear modeling algorithm, limma, was also used to identify differentially methylated 
probes [113]. Based on the trends observed with A-clust and limma approaches, the similarity 
between the IUI and FZ was considered reliable. This similarity was independent of BMIQ 
normalization and was not due to the batch correction or the A-clustering algorithm or 
inadvertent sampling bias, as shown by random subsampling. 
 
Figure 2.2. Intracytoplasmic sperm injection and IUI compared with NAT show 
differential methylation of clusters and gene bodies. (A) Total counts of differentially 
methylated clusters between conception groups for males and females, shown in blue and 
pink, respectively. Red bracket indicates comparisons of FH and FZ with IUI, presenting the 
greater degree of differential methylation in the FH vs. IUI comparison than that of FZ vs. IUI. 
(B) Distribution of the change in the β-value for statistically significant clusters, as a function 
of conception comparison. Changes in the female and male comparisons are shown in light 
red and blue, respectively. (C) Pie chart labeled “Genome Annotation” indicates the proportion 
of the human genome that lies within exons, introns, promoters, and intergenic regions. The 
pie chart labeled as “Cluster Annotation” provides the proportion of all statistically significant 
clusters (regardless of methylation change) that overlap exons, introns, promoters, and 







Figure 2.3. Trends in differentially methylated clusters between males and females of 
identical conception groups. Hypermethylation in the female group (compared with a male 
control) is shown in red, whereas hypomethylation is presented in blue. (A) Counts of clusters 
differentially methylated between females and males of the same conception group. (B) 
Counts of gene bodies differentially methylated between females and males of the same 
conception group. 
 
Differentially methylated clusters tended to be associated with promoters and exons 
of protein-encoding loci (Figure 2.2C) with β-value changes averaging approximately 5% 
(Figure 2.2B). Several clusters exhibited changes larger than 10%, including a 
hypomethylation of the Speriolin-like protein (SPATC1L) promoter in IUI and ICSI (FH and 
FZ) when compared to NAT (with the hypomethylation frequently exceeding 10%). 
Characteristics of Differential Methylation 
Methylation changes between the individual conception methods were first examined 
with respect to the promoters and gene bodies of all unified RefSeq genes. Differential 
methylation in gene bodies was observed more frequently than differential promoter 
methylation. Figure 2.4 summarizes the counts of differentially methylated gene bodies, 
which reflected the overall number and direction of methylation changes of differentially 
methylated clusters for each given comparison. Collectively, these gene-specific methylation 







Figure 2.4. Intracytoplasmic sperm injection and IUI show considerable differential 
methylation in gene bodies compared with NAT. Bars indicate the counts of differentially 
methylated gene bodies between conception groups. Counts of differentially methylated gene 
bodies generated for (A) male- and (B) female-specific comparisons. Hypermethylated and 
hypomethylated gene bodies are represented in red and blue, respectively. 
 
In addition to providing coverage of RefSeq genes, the Infinium HumanMethylation450 
BeadChip contains probes designed for various intergenic regions. These regions can 
encompass regulatory loci (e.g., enhancers and silencers/regulators) residing outside of 
promoters and gene bodies. Such regulatory loci can act independently or in concert with 
proximal regulatory regions, and consequently alter chromatin organization and tissue 
expression [116, 117]. Using putative regulators identified from the FANTOM5 cap analysis 
of gene expression atlas, changes in the methylation status of regulators [114, 118] between 
conception types was examined. 
Numerous regulators were differentially methylated when the three assisted and NAT 
conception groups were compared (Appendix B). Fewer regulators were differentially 
methylated when FZ was compared with IUI, as opposed to when FH was compared with IUI 
or FZ, reflecting the relative similarity of the FZ and IUI groups (Appendix B). As shown in 





conception group, suggesting that certain enhancers may exhibit gender-specific methylation 
patterns. A total of 21 regulators exhibited altered patterns of methylation between the 
genders in two or more conception groups (Appendix C). This common group of 21 regulators 
may play therefore a role in sexual dimorphism of the human fetus [86, 119]. 




















Hypermethylated 28 44 5 12 
Hypomethylated 15 4 5 10 
Total 43 48 10 22 
 
Comparing ICSI (FH and FZ) and IUI with a NAT control showed that regulators were 
most frequently hypomethylated (Figure 2.5 and Appendix D), which reflected the general 
trends towards hypomethylation in the complete cluster set for the given comparisons. 
Interestingly, three hypomethylated regulators were consistently differentially methylated 
among all three assisted conception groups and NAT control. In addition, 15 regulators were 
consistently altered between the ICSI (FH and FZ) and NAT control, as well as the subset of 
5 regulators (Appendix D) altered between all three assisted conception groups and NAT 
control. 
 
Figure 2.5. Enhancers consistently altered in ICSI 
groups compared with NAT. Populations of 
hypermethylated and hypomethylated enhancers altered 
in the IUI, FH, or FZ vs. NAT comparison were identified 
and enumerated. Quantities of hyper- or hypomethylated 
enhancers are denoted as “Hyper” and “Hypo,” 
respectively. The quantity of enhancers found in common 
between two or more comparisons and exhibiting identical 
methylation trends (e.g., increased or decreased 
methylation in both comparisons) are indicated in the 





Imprinted Genes are Differentially Methylated in IUI and ICSI Newborns 
Imprinted genes play a critical role in fetal growth and are epigenetically repressed in 
a parent-of-origin-specific manner [120]. Due to this epigenetic repression by cis-acting 
differentially methylated regions, an imprinted gene will exhibit preferential expression from 
either the paternal or maternal allele [121]. In humans, the combination of the 450k platform 
and bisulphite sequencing has allowed for the identification of cis-acting differentially 
methylated regions, which may act as imprinting control regions [121]. 
Previous mouse and human studies have investigated changes in the methylation 
status at imprinted loci, including loci associated with metabolism and fetal growth (e.g., H19 
and IGF2) after ART [75, 83, 88, 90]. Recent work has also shown that high-quality human 
embryos generated from ART exhibit a high degree of DNA methylation errors in imprinted 
loci [122]. Within the collections of differentially methylated genes, an enrichment of imprinted 
genes was found when comparing ICSI (FH and FZ) with the IUI control (Table 2.2), with 
hypomethylated genes contributing strongly to this enrichment. This enrichment trend was 
also observed in the comparison of ICSI (FH and FZ) with NAT. Taken together, imprinted 
genes were differentially methylated more often than expected by chance when comparing 
any assisted conception group with NAT (P value: 1.47 × 10−3 to 2.04 × 10−11). The 
biological implications of the observed methylation changes in the imprinted genes remains 






Table 2.2. Imprinted genes are differentially methylated between different conception 
types. Enrichment of differentially methylated imprinted genes between conception groups, 
segregated according to gender. Comparisons yielding P-values less than 0.05 and 0.01 are 

























FZ vs FH, 
Male 






















genes 687 565 103 197 813 1069 93 85 1417 1187 982 968 695 887 766 922 
Imprinted 
genes 18 18 4 4 23 23 5 10 27 27 32 25 18 25 27 33 
Maternally 
imprinted 
genes 7 9 1 2 8 15 3 1 14 16 16 13 8 13 13 14 
Paternally 
imprinted 


































































































































The effect of IVF/ICSI conception on long-term health and metabolism is still actively 
debated. Therefore, our collection of imprinted genes were assessed for known associations 
with human metabolism. Differentially methylated clusters in the promoter and gene body of 
the maternally expressed long noncoding RNA H19 were observed when IUI and ICSI (FH 
and FZ) were compared with NAT, but not when ICSI (FH and FZ) was compared with IUI 
(Figure 2.6) [123]. These observed cluster changes occurred in the paternally methylated 
H19 Differentially Methylated Region (DMR) [121]. IGF2, a paternally expressed growth-
promoting hormone, was also hypomethylated in both promoter and gene body clusters when 
female IUI and ICSI (FH and FZ) were compared with NAT (Figure 2.6). The paternally 
methylated IGF2 DMR2 region [121], located in the last two exons of the IGF2 gene, was 






Figure 2.6. Certain imprinted genes associated with metabolism and cancer exhibit 
differential methylation. UCSC genome browser images of promoter and gene bodies of 
imprinted genes (A) H19, (B) IGF2. Hypermethylated clusters and hypomethylated clusters 
are colored in blue and orange, respectively. Cluster heights represent the magnitude of 






MEs are Altered in Both the Infertile Control and ICSI Newborns 
The nutritional environment encountered by the early embryo is among the factors that 
likely differ between unassisted conception and IUI or ICSI (FH and FZ). Correspondingly, a 
modulation of metabolism-associated genes suggests that a nutritional component, such as 
the culture conditions of IVF/ICSI protocols, may affect the epigenome. Therefore, genomic 
loci known to be impacted by periconceptional nutrition (i.e., metastable epialleles), were 
assessed. 
Metastable epialleles (MEs) were first characterized in mouse models [124] and have 
recently been identified in humans [79]. DNA methylation at these loci is stochastically 
established within the blastocyst and is also driven by periconceptional nutritional status [79, 
125, 126]. In order to assess effects of the early embryonic nutritional environment associated 
with ART, the clusters identified as differentially methylated in the comparison of NAT with the 
three assisted conception groups were overlapped with MEs. Of 109 high-confidence MEs 
identified in a recent genome-wide screen [127], 22 were informative in the 450k-based 
analysis. Remarkably, 19 (86%) of these, plus two MEs that were not directly assayed but 
existed within a cluster, were differentially methylated in at least one of all possible conception 
group comparisons (Table 2.3). Hypomethlation predominated the MEs in all three assisted 
vs. NAT comparisons.  Taken together, these clusters suggest that certain epialleles (e.g., 
those associated with DUSP22 and SPATC1L) are indeed susceptible to methylation changes 
in both genders upon IUI or ICSI (FH and FZ) as compared with NAT conception (Figure 2.7, 
Table 2.3). Interestingly, DUSP22, a dual specificity phosphatase, has been implicated as a 
negative regulator of estrogen receptor-α–mediated signaling and STAT3-mediated signaling, 
and hypermethylation of the DUSP22 promoter is correlated with Alzheimer's disease risk 
[128-130]. The function of the protein encoded by SPATC1L is unknown, but it has been 
shown to be expressed in testis as well as certain cell lines. The paralog of SPATC1L, 





perhaps SPATC1L plays a yet undetermined broader role in reproduction. The long-term 
health implications of altering methylation at these sites has yet to be determined. 
 
Figure 2.7. Metastable epialleles at DUSP22 and SPATC1L show considerable and 
concerted differential methylation. University of California Santa Cruz (UCSC) genome 
browser representation of female comparisons between conception groups for MEs located 
at (A) DUSP22 and (B) SPATC1L. Hypermethylated clusters and hypomethylated clusters are 
colored in blue and orange, respectively. Cluster heights represent the magnitude of 







Table 2.3. Metastable epialleles are differentially methylated between conception 
types. Differentially methylated metastable epialleles were segregated into hypermethylated 
and hypomethylated loci. Genes associated with the respective epialleles are then indicated. 
The magnitude of the methylation change, in units of β-values, are shown in italics for each 
epiallele. FH = fresh embryo transfer; FZ = frozen embryo transfer groups; IUI = intrauterine 








Hypomethylated MEs Associated genes 























SPATC1L chr14:54816001-54816200 (−0.09); chr19:29218001-
29218200 (−0.19); chr2:113992801-113993000 (−0.08); 
chr2:113993001-113993200 (−0.08); chr5:135415601-
135415800 (−0.14); chr5:135415801-135416000 (−0.14); 
chr5:135416201-135416400 (−0.14); chr6:291801-292000 
(−0.29); chr6:292001-292200 (−0.29); chr6:292201-292400 
















FZ vs IUI, 
female 
    












128453400 (−0.27); chr2:128453401-128453600 (−0.27); 
chr6:291801-292000 (−0.40); chr6:292001-292200 (−0.40); 








128453600 (−0.25); chr21:47604201-47604400 (−0.10); 
chr21:47604801-47605000 (−0.10); chr21:47605001-
47605200 (−0.10); chr4:1523001-1523200 (−0.10); 
chr5:135415601-135415800 (−0.12); chr5:135415801-








47605000 (−0.23); chr21:47605001-47605200 (−0.23); 
chr7:4305001-4305200 (−0.08); chr2:128453201-
128453400 (−0.21); chr2:128453401-128453600 (−0.21) 
SPATC1L; SDK1; 
SFT2D3; WDR33 






47605000 (−0.27); chr21:47605001-47605200 (−0.27); 
SPATC1L 






128453600 (−0.16); chr6:291801-292000 (−0.11); 










47605000 (−0.16); chr21:47605001-47605200 (−0.16); 
chr6:291801-292000 (−0.14); chr6:292001-292200 (−0.14); 
chr6:292201-292400 (−0.14); chr6:292401-292600 (−0.14); 
SPATC1L; 
DUSP22 






19111000 (−0.13); chr2:128453201-128453400 (−0.22); 
chr2:128453401-128453600 (−0.22); chr6:291801-292000 
(−0.13); chr6:292001-292200 (−0.13); chr6:292201-292400 
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47604400 (−0.22); chr21:47604801-47605000 (−0.22); 
chr21:47605001-47605200 (−0.22); chr6:291801-292000 
(−0.11); chr6:292001-292200 (−0.11); chr6:292201-292400 






















Several adjacent MEs on chromosome 2 were observed to be hypomethylated solely 
in the male comparisons of ICSI (FH and FZ) groups to NAT. Within the same comparisons, 
these MEs were not consistently altered in the female cohort. These MEs are located in a 
potential regulatory region adjacent to SFT2D3, WDR33, and LIMS2. Additionally, these loci 
were hypomethylated in both FZ as compared with FH males and females. Taken together, 
this suggests that the type of IVF/ICSI treatment (i.e., cryopreserved or fresh embryo transfer) 
impacts methylation status to varying degrees, with FZ embryo transfer increasing the level 
of hypomethylation at this locus in the male cohort. A significant methylation change at this 
ME in males alone (FH vs. NAT, FZ vs. NAT) suggested a gender-specific effect on 
establishing the epigenome of this locus. Although Silver et al. [127] identify the top 10 MEs 
altered by season of conception in Gambian individuals, the DUSP22-, SPATC1L-, and 
SFT2D3-associated MEs found to be hypomethylated in ART individuals compared with NAT 
are not among them. Therefore, the differences in nutritional and periconceptional milieu 
between the rainy and dry season are likely different from those of unassisted and assisted 
conceptions. 
v. Discussion 
ART has been successfully applied to produce many phenotypically healthy human 
children. However, in both humans and model organisms, the impact of ART on the 





lack of understanding of the epigenetic contribution to the health of ART conceptuses. To 
begin to disentangle the possible epigenetic impact of ART techniques, such as ICSI and 
cryopreservation, from that of underlying infertility, the present cohort included both NAT- and 
IUI-conceived newborns as comparative groups. This work verified previous literature 
indicating that ART does not induce extensive global changes in DNA methylation [103].  
In contrast, numerous differentially methylated loci were identified when conception 
types were compared. The three assisted conception groups also exhibited differences from 
the natural conception group, thus supporting the view that subtle epigenetic changes 
occurred in children from parents who sought fertility treatment, relative to those conceived 
naturally. Consistent with this tenet, 4 of the 18 candidate CpG sites altered in placental tissue 
from children born to fertile parents compared with infertile parents [99] are located in or near 
significant clusters of two imprinted genes, growth factor receptor-bound protein 10 (GRB10) 
and necdin (NDN). While A-clustering recapitulated the hypomethylation of placental GRB10 
CpG sites in bloodspots of ART children compared with fertile controls [99], it was not 
congruent with NDN. This discordance is likely reflective of tissue-specific DNA methylation 
in peripheral blood and placenta. Methylation differences between ICSI and naturally 
conceived controls were generally discordant with previous studies’ conclusions on imprinted 
genes [95, 98]. This discordance is likely reflective of study differences in sample size and 
composition. Overall, a screen of imprinted DMRs does not identify altered DNA methylation 
profiles in placenta and cord blood samples in ART newborns compared with those 
spontaneously conceived [132]. This screen agreed with the conclusions drawn from the 
current cohort, in which the majority of imprinted genes in human do not show consistent or 
significant methylation changes. 
The results of this work suggested that alterations in DNA methylation may explain at 





increased birth defect risk in individuals with a history of infertility [89]. As we have shown, the 
IUI and FZ groups exhibit noted epigenetic similarity.  
This is consistent with the recent suggestion that cryopreservation, in conjunction with 
ICSI, can reduce the risk of birth defects associated with ICSI births to that of the general 
population [89]. Interestingly, a Drosophila model of intergenerational metabolic 
reprogramming recently demonstrated a resetting of the fly sperm epigenome after heat shock 
[12]. It is tempting to suggest that cryopreservation in ART may yield a similar outcome (i.e., 
the epigenetic resetting of the human embryo). However, the true nature of the mechanism 
underlying the reduction in aberrant DNA methylation in the FZ newborns remains unknown. 
In all human studies to date, the combined effects of cryopreservation, embryo quality, uterine 
receptivity, and parental health have yet to be segregated. Moreover, the endometrial 
receptivity of women undergoing ovarian stimulation, which is often utilized in fresh embryo 
transfer, is likely shifted in comparison with that of naturally cycling women undergoing frozen 
embryo transfer [31]. This suggests that the relative endometrial receptivity may play a role in 
establishing the implantation environment and ultimately, the epigenome, of the conceptus. 
Previous studies considering the impact of ART on the human conceptus have largely 
been limited in the number and type of genomic loci examined. Uniquely, the present work 
identified both regulatory regions (i.e., enhancers) and MEs as being affected by infertility and 
ART. The 450k array locus-specific β-values for various MEs, including PAX8, SPATC1L, and 
VTRNA2-1 of Table 2.1, through comparison to quantitative bisulfite pyrosequencing of MEs, 
are known to provide a reliable proxy for methylation status [127]. Altered methylation at 
enhancers, and more broadly, regulatory regions has the potential to impact gene expression 
and long-term health status. Modulation of MEs was consistent with previous nutritional 
studies [79, 127], thus indicating that the periconceptional environment of the early human 
embryo, which includes IVF culture conditions for the IVF and ICSI conceptus, leaves a lasting 





Compared with unassisted pregnancies in the general population, ART pregnancies 
are susceptible to multifetal gestation and adverse pregnancy complications. One must 
therefore consider the clinical characteristics that may impact DNA methylation and blood cell 
populations in neonatal studies. These include gestational age, multifetal pregnancies, 
pregnancy complications, fetal–maternal characteristics, racial characteristics, and 
sociodemographic status, sample characteristics to which this study was blinded. 
Nevertheless, although gestational age ranged from 30 to 40 weeks, approximately 80% 
reached full term; 89.5% were singletons. Accordingly, the majority of each conception group 
was comprised of full-term, singleton pregnancies. 
With current available approaches, the veracity of bloodspot composition estimates 
from newborn bloodspots is unproven [133]. However, methylation at MEs is known to be 
established in the early embryo and remain consistent across diverse tissues ranging from 
blood to hair follicles [79, 127]. Additionally, previous DNA methylation studies suggest that 
although leukocytes are composed of approximately 54% neutrophils, the remaining 
approximately 19 different cell types do not affect the majority of loci examined [134]. In the 
present cohort, leukocyte composition was estimated using the method of Jaffe and Irizarry 
[135], and the resulting blood cell proportion estimates do not significantly influence the 450k 
methylation profiles. Hence, any differences in leukocyte composition do not seem to underlie 
the group differences in ME methylation. 
This work serves as a resource for future studies on IVF populations. It provided the 
first large-scale 450k dataset on cytosine methylation in newborns conceived through three 
different assisted conception procedures: IUI, ICSI–fresh embryo transfer, and ICSI–
cryopreserved embryo transfer, and provided comparison to a naturally conceived cohort. The 
association of methylation changes in these loci with ART-conceived child's clinical 
phenotypes and long-term health can now be investigated. Identification of differentially 





mechanisms may at least partly underlie the observed risks of neurologic and birth defects 
seen in the ART population and assisted births [89, 90]. The reduction in birth defects from 
after cryopreserved embryo transfer [89] is suggested here to have an epigenetic basis, given 
that FZ groups exhibited reduced epigenetic changes. This tenant biologically supports the 








“DEFINING THE SPERM TRANSCRIPTOME: RNA ELEMENT DISCOVERY FROM GERM 
CELL TO BLASTOCYST” 
This chapter was adapted from the following publication: 
Molly S Estill, Russ Hauser, Stephen A Krawetz. “RNA element discovery from germ cell to 
blastocyst”. Nucleic Acids Research. 2018 Dec 21. Cover feature. doi: 10.1093/nar/gky1223. 
i. Summary 
Recent studies have shown that tissue-specific transcriptomes contain multiple types 
of RNAs that are transcribed from intronic and intergenic sequences. The current study 
presents a tool for the discovery of transcribed, unannotated sequence elements from RNA-
seq libraries. This RNA Element (RE) discovery algorithm (REDa) was applied to a spectrum 
of tissues and cells representing germline, embryonic, and somatic tissues and examined as 
a function of differentiation through the first set of cell divisions of human development. This 
highlighted extensive transcription throughout the genome, yielding previously unidentified 
human spermatogenic RNAs. Both exonic and novel X-chromosome REs were subject to 
robust meiotic sex chromosome inactivation, although an extensive de-repression occurred 
in the post-meiotic stages of spermatogenesis. Surprisingly, 2.4% of the 10,395 X 
chromosome exonic REs were present in mature sperm. Transcribed genomic repetitive 
sequences, including simple centromeric repeats, HERVE, and HSAT1, were also shown to 
be associated with RE expression during spermatogenesis. These results suggest that 
pervasive intergenic repetitive sequence expression during human spermatogenesis may play 
a role in regulating chromatin dynamics. Repetitive REs switching repeat classes during 









Expression profiles of known RNAs have been catalogued for a range of cell types, 
with the use of expression arrays and, more recently though RNA deep-sequencing studies. 
This has yielded a series of useful databases including GTEx 
(https://www.gtexportal.org/home/), EMBL-EBI’s Expression Atlas 
(https://www.ebi.ac.uk/gxa/home/), The Human Protein Atlas (https://www.proteinatlas.org/), 
and ENCODE (www.encodeproject.org) [135-140]. These databases and RNA-seq studies 
generally focus on annotated genes and transcript variants that are derived from transcript 
modeling programs such as Cufflinks [141] and are provided as part of the Refseq and 
Gencode annotation [142, 143].  
Both coding and non-coding RNAs play major roles in all cellular processes. In addition 
to protein-coding RNAs, at present, there are 48 different non-coding and pseudogene 
classes of RNA documented in the version 27 annotation of the Human Gencode. 
Approximately 40% of the annotated genes in Gencode correspond to long and short non-
coding RNA genes [144]. Non-coding intergenic regions are known to contain regulatory 
RNAs. These include long intergenic non-protein coding RNA (lincRNA), enhancer RNA 
(eRNA), piwi-interacting RNA (piRNA) and circular RNAs, with others just beginning to be 
described [145-148]. The human transcriptome is likely to be more complex than even these 
annotations indicate, as an estimated three quarters of the human genome is transcribed 
[149]. This would include novel tissue-specific RNAs, whose roles remain to be established 
[150]. 
The palette of RNAs appear enriched in certain specific tissues, with each providing a 
specialized function, e.g., brain - cognitive and functional system level control, and germline 
– stem cell – defining development [151-153]. Their corresponding complexity is exemplified 
in the testis by the collection of unique structural and functional spermatozoal-specific 





shape. This culminates with the compaction of the sperm nucleus to a transcriptionally and 
translationally inert structure. The latter is ensured by fragmenting rRNAs [155], as well as 
others and completes with the expulsion of the majority of the cytoplasm. In addition to the 
paternal genome and sperm encapsulated RNAs [156], RNA/proteins and other molecules 
from distant tissues acquired during epidydimal transit [71, 157] are delivered at fertilization. 
This provides a pathway for soma-to-germline transmission [156, 158, 159] that perhaps 
conveys signals echoing how other tissues have responded to the environment (reviewed in 
[160]).  
Previous literature has shown that unannotated transcripts corresponding to intronic 
and intergenic regions of the spermatogenic genome are comparatively abundant in human 
sperm [154, 161-163]. They vary amongst species and in response to and can provide 
markers of disease [163-165]. These observations drove the development of an algorithm to 
systematically identify the genomic locations of RNAs, defined as RNA elements (RE)., i.e., 
regions transcribed throughout the genome. This unbiased analysis tool is not limited to those 
RNAs currently defined in the databases as it does not seek to generate gene structures from 
REs. It is compatible with a range of Next Generation Sequencing (NGS) platforms, RNAs 
from varied sources, abundance, quality, and levels of fragmentation, i.e., FFPE-like RNAs. 
The RNA Element Discovery algorithm (REDa) approach only requires the BAM file of 
genomic alignments to detect transcribed regions of novel loci in conjunction with well-known 
annotated loci. 
RE discovery was applied from the perspective of the human male germ cell to 
blastocyst paradigm. A series of spermatogenesis and embryogenesis pattern specific 
intergenic human REs were identified, indicating that the transcriptome extends well-beyond 
the annotated genes, including those delivered at fertilization. Tissue-specific REs comprised 
of intronic and intergenic REs were uncovered and, in some cases, exon boundaries 





HSAT1, were shown to be associated with RE expression during spermatogenesis, and may 
play a developmental stage specific role. Similarly, in the human embryo, MER73 was 
associated with RE transcription at the minor wave of zygotic genome activation and MLT2A1 
and SVA-D expressed through the major wave during the transition to the embryonic genome. 
This provided a deeper understanding of the dynamic transcriptome of human sperm, as well 
as uncovering the possible role of specific repetitive sequences in the spermatogenesis. 
iii. Materials And Methods 
RE discovery  
The current study used Gencode release 26 (for GRCh38) and the GRCh38 genome 
for RE discovery, which is detailed in Appendix E. RNA-seq samples used in RE discovery 
are described in Appendix F. Sample reads were pre-processed prior to RE discovery with 
Trimmomatic version 0.36, trimming Illumina adaptors and poly(A+) sequences, where 
appropriate, with parameters “LEADING:3 TRAILING:3 SLIDINGWINDOW:4:15”. Reads 
were aligned to the GRCh38 genome using HISAT2 (version 2.0.6), using the parameters “-
p10 -max-seeds 30 -k 2”. Read coverage was provided to the RE discovery tool in bigwig 
format, generated by converting BAM files to bedgraph format, using the bedtools tool 
genomeCoverageBed, with the parameters “-split –bg”, and subsequently bigwig format, 
using the bedGraphToBigWig program (available from the UCSC Genome Browser utilities). 
The threshold parameter µ for RE discovery was set to 2.5 reads per million, to minimize their 
contribution of background noise. Novel REs from each study were combined using custom 
R commands, which merged overlapping novel REs, re-annotated the merged REs, and 
added the merged REs to the exonic REs, to produce a collective set of REs. The collective 
set of REs for the different samples was subsequently used in all analyses. For comparison 
of RE discovery to established transcript-building software, Cufflinks (v2.2.1) and Stringtie 





166]. Default parameters for both Cufflinks and Stringtie were employed, using Gencode 
release 26 (for GRCh38) as the reference annotation.  
Differential expression (LMEM, fold change, LM) 
A linear mixed-effects model (LMEM) was used to calculate differential expression 
between poly(A+) and total RNA libraries from oocyte through early embryonic development 
[167-169]. The LMEM was used with a random slope and intercept for each cell type, to 
consider heterogeneity across cell types [formula= RPKM ~ RNA.type + (1 + RNA.type | 
Tissue)]. Residuals of randomly selected REs were analyzed for homoscedasticity, ensuring 
that the assumptions of the LMEM were satisfied. Multiple testing correction was applied to 
P-values for resultant slopes, using Benjamini-Hochberg correction [170].  
Differential expression of poly(A+) and total RNA libraries in sperm and testis tissue 
was determined using a fold-change (Fold change= 𝑙𝑜𝑔2 (
𝑚𝑒𝑎𝑛(𝑇𝑜𝑡𝑎𝑙 𝑅𝑁𝐴)
𝑚𝑒𝑎𝑛(𝑝𝑜𝑙𝑦(𝐴+))
)). The use of an 
expression ratio, rather than linear modeling, was necessary due to the technical differences 
between the total RNA sperm samples [163] and the three poly(A+) sperm libraries [171], as 
well as the absence of multiple independent total RNA testis samples [154]. 
RE enrichment for repetitive sequences 
In cases when median RE RPKM in spermatozoa exceeded 1 RPKM (thus removing 
REs with low coverage in most samples), peak RE RPKM was 25 RPKM and subsequently 
used as an expression threshold. REs were first assigned as “Expressed” if the median RPKM 
for the cell/tissue type was greater than 25 RPKM. The enrichment or depletion of repetitive 
sequences in the expressed REs was calculated using UCSC’s Repeatmasker track (for 
GRCh38), a hypergeometric test and custom R code. The proportion of each genomic repeat 
in all available REs was used as input probability, with the number of expressed REs for the 
given cell type used as the sample size. The probability of drawing the actual number of 





[172]. To identify repeats of interest, significantly enriched or depleted repeats were 
additionally filtered to remove repeats with minimal over- or under-enrichment. Thus, only 
repeats whose difference between the expected and observed RE count was greater than 10 
REs were retained.  
Expression clustering 
Expression patterns across spermatogenic cell types were identified using the R 
package Mfuzz [163, 173-175]. Mfuzz is designed for soft clustering of gene expression time-
series data. Soft clustering is a form of clustering where a data point (e.g. transcript) can 
belong to more than one pattern. The samples used in clustering were the Jan et al. 
spermatogenesis libraries [175], as well as a set of 7 ejaculated sperm samples from fertile 
males [163]. It should be noted that these 7 samples are a subset of the 52 “Control” sperm 
samples used for expression comparisons in Chapter 4. The median expression value for the 
7 mature sperm samples was used to represent the mature sperm samples as a single value. 
The RE dataset was then composed of a single library for Adark SSCs, Apale SSCs, 
Leptotyne/Zygotene, Early Pachytene, Late Pachytene, and Round spermatids, while the 
library for ejaculated sperm was the median expression value for 7 fertile males. In a step 
intended to remove universally lowly expressed REs, REs were processed to remove those 
which did not exceed 25 RPKM in at least one sample. Mfuzz clustering was performed, 
generating 20 cluster patterns, with a minimal membership of 0.7 required for inclusion of an 
RE in a pattern.  
Paternal/maternal transmission 
REs were assigned as maternally transmitted to the zygote with median zygotic level 
˃ 10 RPKM, sperm < 2 RPKM, and oocyte > 25 RPKM. REs were assigned as paternally 
transmitted with moderate confidence with median zygotic level > 10 RPKM, sperm > 25 
RPKM, and oocyte < 5 RPKM. REs were assigned as paternally transmitted with greatest 





FDR calculation for GTEx and PPV calculation for sperm 
The accuracy of the RE discovery algorithm to identify expressed loci was calculated 
using the Jodar et al. dataset, which consisted of 7 fertile human sperm samples, prepared 
using total RNA [163]. RE discovery was performed on the 7 samples, at a range of µ from 1 
to 10 RPM, at increments of 0.5 RPM. The RPKM of the resulting novel REs for each sample 
was calculated, along with the median RPKM across the 7 samples. Experimental thresholds 
for calling a RE as “expressed” ranged from 1 to 200 RPKM, at increments of 1 RPKM. At 
each expression threshold, the number of REs with a median RPKM at or exceeding the 
threshold were recorded. The Positive Predictive Value (PPV) at each expression threshold 
and µ was calculated as  
𝑃𝑃𝑉 =
𝑁𝑜𝑣𝑒𝑙 𝑅𝐸𝑠 > 𝐸𝑥𝑝𝑟𝑒𝑠𝑠𝑖𝑜𝑛 𝑡ℎ𝑟𝑒𝑠ℎ𝑜𝑙𝑑
𝑁𝑜𝑣𝑒𝑙 𝑅𝐸𝑠 > 𝐸𝑥𝑝𝑟𝑒𝑠𝑠𝑖𝑜𝑛 𝑡ℎ𝑟𝑒𝑠ℎ𝑜𝑙𝑑 + 𝑁𝑜𝑣𝑒𝑙 𝑅𝐸𝑠 ≤ 𝐸𝑥𝑝𝑟𝑒𝑠𝑠𝑖𝑜𝑛 𝑇ℎ𝑟𝑒𝑠ℎ𝑜𝑙𝑑
 
The ability of the RE approach to recapitulate tissue expression in the established 
databases was determined using the testis expression in the GTEx database [138]. The 
median TPM for all GTEx testis samples was downloaded and was processed to replace 
duplicated common gene names with the mean TPM for all instances of the gene name. Only 
gene names found in both GTEx and exonic REs were used in subsequent intersect analysis. 
The unique gene names with expression exceeding 5 TPM were compared to those of the 
exonic REs exceeding 25 RPKM. 
Gene ontology 
Ontological analysis was performed with the Genomatix software suite 
(https://www.genomatix.de/), version 3.10. The GeneRanker function (using Genomatix 








iv. Results and Discussion 
RE identification and classification 
The RE discovery algorithm was designed to detect expressed regions of the genome 
using RNA-seq, regardless of the sequencing platform or read structure. A detailed 
description of RE discovery is presented in Appendix E, and the corresponding code is 
provided online (https://github.com/mestill7/RE_discovery). Briefly, the known gene 
annotation (e.g., RefSeq, Ensembl, Gencode) for the genome of interest is parsed into 
individual exon locations. In the current study, Gencode release 26 (GRCh38) was used, with 
non-coding entries considered as annotated “exons” [144]. As summarized in Figure 3.1A, 
RE discovery first requires the sequenced reads to be processed, e.g., adaptors trimmed and 
low-quality bases removed, prior to alignment to the genome of interest. For the unannotated 
regions of the genome, the mean read coverage was calculated for each 10 bp genomic 
segment and the 10 bp segments with sufficient read coverage, determined by a threshold µ, 
retained. For the purposes of this study, µ = 2.5 reads per million provided well-balanced 
signal to noise ratio (Figure 3.2) that was suited for RNA libraries generated from low-input, 
potentially fragmented RNAs, as is often found in clinical Formalin-Fixed Paraffin-Embedded 
(FFPE) samples and spermatozoa [154, 176]. The overlapping 10 bp regions were 
subsequently merged to yield the final novel REs for each collection of samples studied. The 
merging steps allow for a maximum of 150 bp between element bins, intended to allow for 





 Figure 3.1. Pre-processing for RE 
discovery. (A) RNA-seq reads, in fastq 
format are processed to remove low-
quality bases and adaptor sequences. 
The trimmed reads are then aligned to 
the genome, and the duplicate 
alignments removed. Read coverage is 
then used to identify 10 bp segments with 
read coverage surpassing μ. The 
expressed 10 bp segments (shown in 
blue) are merged and annotated 
according to their adjacency to exons 
(shown in red). (B) RE discovery 
workflow for four theoretical RNA-seq 
samples. Each sample has a different 
library size, and correspondingly, 
different read coverage thresholds at a μ 
of 2.5 Reads per million (RPM). Non-
exonic regions of read coverage 
surpassing the assigned threshold are deemed “Novel REs”. Merging novel REs from the four 
different samples, yields two novel REs, one from Sample 1 (S1) and one from Sample 3 (S3) 
that are separated by up to 150 bp. Novel REs of the different samples S1 and S3 are merged 
into a final RNA element, represented in purple. Exonic REs are excluded from this merging 
step. The final novel RE set for the four samples is then annotated as intronic, near-exon, 
purple, (<10kb from exon), and orphan REs (>10kb from exon). 
 
 
 Figure 3.2. Background noise for read coverage thresholds. X-axis represents the 
experimental threshold for calling a RE as “true positive (TP)”. The corresponding Positive 
Predictive Value (PPV) is calculated as (TP/(TP+FP)). The PPV curve is provided for levels 
of μ from 1 RPM to 10 RPM. The X-axis represents the expression threshold required for 
assigning a RE as expressed, and ranges from 1 to 200 RPKM. A PPV of 0.95 (corresponding 






Novel REs were then annotated according to their genomic position, relative to known 
exons (Figure 3.1B). “intronic” REs were located within introns, while any non-intronic REs 
located within 10 kb of an annotated exon were designated “near-exon” REs; “orphan” REs 
were at a distance greater than 10 kb from any known exon. An exonic RE was extended into 
a near-exon RE if they were within 50 bp and the difference in read coverage was < 50%. As 
summarized in Figure 3.3, previously published RNA-seq studies representative of human 
spermatogenesis, mature sperm, oocyte, embryonic stages, and liver samples, detailed in 
Appendix F, were subject to RE discovery. This set of RNA-seq libraries encompassed both 
poly(A+) selected and total RNA preparations. A database of REs across the different tissue 
and types was created by merging the novel REs from each study with the exonic and non-
coding transcript REs and used in all subsequent analyses.  
A specific set of RE discovery parameters (µ = 2.5 reads per million and minimum 
required distances between genomic bins), were used to provide an acceptable signal to noise 
ratio in the sperm RNA libraries. Due to the exploratory nature of this study, maximizing the 
number of REs, while still excluding spurious signals, was of particular interest. Modification 
of the parameters used in the REDa method will allow increased detection stringency (thus 
reducing the number of REs detected) or more permissive RE detection (thus increasing the 
number of REs detected). Increased stringency during RE detection can easily be achieved 
by increasing the required µ (thus increasing the threshold required to mark genomic bins as 
“expressed”) or by increasing the minimum proportion of samples with the required minimum 
read coverage to retain a genomic bin for RE designation.  
The accuracy of the RE approach, which separates exons into individual units, rather 
than linking exons into a whole transcript, was tested by comparing expressed REs in testis 
libraries to the testis expression levels given by GTEx. At least 91% of gene names associated 





suggesting that the RE approach can recapitulate the patterns designated in established 
expression databases.  
 
Figure 3.3. Tissue types used for RE discovery. The male germline within the testis tissue 
is divided into and represented by seven stages of spermatogenesis. The female germline is 
represented by a single-cell oocyte with embryonic stages that range from zygote to 
blastocyst. Somatic tissue is represented by the liver sample. Total RNA or poly(A+) enriched 
RNA-seq libraries are indicated in split squares, with blue representing poly(A+) selected 
samples, red indicating total RNA samples, and a split blue/red square as both library 
preparations. 
 
The above RE identification method was developed to ensure accuracy in face of 
extensive RNA fragmentation, naturally occurring in human sperm. Certain tissue 
preparations, such as FFPE, also yield compromised RNA preparations. Given that several 
established transcript-building algorithms are readily available, I compared both Stringtie 
(v1.3.4) and Cufflinks (v2.2.1) to the RE approach for two random sperm samples and two 
male human cell lines. RNA-seq datasets from human cell lines, i.e., SRR020288 (h1 hESC) 
and SRR3192556 (OCI-LY7, derived from a B cell lymphoma), provided independent datasets 
when testing the RE method. Using minimal thresholds of expression (>10 RPKM in REs, >1 
FPKM in Cufflinks and Stringtie), the majority of expressed REs overlap locations of 





“expressed” REs overlap Stringtie results, and 81%-90% overlap Cufflinks results at the above 
thresholds of expression. Notably, regardless of the transcript-building method and required 
expression thresholds, a majority of REs (complete range 21%-93%) lacking overlaps with 
Cufflinks and Stringtie results are exonic REs, suggesting that the established transcript-
building methods are less than ideal for fragmented or unevenly covered transcripts. 
Additionally, the presence of spliced reads, a critical component to transcript-building, is 
reduced in spermatozoal RNAs (36% - 40%) compared to RNAs from cell lines (41%-64%). 
Other investigators have also employed a targeted Cufflinks [168] discovery approach to 
identify novel linear embryo transcripts. Reflective of the low level of expression and rigor 
required for identification, the majority of these linear transcripts were not discovered using 
the RE strategy (data not shown). 
With the function of the novel REs being unknown, I hypothesized that the novel REs 
may have regulatory roles. To assess this, REs were overlapped with a series of epigenetic 
marks and regulatory genomic sequences (Figure 3.4). For regulatory chromatin marks 
(proximity to DNase hypersensitive regions, proximity to CTCF binding sites, proximity to 
Topologically Associating Domains (TADs), and proximity to ENCODE Transcription Factor 
Binding Sites (TFBS)) [177-182], the novel RE classes largely showed a similar overlap 
proportion as exonic REs. All RE classes showed very little overlap with piRNA clusters [183, 
184]. TADs mark the physical interaction of genomic regions and the minimal overlap of all 
RE classes with TAD boundaries suggests that novel REs are not primarily involved in 
establishing TADs. However, it is important to note that the compilation of REs are detected 
in at least one of a variety of tissues (across spermatogenesis, embryogenesis, and somatic 
tissue). Therefore, the overlaps summarized in Figure 3.4 do not preclude a tissue-specific 
relationship of REs with a given epigenetic mark, such as TADs. Notably, all classes of novel 
REs had a high overlap (>50%) with repetitive sequences (UCSC’s Repeatmasker track (for 






Figure 3.4. Overlap of REs with epigenetic marks and regulatory genomic sequences. 
The proportion of each RE class classified as overlapping a given epigenetic mark or genomic 
sequence is indicated on the Y-axis, with the type of epigenetic mark or genomic sequence 
indicated on the X-axis. The type of RE class is indicated with exonic REs in black, near-exon 
REs in light blue, intronic REs in green, and orphan REs in yellow. “DNase” indicates overlaps 
within DNase I Hypersensitivity Peak Clusters from ENCODE (95 cell types) or 5 kb of a 
cluster. “CTCF” indicates overlaps within CTCF binding sites in the GM12878 cell line 
(determined from ChIP-seq) or 5 kb of a binding site. “TAD” indicates overlaps within 5 kb of 
a topologically associating domain (TAD) ending site. “ENCODE TFBS” indicates overlaps 
with Transcription Factor Binding Sites (TFBS) from Encode (ENCODE Mar 2012 Freeze). 
“piRNA Cluster” indicates overlaps with piRNAs in the human genome. “Repetitive 
sequences” indicates overlaps with UCSC’s Repeatmasker track (last updated 2014-01-10). 
 
RNA-seq complexity of RNA elements 
The RE discovery algorithm was developed to identify transcribed intergenic loci from 
RNA-seq data. Many novel loci (e.g., near-exon and orphan REs) were hypothesized to be 
derived from non-polyadenylated RNAs, since this class appears underrepresented in the 
genome and the GENCODE annotations. A series of poly(A+) selected and Total RNAs from 
a range of cell types that capture fertilization to early embryonic development from oocyte, 
zygote, 2-cell embryo, 4-cell embryo, 8-cell embryo, and morula (Figure 3.3) and the male 
germline, through ejaculated sperm and testis, were examined [167-169]. Applying a linear 
mixed-effects model (LMEM) to Total and poly(A+)-selected RNAs from the human oocyte and 
various stages of early embryonic development, revealed a comparatively lower number of 
REs detected within the poly(A+) selected fraction (Figure 3.5). In general, the number of 





differ (Figure 3.5B). Interestingly, the number of orphan REs approximately doubled upon 
poly(A+)-enrichment as compared to the Total RNA fractionation. This suggests that a 
population of orphan REs belong to a larger, yet unknown set of polyadenylated transcripts. 
To determine if poly(A+) enrichment of orphan REs reflected a genomic repeat, the distribution 
of repeats within the 150 poly(A+) enriched orphan REs was assessed and is shown in Figure 
3.5C. Within the 129 orphan REs that contain a repetitive element, the majority were LTRs 
and SINEs. It is worth noting that 40 of the 55 LTR-containing REs were ERVL-MaLRs. This 
is a non-autonomous LTR-retrotransposon element derived from ERV [186, 187] that may 
function in regulating gene expression during the oocyte-to-embryo transition [188]. 
 
Figure 3.5. Orphan REs are enriched in poly(A+) samples. (A) Volcano plot of slope 
changes in REs from LMEM in oocyte and embryo, with the X-axis representing slope change 
in log10-transformed RPKM, and the Y-axis representing the Benjamini-Hochberg-adjusted 
P-value as a negative log10-transformed P-value. Positive slope and negative slope indicate 
increased abundance in total RNA and poly(A+) preparations, respectively. Each point 
represents a single RE, with blue points indicating statistically significant REs (adjusted P-
value <0.05) with absolute slope changes exceeding 25 RPKM. (B) Distribution of REs 
enriched in either total RNA or poly(A+) libraries, according to the annotation class. (C) The 
distribution of orphan REs enriched in either total RNA or poly(A+) libraries, according to 
repeat class.  
 
The effect of poly(A+) enrichment was also assessed individually for human sperm and 
testis samples, providing the other half of the equation to early post-fertilization development. 
Poly(A+) enrichment has contrasting effects on exonic REs in spermatozoa and testis, with 





However, unlike embryos, novel REs were markedly enriched in sperm and testis total RNA 
libraries, reflective of the relatively uncharacterized state of this cell type (Figure 3.6). 
Although poly(A+) enrichment does effectively reduce RNA library complexity, it does not 
appear to select for RNAs of any given biological function or pathway, with many GO terms 
shared in both the poly(A+)-enriched and Total RNA-enriched gene sets of the human embryo. 
This reiterates previous studies that indicate a reduction of transcript diversity and exon 
expression upon poly(A+) enrichment [189]. 
The number of human zygotic LTR and SINE-associated REs that may be derived 
from poly(A+) intergenic transcripts is of note. In accord with the data of others [190-193], this 
could afford transcript stabilization and nuclear export [194] perhaps increasing their retention 
in a given cell of the dividing embryo. Notably, at least in mouse, the transcription of 
retrotransposon-derived RNAs is thought to impact chromatin accessibility, and thus 





Figure 3.6. Total RNA libraries are 
enriched for Novel REs in sperm 
and testes. (A) Histogram of fold 
changes (log2 transformed) are shown 
for (A) mature sperm and (B) testes 
samples. The X-axis indicates the 
Log2 of the Total RNA/polyA+ ratio, 
with positive change and negative 
change representing enrichment in 
total RNA and poly(A+) libraries, 
respectively. Note the novel REs all 
exhibit a shift to the right, indicating 













RNA element expression across spermatogenesis 
RE expression throughout spermatogenesis was examined as a comparison to 
previously published patterns of whole transcript expression during the spermatogenic 
cycle[175]. The spermatogenic stages encompassed 6 cell types (Spermatogenic Stem Cells 
(SSCs) through Round Spermatids), isolated using laser capture microdissection [175]. 
Clustering of the various REs expression patterns across spermatogenesis was initially 
performed using Mfuzz, [173, 174] with the published 6 cell types [175]. RE expression across 
spermatogenesis recapitulated those patterns previously observed using whole transcripts. 
To extend the analysis to the final stage of spermiogenesis, RNA-seq from ejaculated sperm 
datasets from fertile males [163] were included (Figure 3.3). The addition of mature sperm 
enabled the discovery of several patterns specific to early round spermatids and maturing 
round spermatids, as observed through mature spermatozoa (Figure 3.7A-D). The final 
stages of spermatogenesis involve a burst of transcription, as well as the formation (and 
eventual loss) of the residual body as the majority of the cytoplasm is expunged from the cell. 
The burst of transcription in round spermatids was observed as a general increase in 
transcription of exonic REs that include 34,226 REs found in round spermatids but not in the 
late pachytene stage spermatocytes. Interestingly, a large portion of spermatid and/or mature 
sperm-specific clusters were generated from novel REs, suggesting that intergenic and 
intronic REs play a substantial role in the final stages of spermatogenesis that forms each 
spermatozoon as summarized in Table 3.1. To verify these observations, expressed (median 
expression >25 RPKM) REs for each spermatogenic stage were partitioned according to RE 
class (Figure 3.7E). The vast majority of REs expressed in pre-meiotic and meiotic stages 
were exonic (85%±7%). This was followed by a notable increase in the number of novel REs 
in Round Spermatids and Spermatozoa. The contribution of novel REs to the total 






Figure 3.7. Mfuzz clusters highlighting the round spermatid to spermatozoon transition. 
(A-D) Clusters with increased expression in round spermatids and/or mature spermatozoa. 
(E) RNA element abundance as a function of annotation class and cell type with median 
RPKM >25.  
 
Table 3.1. RE class distribution of Mfuzz clusters. The “Pattern” column indicates the 
expression pattern across spermatogenesis. The count of exonic REs, near-exon REs, 
intronic REs, and orphan REs belonging to the given pattern are indicated in columns “EXON”, 
“NOVEL_10KB_EXON”, “NOVEL_INTRONIC”, and “NOVEL_ORPHAN”, respectively.  
 
PATTERN EXON NOVEL_10KB_EXON NOVEL_INTRONIC NOVEL_ORPHAN 
High Round spermatids 
and Spermatozoa 
1992 513 1333 286 
High Round spermatids 5502 1325 5019 1453 
High Spermatozoa 5012 4157 11874 4458 
High 
Leptotene/Zygotene 
and Round spermatids 
1607 59 167 27 
High 
Leptotene/Zygotene 
3403 345 1727 333 
High Adark and Apale 618 3 11 2 
High Adark 1198 23 105 18 
High Adark, Apale and 
Late Pachytene 
513 29 32 11 
High Apale 996 16 64 10 
High 
Leptotene/Zygotene, 
Low Round spermatids 
& Spermatozoa 
519 28 33 12 
 
Ontological analysis of the exonic and novel REs (with the exception of orphan REs) 
showed that the most abundant REs in round spermatids were enriched for genes involved in 





occurring during spermiogenesis. REs that are abundant in both round spermatids and 
spermatozoa were enriched for TNF-alpha signaling, associated with maintaining a 
homeostatic state [196, 197]. The TNF-alpha signaling-associated REs enriched throughout 
the post-meiotic phase of spermatogenesis may be another part of a surveillance mechanism 
to ensure an optimal contribution [165]. REs that were primarily abundant in spermatozoa 
were associated with a range of signaling pathways, such as Glutamate Receptor signaling, 
WNT signaling, NGF signaling, EGFR1, and Signaling by Rho GTPases. WNT signaling has 
several roles in spermatogenesis, from maintenance to maturation, and thus motility [198-
200]. The role of NGF signaling in spermatogenesis in humans is unclear but has been 
implicated in mammalian Sertoli-germ cell signaling, sperm motility, and the acrosome 
reaction [201, 202]. Sperm EGFR activation is a major driver of sperm capacitation [203, 204], 
while Rho GTPases are likely to aid as mediators of the acrosome reaction [205]. Odorant 
receptors may be required for sperm chemotaxis in mammals [171], while glutamate receptors 
may also be involved in capacitation and/or sperm chemotaxis [206, 207] although such 
functions have yet to be demonstrated in mammalian systems. 
Sex-chromosome expression during spermatogenesis 
Meiotic sex chromosome inactivation (MSCI), the process by which genes located on 
the X-chromosome are repressed during meiosis, is essential for successful meiosis during 
human spermatogenesis [208]. However, abundant evidence suggests that numerous X-
linked genes escape post-meiotic X chromosome silencing (PMCI), a process that may be 
less effective in humans than other species [209, 210]. In comparison, most classes of Y-
linked REs undergo silencing during MSCI, with the exception of Y-linked orphan REs that 
are present throughout spermatogenesis.  
As shown in Figure 3.8, repression of exonic X-linked REs during spermatogenic 
MSCI is evident. This is followed by de-repression of X-linked exonic and novel REs, that 





were intensely expressed (at a threshold of 25 RPKM) in solely one spermatogenic stage, 
including the post-meiotic stages, i.e., round spermatids and to a greater extent, mature sperm 
(Figure 3.8B). Overall, the patterns of X-linked REs across spermatogenesis imply a larger 
upregulation of genes and novel REs in the post-meiotic stages than previously thought, with 
the number of expressed X-linked REs largely following the patterns laid by autosomes. Of 
the 289 paternally transmitted REs, two were located on the X-chromosome, and both were 
exonic REs. The two REs are located (in hg38 coordinates) at chrX_2717605_2717652 and 
chrX_149929645_149930127, corresponding to CD99 and XX-FW81066F1.2, respectively. 
The spermatogenic roles of CD99, a cell surface glycoprotein involved in T-cell adhesion 
processes, and XX-FW81066F1.2, a poorly described transcript with a putative protein 
structure or antisense lncRNA function [135], are unknown. Although few paternally derived 
zygotic RNAs are X-linked, the expression patterns of REs located on the X chromosome 
were largely congruent with the current paradigm of Meiotic sex chromosome inactivation 
(MSCI) and reactivation during spermatogenesis [210]. However, the data also suggest that 
the process of post-meiotic X chromosome silencing (PMCI) during human spermatogenesis 





Figure 3.8. X-chromosome expression during spermatogenesis. (A) The number of 
expressed REs across each spermatogenic stage, for two representative autosomes (upper 
panels chr1 and chr2) and the sex chromosomes (lower panels chrX and chrY). The 
connected points are colored according to the RE class, with exonic REs in orange, intronic 
REs in green, near-exon REs in light blue, and orphan REs in purple. The X-axis of each 
graph presents the spermatogenic stage, with the pre-meiotic stages represented by Adark and 
Apale, the meiotic stages represented by Leptotene/Zygotene, and early/late Pachytene, and 
the post-meiotic stages represented by round and mature sperm. (B) An expression heatmap 
of X-chromosome REs that are primarily expressed (>25 RPKM) at one spermatogenic stage. 
RE class, shown adjacent to the RE expression column, shows exonic REs in black, intronic 
REs in green, near-exon REs in light blue, and orphan REs in yellow. 
 
Paternal transmission of REs to the human embryo 
It has been proposed and shown in vitro that human sperm deliver a cadre of RNAs 
upon fertilization [154, 160, 211, 212]. In the current study, the series of human RNA-seq 
profiles from sperm, oocyte, and embryo allowed for the identification of REs that are 
transmitted to the human oocyte solely by sperm. These are in addition to those 26,740 
zygotic REs (5% FDR), associated with a total of 6,118 individual named genes, which are 
essentially provided by the oocyte, but not present in sperm (Figure 3.9). Up to 289 sperm 
REs were identified as a majority contributed by paternal transmittance, with an FDR of ~3.4%, 





Interestingly, the 289 REs were enriched for “cycling of RAN in nucleocytoplasmic transport” 
(p=8.36 x 10-8) and the Unc 51 Like Kinase (p=1.47 x 10-3). RAN cycling is required for 
effective translocation of RNA and proteins across the nuclear pore. The human sperm REs 
contain RANGAP1, XPO7, XPO6, NUP210, and NUP214, as members of the nucleoporin 
complex. Interestingly others have shown that at least in embryonic stem cells, the 
nucleoporin complex may regulate parentally imprinted genes [213]. In comparison, the Unc 
51 Like kinase is associated with autophagy a process that is essential for the oocyte-to-
embryo transition [214]. These observations are consistent with the view that the paternal 
RNAs may contribute to re-establishing nuclear transport in the zygote and clearance of 
extraneous cellular complexes post-fertilization, when cell lineages begin to be established.  
Compared to the oocyte’s maternal contribution, relatively few paternal full-length RNAs are 
likely to be exclusively contributed to the embryo [156]. Of note, the genes associated with 
the paternally transmitted REs did not overlap those long RNAs suggested to be paternally 
derived in mouse [215]. This is likely due to the differences in genome activation, which occurs 
in the late 1- cell zygote in mouse [216], compared to the later 4-8 cell stage of human 








Figure 3.9. Expression heatmap of 
maternally derived REs. The overall 
expression level is represented in “RE 
expression”, with red indicating a median 
expression exceeding 25 RPKM. RE class, 
shown adjacent to the RE expression 
column, shows exonic REs in black, intronic 
REs in green, near-exon REs in light blue, 
and orphan REs in yellow. The REs 
presented are supplied by the oocyte to the 
zygote (Sperm < 2 RPKM; Oocyte > 25 






Figure 3.10. Expression heatmap of paternally derived REs. The overall expression level 
is represented in “RE expression”, with red indicating a median expression exceeding 25 
RPKM. RE class, shown adjacent to the RE expression column, shows exonic REs in black, 
intronic REs in green, near-exon REs in light blue, and orphan REs in yellow. The REs 
presented are supplied by the sperm to the zygote, with strong sperm preference (A) Sperm 
> 25 RPKM; Oocyte < 2 RPKM; Zygote > 10 RPKM and moderate sperm preference (B) 






Differential gene expression during embryogenesis 
Transcriptomic changes across mammalian embryogenesis have been well-studied, 
using both microarrays and RNA-seq [218-222]. However, these experiments have not 
addressed the contribution of intergenic RNAs to embryogenesis and, importantly, during 
human embryogenesis. Towards filling this gap, examination of expression changes of novel 
REs from oocyte to blastocyst, while considering the contribution of the spermatozoon, tested 
the hypothesis that both exonic and novel REs would exhibit distinct patterns. 
To identify differentially expressed REs, a linear model was applied to the single-cell 
oocyte and embryonic RNA-seq datasets [168, 223]. Differential expression with REs 
reiterated previous analysis of RefSeq-annotated genes suggested that the oocyte, zygote, 
and 2-cell embryo contain a similar distribution of transcripts [168]. Few differences (59 REs) 
were identified between oocyte and zygote, and no differential REs were identified between 
zygote and 2-cell embryo (Figure 3.11). As expected, exonic REs exhibited characteristics of 
maternal genes, which are supplied by the oocyte and diluted as the embryo develops in 
anticipation of the 4 & 8-cell stage extensive Embryonic Genome Activation (Figure 3.12) 
[224]. This included a set of novel maternal REs specific to the early zygote (maternal genes) 
and EGA (the 4 & 8-cell stage). The majority of these novel maternal REs were intronic, 
suggesting e.g., (1) incomplete processing, (2) expression within an intron, (3) retention of 
circular RNA, or some other form. They were supplemented by a series of maternal intergenic 
orphan REs. Interestingly, novel REs also followed similar patterns, defining clusters of REs 
that are present during the minor first wave of human ZGA, as well as clusters that are active 
during EGA (Figure 3.13). While the novel REs with a maternal gene pattern are enriched for 
neuronal genes (Neuronal system, p=2.12e-05), those expressed during EGA are associated 







Figure 3.11. Differential RE expression across early embryonic development. The count 
of differential up- and down-regulated REs as embryogenesis proceeds is shown below the 
diagrams of cell types. The annotation classes of the total differential REs are summarized in 
the bottom table. 
 
 
Figure 3.12. Expression heatmap of differentially expressed exonic REs across early 
embryogenesis. The overall expression level is represented in “RE expression”, with red 
indicating a median expression exceeding 25 RPKM. RE class, shown adjacent to the RE 
expression column, shows exonic REs in black. The REs presented are differentially 






Figure 3.13. Differential novel REs across embryogenesis. The overall expression level is 
represented as left panel “RE expression”, with red indicating a median expression exceeding 
25 RPKM. RE class, shown adjacent to the RE expression column, shows intronic REs in 
green, near-exon REs in light blue, and orphan REs in yellow. The REs presented from oocyte 
to blastocyst are differentially expressed across at least one developmental stage.  
 
Expression of genomic repeats across spermatogenesis and embryogenesis 
Genomic repetitive elements and small non-coding RNAs are thought to play a role in 
confrontation-consolidation of the maternal and paternal genomes after fertilization [162, 225]. 
As novel REs tend to overlap genomic repetitive sequences, I examined RE expression to 
determine what genomic repeats may influence RNA expression throughout spermatogenesis 
and early human embryo development (Figure 3.14). The relative enrichment or depletion of 
repetitive sequences in the expressed REs was calculated for each available cell type. Briefly, 
the number of instances of genomic repeats overlapping expressed REs in each cell type 
were compared to an expected random distribution, with the random distribution drawn from 





enrichment and depletion of repeat families were calculated across cell types. Despite the 
many instances of repeat depletion, there were relatively few instances of enrichment.  
Figure 3.14. Expression of repetitive sequences across spermatogenesis and 
embryogenesis. Moderate enrichment (mean RE expression > mean expression across all 
cell types) is shown in pink, and strong enrichment (mean RE expression is an upper outlier) 
is shown in red. The name of the genomic repeat is given on the left of the diagram, and the 
cell type is shown at the top of the diagram. 
 
Although several studies have examined the influence of environment on epigenetic 
marks, such as DNA methylation, at genomic repeats in spermatozoa, much less is known 
about genomic repeat expression during spermatogenesis and if genomic repeats are in part 
driving spermatogenesis, perhaps through transcriptional regulation or chromosomal 
reorganization [226, 227]. Four repeat families, LTR71B, HERVE-int, HSAT1, and MER1A 
were primarily expressed in both round spermatids and mature spermatozoa, while the 
centromeric repeat AATGG(n) showed greatest expression in the leptotyne/zygotene and late 
pachytene stages through the post-meiotic phase [228]. The simple repeat AAGA(n) was 





during spermatogenesis suggest that different repeats have different roles in 
spermatogenesis. For example, the centromeric repeat AATGG(n) likely plays a role in 
establishing stage specific chromosomal structure and position throughout spermatogenesis 
[229, 230]. The simple repeat AAGA(n) and HSAT1, primate-specific Satellite repetitive 
element, may also play a role in organizing sperm nuclear structure through Matrix-Associated 
Regions (MARs) of sperm, which are enriched in TTCT(n) and TCTT(n) repeats [230]. The 
remaining spermatogenesis-associated repeats LTR71B, HERVE, MER1A are all members 
of the HERV family of retroviruses or DNA transposons. The murine embryo and sperm are 
known to express a LINE-1-encoded Reverse Transcriptase (RT) that may serve to reverse 
transcribe the sperm-supplied retroviral and transposon RNAs for integration into the genome 
[44, 231, 232]. Insertion by retrotransposition might then act to provide regulatory networks, 
or genetically/epigenetically modify the developing embryo [44, 231] during syngamy. 
However, the presence of LINE-1-encoded RT in mature murine spermatozoon does not 
appear to extend to an enrichment of LINE1 RNAs in human sperm or zygote. This likely 
reflects a species differences, although one cannot exclude the influence of differing 
methodologies. However, MLT2A1 and SVA-D were both present during EGA, while MER73 
was strongly enriched in oocyte and the early embryo (Figure 3.14). Both MLT2A1 (primate-
specific) and MER73 are LTRs for ERVL endogenous retrovirus, while SVA-D is a hominid-
specific composite retroelement (SINE-R + VNTR + Alu) [187]. Although SVA-D is a marker 
of naive human ESCs, consistent with the enrichment from 4 cell to morula stage, it is not 
enriched in blastocyst stage, from which human ESC cell lines are derived [233]. The ERVL 
retrotransposon has been previously implicated in mammalian embryonic development [188]. 
Notably, the presence of an RT in the early embryo would provide the opportunity for LTR71B, 






 Overall, the above data suggest that the mechanism(s) driving spermatogenesis may 
involve the use of repetitive sequences as regulators of transcription and/or chromatin states 
[195, 235, 236]. Its nuclear architecture reflects the complex and orchestrated compaction 
and restructuring of its chromatin via protamination. This is linked through the nuclear 
matrix/lamina in a non-random manner [237], consistent with the current 3D models [238]. 
The enrichment of centromeric AATGG(n) repeat RNAs appears in the leptotyne/zygotene 
and late pachytene stages through the post-meiotic phase [228]. This repeat can form a 
double folded hairpin [228], that in mice can promote RNA:DNA hybrids mediating 
heterochromatin formation [239]. Perhaps this aids in excluding large repetitive DNA domains 
from homology searching enhancing the fidelity of meiosis as observed by the clustering of 
pericentromeric chromatin during meiosis [240]. 
In summary, this work introduced a RE discovery algorithm (REDa) that identifies 
tissue and cell type specific expression in both exonic and intergenic REs. Expression patterns 
of REs were identified across human spermatogenesis, extending the current knowledge of 
the transcriptome in developing human sperm. In addition to observing considerable effects 
of poly(A+) enrichment, the sheer abundance of intergenic RNAs suggests that they play a 
large role in spermiogenesis. Of note, extensive expression of repetitive elements during 
spermatogenesis, suggests that perhaps these are driving spermatogenesis, while sperm-







“THE EFFECTS OF DI-BUTYL PHTHALATE EXPOSURE FROM MEDICATIONS ON 
HUMAN SPERM RNA” 
This chapter was adapted from the following publication: 
Molly Estill, Russ Hauser, Feiby L. Nassan, Alan Moss, and Stephen A. Krawetz. “The effects 
of high exposure to di-butyl phthalate from medications on human sperm RNA among men”, 
In review with Scientific Reports. 
i. Summary 
Endocrine disruptors, chemicals that perturb hormonal function, are suspected of 
affecting reproductive function. Low-dose exposures to endocrine disruptors such as 
phthalates, widely used as plasticizers, is widespread. Patients with Inflammatory Bowel 
Disease (IBD) are often prescribed mesalamine, that in some forms is encapsulated within a 
di-butyl phthalate (DBP)-containing coating. The Mesalamine and Reproductive Health Study 
(MARS) was designed to address the physiological effect of in vivo phthalate exposure on 
male reproduction. As part of this effort, sperm RNA profiles among men with IBD and their 
relationship to DBP was longitudinally assessed across binary (high or background) DBP 
crossover exposures. As the level of DBP was altered as +/- DBP (H, high vs B, background), 
numerous changes in the composition of sperm RNA elements were detected. This was 
observed when the acute and recovery phases were compared, suggesting that, exposure to, 
or removal from high DBP, produces effects that require longer than one spermatogenic cycle 
to resolve, if at all. While the two study arms exhibit enrichment of different biological 
pathways, the arm which initiates the study on high-DBP mesalamine displayed activation of 
oxidative stress and DNA damage response pathways. However, DBP exposure has a 
minimal effect on small RNAs. Small RNAs were negatively correlated with specific genomic 





both the influence of phthalate on the male germline, as a dynamic function of RNA during 
human spermiogenesis. 
ii. Introduction 
Endocrine disruptors, exogenous chemicals that can mimic or alter hormonal 
responses, are a prevalent feature in urban environments. A heterogeneous collection of 
natural and synthetic chemicals have been identified as likely EDs, including several well-
publicized pesticides, such as dichlorodiphenyltrichloroethane (DDT), and plastic 
components, such as bisphenol A (BPA) and phthalate esters [55]. Phthalates, suspected 
endocrine disruptors, are commonly used as solvents and plasticizers in consumer products, 
such as polyvinyl chloride. They are also incorporated into coatings used in medications [56, 
57]. Phthalates have been noted to act on peroxisome proliferator‐activated receptors (PPAR) 
[58, 59]. Additionally, different phthalate species, including phthalate metabolites, have 
different capacities for modifying an endocrine response [58-60]. Although considerable 
literature suggests that gestational and neo-natal phthalate exposure is detrimental to 
reproductive function [61], the health effects of phthalates at environmentally relevant doses 
in adult humans is uncertain, particularly in the adult male. 
To directly address the effect of physiological, in vivo phthalate exposure on male 
reproduction, the Mesalamine and Reproductive Health Study (MARS) (NCT01331551), 
designed as a clinical trial (https://clinicaltrials.gov/ct2/show/NCT01331551), was initiated. 
The MARS study, implemented from 2010-2018, was designed to assess semen quality and 
hormone levels in human males with longitudinally alternating DBP exposures, administered 
via mesalamine-containing medication for the treatment of Inflammatory Bowel Disease and 
Ulcerative Colitis. Patients with Inflammatory Bowel Disease (IBD) are often prescribed 
mesalamine, a medication which, in some formulations, has di-butyl phthalate (DBP) in the 
coating to allow for release of the active ingredient in the distal small intestines and colon [56, 





designated EPA Reference Dose (RfD) for a 150-pound individual [241-243]. The use of the 
DBP-coated medication produces urinary monobutyl-phthalate (MBP) levels 1000x higher 
than the levels found in the general U.S. population [69]. 
With the MARS study longitudinal data structure, each individual acts as their own 
control, thus mitigating the potential exposure fluctuation, genetic variation and minimizes 
within environmental variation that often complicates accurate causal assessment of 
epidemiological data. As shown in Figure 4.1, the recruited subjects provided semen, urine, 
and blood samples across the longitudinal study. The cycle of human spermatogenesis and 
subsequent ductal transport takes approximately 90 days [36]. The MARS study required a 
minimum medication duration of 90 days, ensuring that an entire spermatogenic cycle 
occurred on a single medication. This duration was necessary to ensure that collected semen 
samples had developed solely from the current medication period. A total of 73 individuals 
were recruited for the MARS study. A subset of the individuals provided longitudinal samples 
across alternating DBP exposures, with a total of 60 individuals enrolled in the full protocol 
(baseline, crossover, and crossback visits collected) [69]. 
 
Figure 4.1. Crossover study design. Men enter the study having taken a mesalamine 
medication coated with (+) or without (-) DBP for at least 3 months. Semen, blood and urine 
were collected twice (green star) at baseline, after 4 months on an alternate drug (crossover), 






Ejaculated spermatozoa, and their RNAs provide a snapshot of transcriptomic 
processes, capturing the influence of the paternal environment [17, 71, 73, 244] during 
spermatogenesis. MARS sperm samples were processed for RNA-seq, generating both a 
series of long RNA (>200 nucleotides) and small (<200 bp) RNA libraries to elucidate the 
biological processes being modified through phthalate exposure. The transcriptomic effects 
of both IBD and DBP exposure were assessed as a function of sperm RNA elements (REs), 
to provide a robust quantitative measure of effect [245]. Differential responses to high-DBP 
exposures were readily apparent in DBP-naïve men and men chronically exposed to high-
DBP mesalamine. RNA levels of genomic repeats were examined to determine both which 
genomic repeats were well-represented in human sperm and which genomic repeats were 
part of the response to high-DBP exposure. While transcription is a dynamic process, the 
interactions of the sperm transcriptome until now remained unknown. Correlations between 
small RNAs and genomic repeats suggest a dynamic regulatory relationship.  
iii. Materials and Methods 
Sperm purification and library construction 
To perform spermatozoal purifications, MARS samples were brought up to 1 ml 
volume with PureSperm Buffer (Nidacon) and laid onto a 50% PureSperm (Nidacon) gradient, 
then centrifuged at 300xg for 20 minutes [246]. The pellet was removed and washed in 
PureSperm Buffer. Cell counts were performed with a hemacytometer and microscope 
including a visual inspection for somatic cells and round spermatids.  
Each sample was added to a 2ml tube containing 500ul RLT buffer (Qiagen) with 7.5ul 
BME (14.3M), 100 mg 0.2 mm nuclease free SS beads. The sample were homogenized, 500 
ul Qiazol (Qiagen) added and homogenized again. 200 ul chloroform (0.124M) was added 
and samples shaken by hand then centrifuged at 12,000 x g for 20 minutes at 4⁰C and the 
upper aqueous layer removed. RNA was isolated from the aqueous layer using a customized 





for 20 minutes at room temperature. Samples were tested for DNA contamination by RT-PCR 
and intron spanning PRM1 primers [246]. Samples still containing DNA were treated a second 
time and tested again by RT-PCR. The RNA samples void of DNA were quantified with a 
fluorescent assay as described [247]. An aliquot of RNA (5 ng or 10 ng) of each sample was 
used to make cDNA with SuperScript III RT (Invitrogen). The cDNA’s were used as template 
for RT-PCR with intron spanning PRM1 primers providing verification of RNA.  
Two nanograms of RNA per sample was used with the Seqplex (Sigma-Aldrich) 
amplification kit prior to library construction. Fifty nanograms of Seqplex cDNA product was 
used with the NEBNext Ultra DNA Library Prep Kit for Illumina (New England Biolabs) to 
create sequencing libraries. Complete barcoded libraries were quantified and pooled for 
sequencing at a concentration of 2 nM per sample. All samples were subject to paired-end 
sequencing using either the NextSeq 500 (Illumina) sequencer, HiSeq 2500 (Illumina) 
sequencer or the HiSeq 4000 (Illumina) sequencer. 
One nanogram of small RNA per sample was used with the NEXTflex Small RNA-Seq 
Kit v2 (Bioo Scientific) to create small RNA sequencing libraries. Complete barcoded libraries 
were quantified and pooled for sequencing. Samples were subject to paired-end sequencing 
using the MiSeq (Illumina) sequencer. 
RNA-seq data processing methods 
As a control cohort, RNA-seq datasets from males of idiopathic infertile couples who 
fathered a child were downloaded from the Gene Expression Omnibus (GEO), accession 
number GSE65683 [163]. A total of 52 RNA-seq datasets were downloaded from the Gene 
Expression Omnibus (GEO), accession number GSE65683 [163]. The MARS long RNA 
libraries were processed similarly to the GSE65683 samples. Paired-end reads were trimmed 
of adaptors and low-quality bases using Trimmomatic (version 0.36) [248], using default 
parameters (2:30:10 LEADING:3 TRAILING:3 SLIDINGWINDOW:4:15), and requiring a 






was used as input to Trimmomatic. Paired and unpaired reads were aligned to the consensus 
human ribosomal RNA (GenBank: U13369.1) using HISAT2 (version 2.0.6) and the non-
default parameters (-p10 --max-seeds 30 -k 2), then aligned to the human genome (hg38) and 
exogenous RNA spike-in sequences, using the same HISAT2 parameters. Reads without 
alignments in either U13369.1, the human genome (hg38), or an exogenous RNA were further 
assessed for alignments to repeat sequences (RepBase, February 2017 release), using 
HISAT2, with the following parameters (-p10 --no-spliced-alignment --max-seeds 10 -k 3). 
Reads without alignments in either U13369.1, hg38, an exogenous RNA, or RepBase were 
aligned to bacterial and viral genomes using Kraken (version 0.10.5-beta) and Jellyfish 
(version 1.1.10), implementing the full Kraken library and filtering alignments with a threshold 
of 0.15. Read alignments to the human genome, exogenous RNAs, and U13369.1 were 
processed to remove duplicated reads using Picardtools MarkDuplicates (version 1.129).  
QC of the MARS study’s long RNA samples was accomplished by examination of 
alignment statistics, allowing for the quantitative classification of samples failing QC (Table 
4.1) into one of five categories (Category 1: Low genomic alignment, Category 2: High 
intergenic reads, Category 3: High bacterial and viral reads, Category 4: High spike-in reads; 






Table 4.1. Summary of sample quality. The first two columns (“Study arm” and “RNA type”) 
indicate the study arm(s), and RNA type (small RNA or Long RNA library) for the given table 
row. “Total Samples” and “Pass QC samples” indicate the number of RNA-seq samples 
sequenced and the number of sequenced samples that passed quality control, respectively. 
“Subjects with samples” and “Subjects with pass QC samples” indicate the number of patients 
for which sequenced samples and sequence samples that passed quality control measures, 
respectively, were available. “Average pass QC samples per person” indicates the average 
number of sequence samples that passed quality control measures per patient. “Subjects with 
a Pair/trio” indicate the number of patients for whom the sequenced samples that passed 
quality control measures formed either a continouous pair (baseline & crossover visits or 




























Long RNAs 150 bp 124 93 27 27 3.4 20 
B1HB2 
arm 
Long RNAs 150 bp 82 59 21 21 2.8 16 










13-50 bp 24 23 12 12 1.9 6 
All arms Small 
RNAs 
13-50 bp 86 81 33 33 2.6 18 
 
RNA element (RE) discovery algorithm (described in [245]) was applied to the MARS 
and GSE65683 (control) samples. Expression (in Reads Per Kilobase per Million - RPKM) for 
the RE loci was then calculated for all MARS and GSE65683 samples. Due to the use of REs, 
rather than whole transcripts, Paired-end read alignments were treated as individual (single) 
reads, and the common FPKM value was replace by RPKM. Depending on a read pair’s insert 
size and RE length, this approach ran the risk of inflating the read count for a given RE. To 
mitigate this risk, read counts were assessed for the forward and reverse reads separately, 
with the read count from single (non-paired due to mate loss during quality control) reads were 
added to the forward and reverse read counts. The averaged read count between the forward 







Small RNA data processing methods 
MARS small RNA libraries were trimmed of adaptors and low-quality bases, followed 
by removal of reads smaller than 13 bp. sncRNAbench (version 10.14) [249] was used for 
assigning reads to small RNA species and repeat classes, followed by a custom code for 
generating normalized expression values (RPM- Reads Per Million). Among the 86 samples, 
only one had an insufficient number of reads for reliable analysis (a threshold of 1000 aligned 
sense reads were required). Common small RNA species of interest, such as miRNAs, 
piRNAs, tRNAs, tRNA fragments, and siRNA can be detected with small RNA libraries 
(miRNAs ~22 bp) [250], piRNA ~ 24-31 bp [251], and tRNA fragments ~28- to 34-nt [71]). 
Differential long RNAs 
When comparing IBD samples to normal samples, the control cohort was composed 
of couples with idiopathic infertility. Therefore, to reduce the potential effect of infertility on the 
overall RNA expression profiles and concurrently maximize the size of the control cohort, only 
control sperm samples which presented with live birth (LB) (52 samples) were considered for 
use in differential expression [163]. Due to the idiopathic infertility of the couples composing 
the control cohort, the male component of the control cohort is not considered phenotypically 
normal. However, with respect to inflammatory diseases and in particular, inflammatory bowel 
disease or ulcerative colitis, the control samples were assumed to be disease free, and were 
thus labeled “Normal” in differential analyses. 
To identify REs modified by IBD, a LM was used to compare the Normal sperm to the 
B1HB2 arm of the MARS study, with three total comparisons being performed (Normal vs B1; 
Normal vs H; Normal vs B2). The following formula was used for all three comparisons: 
“lm(value ~ seqset + lib + age + protamine_ct + sigma_ct + RNA_conc + 
cellcount_millions,data=input_data). Multiple-testing correction was applied as Benjamin-
Hochberg. REs modified in a consistent manner (e.g. IBD-enriched or Control-enriched) in 





current study, the Control samples were all present in a single sequencing batch, so a batch 
effect would be indistinguishable from the designation as a control sample. Several of the 
differential REs initially identified as IBD-enriched were differential solely due to near-zero 
expression values in all Control samples, suggesting a batch effect. Consequently, such REs 
were removed from consideration if the mean Control expression was less than 1 RPKM. This 
step removed 6 of the 32 REs enriched in IBD for at least two visits.  
To identify REs modified by DBP exposure, a Linear Mixed-Effects Model (LMEM) was 
used to detect REs that changed with DBP exposure. Models were applied to each study arm 
independently. Two comparisons were done for each study arm, in order to find the changes 
occurring from Baseline visit to Crossover visits, and again from Crossover visit to Crossback 
visit. The following formula was applied to the H1BH2 arm: “rpkm ~ visit_simp + lib + 
period_asacol + bmi + season_warm + smokstat + age_bq + sigma_ct + 
percent_genomic_duplicated  + percent_genomic + (1 | patient)”. The following formula was 
applied to the B1HB2 arm of the MARS study: “rpkm ~ visit_simp + lib + bmi + season_warm 
+ smokstat + age_bq + sigma_ct + percent_genomic_duplicated  + percent_genomic + (1 | 
patient)”. Due to the large number of REs tested in each comparison, standard multiple testing 
corrections removed all statistical significance. Therefore, a bootstrapped P-value was 
generated using random resampling. One thousand iterations were performed by permuting 
the RE expression value and running the given model, while maintaining the same sample 
order and covariate order. The empirical P-value was thus defined as the proportion of the 
1000 random iterations that resulted in a P-value less than the original P-value. 




REs were subsequently classified into eight unique expression patterns, with 
significance determined if the absolute value of the slope exceeded 10 RPKM and the 





display a pattern of increased expression from Baseline to Crossover visits, then decreased 
expression from Crossover to Crossback visits, or vice versa. Patterns of acute change were 
defined as those where an RE was significantly up- or down-regulated in the Baseline to 
Crossover comparison, but not altered from Crossover to Crossback. Patterns of recovery 
were defined as those where an RE was unchanged in the Baseline to Crossover comparison, 
but was significantly up- or down-regulated from Crossover to Crossback. Patterns of 
additional interest were those that continuously increased across the study arms or 
continuously decreased across the study arms. 
Differential small RNAs 
The human sperm samples investigated for small RNAs (<50 bp) are described above 
in Table 4.1. A total of 81 small RNA libraries was subsequently used in modeling, using an 
LMEM. Due to the low power in the B1HB2 study arm and insufficient numbers of complete 
trios, the predictive variable used was the DBP state (e.g. High DBP and Baseline DBP levels), 
whereas the long RNA analysis used the study visit as the predictive variable. The formula 
used for both study arms’ small RNAs was “rpm ~ med_simp + bmi + season_warm + age_bq 
+ sigma_ct + percent_genomic_duplicated  + percent_genomic + (1 | patient)”. In this formula, 
the influence of medication (high or low DBP) on small RNA expression was being corrected 
for patient BMI, seasonal warmth, patient age, sigma_ct from long RNA libraries, genomic 
duplication rate from the long RNA libraries, and proportion of long RNA reads aligning to the 
autosomal and sex chromosomes. For concordance of small RNA methods with those of the 
long RNAs, multiple testing correction was applied using a bootstrapped P-value, generated 
using random resampling. The given model was run 1000 times, permuting the RE expression 
value each time, while maintaining the same sample order and covariate order. The empirical 
P-value was thus defined as the proportion of the 1000 random iterations that resulted in a P-
value less than the original P-value. Differential small RNAs were defined as those whose 






Repeat enrichment was measured using the following formula, where “R” indicates the 
REs associated with the repeat of interest, “A” indicates the REs associated with any repeat, 
and the required median expression threshold for a study visit is 25 RPKM. Repeat enrichment 
is the change in contribution of the given repeat to the repeat population, when a given 
expression threshold is applied to both the repeat of interest and the total repeat population.  







The statistical significance of an enrichment or depletion (indicated with a positive or negative 
∆ ratio, respectively) was tested using a hypergeometric test, implemented in stats R package. 
This method is similar to the one implemented in Estill et al [245]. The repeat enrichment 
analysis merely indicates if a repeat type is relatively under- or over-represented in the 
expressed REs, relative to the expected proportion when no expression threshold is applied. 
Small RNA-only Correlations 
Expression levels of genomic repeats and small RNA species were determined using 
the small RNA libraries. The total number of small RNA species and genomic repeats totaled 
12,779 individual sequences. In order to remove spurious results due to poorly expressed 
small RNAs, the compilation was subsetted to those small RNAs with expression exceeding 
5 RPM in a portion of each sample set. In the B1HB2 arm, with a total of 24 Samples, using a 
threshold of 5 RPM in at least 10 samples, this threshold allowed 602 small RNAs for 
correlation. In the H1BH2 arm, with a total of 62 Samples, this threshold allowed 939 small 
RNAs for correlation. Spearman correlation was applied to each individual study arm for 
correlational analysis of small RNAs. 
Correlation of long RNA genomic repeats and small RNAs 
To ensure that the conclusions drawn from the small RNA correlations were 





available REs overlapped a total of 4,449 repeat names. The expression of each repeat 
instance was averaged across a given sample, producing a resulting expression matrix of 
4,449 rows (representing 4,448 repeats and 1 dummy classification of no repeat overlap) and 
n sample columns (where n changes according to study arm size). This was merged with a 
series of small RNAs (generated previously from sncRNAbench), which were expressed 
(greater than 5 RPM) in at least 10 of the 67 small RNA libraries, producing a set of 1,829 
small RNAs. The 1,829 small RNAs were correlated with the 4,449 repeats in both the H1BH2 
arm (n=50 samples) and B1HB2 arm (n=16 samples), with one small RNA library omitted due 
to being a replicate sample. It is important to note that, in order to generate the expression 
values for repeats in the long RNAs, the repeats were summarized across all REs overlapping 
the given repeat. This approach has the disadvantage of negating locus-specific regulatory 
effects (such as cis-regulatory effects), due to the averaging of all individual repeat loci. 
Therefore, in the case that repeats do have a regulatory effect, the summarization across all 
genomic instances (in context of REs) may introduce inaccuracies. 
Ontological enrichment 
Gene Ontology (GO) enrichment was generated using the GeneRanker function of 
Genomatix (Eldorado version 12-2017), from the Genomatix software suite 
(https://www.genomatix.de/), version 3.10. The gene names associated with differential 
exonic, novel near-exon, or novel intronic REs were compiled and used as input to 
GeneRanker. Pathway enrichment was assessed using Ingenuity Pathway Analysis (version 
1-13, Content build 46901286). The expression changes occurring in differential exonic REs 
were compiled and used as input for IPA. The compilation method used was to average the 
expression changes of all differential exonic REs belonging to a given gene. This produced a 







iv. Results  
Expression – RE discovery 
RE discovery was performed on MARS samples and external sperm samples [163], 
with REDa parameters allowing an RE to be detected if it was present in solely a single 
sample. Therefore, downstream analyses used REs that surpass a minimum expression value 
(in RPKM) in several samples, thus reducing the computational burden of the downstream 
analyses. RE expression was then calculated for all MARS samples and external sperm 
datasets described in GSE65683. Novel REs and exonic REs have largely similar length 
distributions (Figure 4.2). However, novel REs tend to have much more uneven length 
distributions, compared to the exonic REs, which is likely due to the lesser number of novel 
REs. Interestingly, each of the novel RE classes exhibited several REs exceeding 1 kb, 
suggesting that at least a small number of intergenic and intronic are expressed along a long 
stretch of the genome (Appendix G). There were 138 novel REs with a width exceeding 1 kb 
(78 near-exon, 50 intronic, and 10 orphan RE classes). Of the 138 novel REs, 103 were 
associated with a genomic repeat, with the most common repeat families being Simple 
repeats, Endogenous RetroViruses (ERVs), and L1 repeats (30, 16, and 16 REs, 
respectively). As expected, approximately 90% of the very long novel REs were within 5 kb of 
DNase site [245]. The very long novel REs were not associated with known Topologically 
Associating Domains (TADs). Approximately a third of the very long novel REs were within 5 
kb of a GM12878 CTCF binding site and/or a known sperm MNase hypersensitive site. The 
proportion of sperm MNase-localized very long novel REs was slightly higher than observed 
for the complete set of RE classes (ranging from 5% to 25%). However, the very long novel 
REs did not appear to be associated with a particular genomic structure, as the overlaps of 
very long novel REs with epigenetic marks and regulatory genomic sequences appear to 






Figure 4.2. RE length distribution. (A) Histogram of RE lengths, segregated according to 
RE type (exonic, intronic, near-exon, and orphan). The X-axis indicates the RE length in log 
10 scale, and the Y-axis indicates the number of REs. (B) Smoothed density estimates of the 
RE lengths, segregated according to RE type. Exonic REs are noted in red, near-exon (<10 
kb from exon) are in green, intronic REs are noted in blue, orphan REs are noted in purple.  
 
Quality control of sequenced sperm RNAs 
Quality control of sperm RNA libraries, prior to sequencing, was assessed using the 
protocol described previously [252, 253]. Suspected low-quality sperm RNA libraries were 
excluded from sequencing. However, despite this precaution, a portion of each set of 
sequenced RNA samples often failed post-sequencing quality control. Within the MARs study, 
quality control determination of the MARs samples was necessary to remove samples with 
poor sequencing performance from subsequent modeling efforts. For QC of the MARS study’s 
long RNA samples, a quantitative approach was developed by first qualitatively assessing 
which samples appeared either deficient in read coverage or had excessive intergenic reads. 
The initial judgement of poor quality samples was based on read profiles and read coverages 
at several key loci, such as the human protamine locus (which is expected to have thousands 
of reads) and ACSBG2 (which is well-expressed and has few intronic reads). Subsequent 





QC into one of five categories (Category 1: Low genomic alignment, Category 2: High 
intergenic reads, Category 3: High bacterial and viral reads, Category 4: High spike-in reads; 
Category 5: High unmapped reads). The specific classification algorithm used in assigning 
the 5 categories is provided in Appendix H. The proportion of samples failing quality control 
for the MARS samples are shown in Table 4.1. It is important to note that small RNA libraries 
use different criteria for assessing sample quality.  
Notably, poorly performing samples tended to have overlapping alignment statistic 
ranges. Therefore, the five classifications are not mutually exclusive. In the case of a sample 
with potential to belong to multiple classifications, the classifications were assigned in a 
sequential order (from Category 1 to Category 5). A sample assigned to one of the five 
classifications may still exhibit an acceptable read distribution (e.g. high reads at expected 
loci, such as PRM1, and relatively few intergenic reads). This is particularly true for Categories 
3 and 5 (Category 3: High bacterial and viral reads; Category 5: High unmapped reads). 
However, such visually acceptable samples were still removed from consideration in order to 
eliminate the possibility that the samples had altered RNA profiles.  
Clinical characteristics were statistically indistinguishable between the study arms, 
with the exception of Total_score, a measure of IBD severity symptoms, which was on 
average higher in the B1HB2 arm. Both study arms were considered to have very low 
Total_scores, with a maximum score of 5 in the current study (observed for a single patient). 
By design, all recruited individuals in the MARS study were required to have a mild IBD score 
on the simple clinical colitis activity index (five or less for UC) or Harvey-Bradshaw index (four 
or less for CD) [69].  
Transcriptomic similarity of human sperm to Testis 
In addition to the previously described quality control measures, the Krawetz 
laboratory developed a method of assessing sample quality through correlational analysis of 





tissue to identify the most highly expressed genes. The top 5,000 most abundant genes were 
chosen as an optimal threshold for including both housekeeping genes (which are expected 
to be highly expressed) and genes unique to the tissue type. The exonic REs associated with 
each gene name were then averaged across a sample to produce a single value. A Spearman 
correlation was then implemented across the top 5,000 gene names to determine the relative 
similarity of a given sample to each of the 53 tissues. The Spearman rho was subsequently 
transformed into a rank, with a rank of 1 given to the tissue with the highest (positive) rho and 
53 given to the lowest rho value. A sperm sample would be expected to be most similar to 
testis, and therefore have a rank of 1. The resulting tissue similarity distribution for MARS 
samples is shown in Figure 4.3. Nearly all quality-controlled sperm samples, such as those 
used in the MARS study, were expected to be most similar to Testis. Accordingly, GTEx 
correlation of the MARS study samples (Figure 4.3) indicated that the gene expression in the 
samples (in the form of averaged exonic REs) was most similar to GTEx testis tissue. The 
only two samples without Testis ranking at 1 are ranked as most similar to “Cells - EBV-
transformed lymphocytes”, with 2nd and 3rd ratings at Stomach and Prostate tissue. However, 
sperm purification protocols make it extremely unlikely that lymphocytes, stomach cells, or 
prostate-derived cells would contaminate the purified sperm. Therefore, this Spearman 
correlation with non-testis tissue (for the two indicated samples) does not indicate a 
contamination of the sperm sample and subsequent failure to sufficiently purify spermatozoa. 
The two samples are in the H1BH2 arm, which is the most populous study arm, and are 
members of a crossover/crossback set and a trio (baseline, crossover, crossback). The 
samples in question are otherwise of acceptable quality, and the diagnostic value of the GTEx 
correlations has not been proven. Based on the overall sample quality and large size of the 
H1BH2 arm, the inclusion of the two samples in modeling was not expected to adversely 






Figure 4.3. GTEx tissue distribution for quality controlled MARS samples. Ranking of 
Spearman correlation for the top 5000 genes of each tissue are shown for 152 quality 
controlled MARS sperm samples. The X-axis represents the individual GTEx tissues, while 
the Y-axis represents the relative ranking of Spearman rho.  
 
In addition to the previous GTEx correlations, the most abundant RNA elements in the 
pass-QC samples from the MARS dataset were examined, with the expectation that the RNA 
elements should reflect transcripts known to be highly expressed in testis [136]. Table 4.2 
presents the top 50 most expressed REs, ordered from highest RPKM to lowest. PRM1, 
PRM2, TNP1, SMCP, CRISP2 are expressed primarily in testis, while GIGYF2 is most highly 
expressed in testis. This basic analysis indicates that the RNA-seq datasets are indeed 
spermatozoal, and therefore, any differentially expressed REs reflect changes in the sperm 
transcriptome. As indicated in the methods used for processing the MARS samples, 
precautions were taken to ensure that somatic cells were excluded prior to RNA extraction. 
The previous GTEx analysis identified two sperm samples were not most similar to testis, but 
to EBV-transformed lymphocytes. However, based on purification protocols, this similarity was 
not expected to be due to contamination with lymphocyte cell lines. At this time, further 





Table 4.2. Highly expressed exonic REs across the MARS study. The top 50 most 
expressed exonic REs, ordered from highest RPKM to lowest, are listed. For REs that 
encompass more than one transcript, the gene names are separated by a comma. REs 
highlighted in bright yellow indicated a series of genes that are known to be primarily 
























Protamine 1, Exon 1 Testis specific 
20530 



















Present in all tissues 
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Mitochondrial Present in all tissues 16720;2798
0;34450 
chrM_3307_4331 MT-ND1 2672.1 Mitochondrial Present in all tissues 22760 
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GYF Protein 2, Exon 
21 
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Present in all tissues 
30.22 













GYF Protein 2, Exon 
10 
Present in multiple 
tissues, highest in 
testis 45.91 
 
Influence of sample characteristics on sperm RNA expression 
Spermatozoa are considered transcriptionally and translationally inert. RNA profiles of 
mature sperm therefore do not reflect active transcriptional activity, but are considered to 
reflect transcriptional activity during spermiogenesis and/or transcripts acquired during 
epididymal transit. Therefore, the use of the term “expression” refers to the RNA profiles of 
the ejaculated spermatozoa. A primary purpose of generating expression values for REs was 





characteristics (patient phenotype and sequencing statistics) that exerted a major influence 
on RE expression, and subsequently account for these characteristics when modeling 
differential expression. Correct covariate selection is necessary for accurately modeling and 
interpreting an outcome (in this case RNA levels). For example, initial differential expression 
attempts of the MARS dataset used covariates chosen primarily for their assumed technical 
and biological importance. However, partly due to an overall increased variance within the 
H1BH2 arm, the outcome of the initial analyses showed a disparity between the two study 
arms, with the B1HB2 arm having a far higher amount of differential expression than the H1BH2 
arm. An unbiased assessment of the sample characteristics that exhibited the most influence 
on RE expression, using Single Value Decomposition, Pearson correlation, and statistical 
significance in linear modeling, identified influential covariates. The implementation and 
results of each of the steps are provided below. When influential covariates were included in 
the expression model, the B1HB2 arm and H1BH2 arm presented a similar number of 
differential REs. Therefore, correct covariate selection reduced the disparity in differential 
expression between the two study arms. 
Covariate selection for the MARS dataset proceeded as described in the following. 
The RE dataset was first reduced to the MARS samples that passed QC, and additionally 
reduced by removing REs that failed to surpass 25 RPKM in at least a third of the samples of 
interest (e.g. Quality-controlled H1BH2 MARS samples). Single Value Decomposition (SVD) 
analysis was performed, with the result visualized as shown in Figure 4.4. In the H1BH2 arm 
MARS samples, SVD analysis revealed that Principle Component (PC) 1, PC-2, and PC-3 
accounted for 93.0%, 5.4%, and 0.49% of the data variance, respectively. In the B1HB2 arm 
MARS samples, SVD analysis revealed that Principle Component (PC) 1, PC-2, and PC-3 
accounted for 91.1%, 7.6%, and 0.46% of the data variance, respectively. In a dataset 
combining both study arms (thus being composed of all quality-controlled MARS samples, 





92.2%, 6.3%, and 0.40% of the data variance, respectively. In all quality-controlled MARS 
samples, PC-1 was significantly correlated with library duplication rates (in both ribosomal and 
genomic reads), percentage of repeat sequence-associated reads, percentage of genomic 
(autosomal and sex chromosomes) alignments, percentage of autosomal alignments, 
percentage of ERCC spike-in reads, and percentage of ribosomal alignments. Potential co-
linearity of the sample characteristics, which would be suggested by the presence of highly 
positive or negative correlations, was tested using a Pearson correlation, shown in Figure 
4.5. The characteristics found to be potentially collinear were the following: library duplication 
rates and protamine_ct; percentage of ribosomal alignments and sigma_ct; percentage of 
ribosomal alignments and percentage of genomic (autosomal and sex chromosomes) 
alignments; percentage of repeat-associated reads and percentage of unmapped reads; 
percentage of repeat-associated reads and percentage of adaptor-derived reads.  
Figure 4.4. Singular Value 
Decomposition Analysis 
of quality-controlled 
MARS samples. (A) 
Association of sample 
characteristics for H1BH2 
arm. (B) Association of 
sample characteristics for 
B1HB2 arm (C) Association 
of sample characteristics for 
all quality-controlled MARS 
samples, regardless of study 
arm. The association of a 
sample characteristic with a 
Principle Component (PC) is 
measured using a standard 
linear model (lm) for numeric 
characteristics, while 
categorical or integer 
characteristics (eg. 
Medication, diagnosis, race, 
season, smoking status, 
R2single_autoXY_dupsremoved) used a Kruskal-Wallis rank sum test (kruskal.test). The P-
value for the linear model or Kruskal-Wallis test is color-coded for each pairwise test of 
Principle Component and sample characteristic, with the color legend provided in the left-






Figure 4.5. Pearson correlation of numeric sample characteristics for all quality-
controlled MARS samples. The Pearson’s rho value is plotted as a color gradient on the 
right-hand side of the graph, with deep red representing a negative correlation and dark blue 
representing a positive correlation as indicated in the bar. 
 
In order to determine which characteristics would be influential in context of the 
research question of interest (expression change with phthalate levels), a basic linear model 
was applied to all quality-controlled MARS samples (formula: rpkm ~ visit_cat + lib + 
RNA_per_million + period_yr + bmi + season_warm + smokstat + age_bq + sigma_ct + 
percent_genomic_duplicated + percent_adaptor_badquality + percent_ercc + 
percent_genomic + percent_bactviral + percent_repbase). The RNA-seq library parameters 
sigma_ct, percent_genomic_duplicated, percent_ercc, and percent_genomic presented a 
significant P-value (P<0.05) for their concomitant beta estimate. sigma_ct, 
percent_genomic_duplicated, and percent_genomic were subsequently used as technical 
(RNA-seq library) covariates in linear mixed effects models and basic linear models of the 
































































































































































































































































in the linear model (P=0.027), ERCC RNA spike-ins were previously noted to have extreme 
variability in the final sperm RNA-seq libraries. Additionally, ERCC spike-in proportions after 
sequencing may correspond to insert quality, as the ERCC mixture may provide a better 
template than the sperm RNA. However, ERCC mixtures were added at different 
concentrations to the different MARS sequencing batches (in an effort to reduce the amount 
of sequencing materials dedicated to the ERCC spike-in). Therefore, ERCC proportion was 
omitted from expression modeling. The final components of the formulas for Linear Mixed-
Effects Modeling (LMEM) and Linear Models (LM) accounted for a series of clinical 
parameters (Sequencing batch, Time on High-DBP drug, Body Mass Index (BMI), Season, 
cigarette smoking, and patient age) and technical parameters (sigma_ct, duplication rate of 
genomic (autosomal and sex chromosomes) reads, and percentage of alignments located on 
autosomal and sex chromosomes. In the case of datasets missing any of the above 
parameters (e.g. external dataset from Jodar et al.), the missing parameters were omitted 
from the given model [163].  
IBD-induced changes on RNA 
Several studies have applied RNA-seq to IBD (previously known as Irritable Bowel 
Syndrome (IBS)), with a primary focus on intestinal biopsies. While IBD is an inflammatory 
condition that is limited to gastrointestinal tissue, altered brain-gut interactions do occur [255], 
and additional direct or indirect effects on peripheral tissues are possible. This is underscored 
by work by Gupta et al, who identified 288 dysregulated genes in peripheral blood 
mononuclear cells (PBMCs) between IBD and healthy control groups, with 12 of the 
dysregulated genes being associated with the immune system (4 anti-inflammatory, 8 pro-
inflammatory). Iborra et al. [256] identified a series of serum miRNAs with altered expression 
in IBD. Machine learning approaches have also uncovered a peripheral blood miRNA 
signature indicative of IBD [257]. Plasma‐induced signature analyses performed using blood 





an immunoregulatory plasma milieu that can induce immune activation in a healthy leucocyte 
population, as measured using a high‐density microarray. Given the growing interest in the 
male germline as a mediator of intergenerational/transgenerational effects, I hypothesized 
that the IBD condition may alter the RNA profiles of the paternal human germline. Using the 
MARS B1HB2 study arm as an IBD cohort, the differences between sperm samples from 
control males and the B1HB2 study samples were determined. The control males used in the 
study were males from idiopathic infertile couples who produced a live birth after infertility 
treatment.  
Relatively few REs (40 REs) were altered in at least two study visit comparisons to 
healthy controls (Figure 4.6). Interestingly, the B2 visit of the B1HB2 study arm exhibits the 
highest number of differential REs, with the majority of those REs being unique to the B2 visit 
comparison to healthy controls. Within the B1HB2 study arm, the Crossback visit, B2 visit, 
represents the return to a low-phthalate condition after an acute exposure to high-DBP 
medication. Therefore, the large number of unique differential RES in the B2 visit comparison 
is likely due to biological processes initiated after the high-DBP exposure. Overall, the few 
differential REs suggest that the IBD condition alone does not substantially alter the 
transcriptome of ejaculated spermatozoa. However, small RNA libraries were not available for 
the Control cohort. Small RNA species, such as miRNAs, piRNAs, and fragmented tRNAs, 
were not compared between IBD and healthy controls. Therefore, I cannot exclude the 
possibility that the abundance of small RNAs, which often have regulatory roles, may still be 






Figure 4.6. REs that differ between Normal and IBD individuals. (A) Volcano plots of linear 
model results for all tested REs. X-axis indicates the log10 expression change (slope) in 
RPKM, while the Y-axis indicates the negative log10 Benjamini-Hochberg adjusted P-value. 
Red points represent REs that are not statistically significant, while blue points represent REs 
that have a Benjamini-Hochberg adjusted P-value less than 0.05 and an absolute slope of at 
least 10 RPKM. REs with a positive slope exhibit higher expression in Control individuals, 
while those with a negative slope have higher expression in IBD individuals. (B) Venn diagram 
of the REs enriched in the IBD individuals, across the three study visits. (C) Venn diagram of 







Table 4.3. REs consistently altered by IBD. Genes with multiple affected REs are indicated 
in bold.  
 
Expression change Element Identifier Gene Symbol RE class 
Enriched in IBD chr10_49703080_49703099 C10orf53 NOVEL_INTRONIC 
Enriched in IBD chr11_22674773_22675014 GAS2 EXON 
Enriched in IBD chr1_245677221_245677520 KIF26B NOVEL_INTRONIC 
Enriched in IBD chr15_33244895_33245438 TMCO5B EXON 
Enriched in IBD chr1_90497041_90497080 NA NOVEL_ORPHAN 
Enriched in IBD chr19_37551371_37551665 ZNF571-AS1,ZNF540 EXON 
Enriched in IBD chr2_178535732_178535828 TTN-AS1 EXON 
Enriched in IBD chr21_8259686_8259815 RNA5-8S5 NOVEL_10KB_EXON 
Enriched in IBD chr2_200797499_200797575 AC007163.1 EXON 
Enriched in IBD chr2_202346319_202346358 AC064836.2 NOVEL_10KB_EXON 
Enriched in IBD chr22_41174591_41174824 EP300-AS1 EXON 
Enriched in IBD chr2_30091379_30091408 AC016907.2 NOVEL_INTRONIC 
Enriched in IBD chr2_97149295_97149361 ANKRD36 EXON 
Enriched in IBD chr2_97151879_97151939 ANKRD36 EXON 
Enriched in IBD chr2_97183582_97183654 ANKRD36 EXON 
Enriched in IBD chr3_113805354_113805525 ATP6V1A EXON 
Enriched in IBD chr3_47772817_47772936 SMARCC1 EXON 
Enriched in IBD chr3_52800965_52801146 ITIH3 EXON 
Enriched in IBD chr4_141231439_141231485 ZNF330 EXON 
Enriched in IBD chr4_15007305_15007595 CPEB2 EXON 
Enriched in IBD chr5_176586651_176586842 CDHR2 EXON 
Enriched in IBD chr5_176589031_176589182 CDHR2 EXON 
Enriched in IBD chr6_147001441_147001543 STXBP5-AS1 EXON 
Enriched in IBD chr9_34839387_34839416 FAM205BP NOVEL_10KB_EXON 
Enriched in IBD chrX_126731815_126731844 MTCYBP38 NOVEL_10KB_EXON 
Enriched in IBD chrY_12915883_12916027 DDX3Y EXON 
Enriched in Control chr15_29716611_29716838 TJP1 EXON 
Enriched in Control chr15_29718266_29719138 TJP1 EXON 
Enriched in Control chr19_10118668_10118727 EIF3G EXON 
Enriched in Control chr19_11024331_11024438 SMARCA4 EXON 
Enriched in Control chr20_38517784_38518000 RALGAPB EXON 
Enriched in Control chr20_410412_410764 RBCK1 EXON 
Enriched in Control chr20_62256057_62256221 OSBPL2 EXON 
Enriched in Control chr3_57268398_57268487 APPL1 EXON 
Enriched in Control chr4_42070526_42070691 SLC30A9 EXON 
Enriched in Control chr7_35872666_35872766 SEPT7 EXON 
Enriched in Control chr7_99353909_99354121 ARPC1A,AC004922.1 EXON 
Enriched in Control chr7_99358340_99358415 ARPC1A,AC004922.1 EXON 
Enriched in Control chr7_99359534_99359738 ARPC1A,AC004922.1 EXON 
Enriched in Control chrM_14747_15953 MT-CYB EXON 
 
Only 14 REs showed higher levels in Controls and 26 REs were upregulated in IBD, 
the majority of which were exonic REs (Table 4.3). However, in the IBD-enriched category, 





category, had two or more differential exonic REs. This suggests that select genes or isoforms 
are consistently up-regulated or down-regulated in sperm from DBP-naïve individuals. 
ANKRD36 is a predicted intracellular protein, with potential nuclear localization, whose 
function has not yet been characterized. CDHR2 is a non-classical cadherin, which mediates 
formation of intermicrovillar adhesion complexes, necessary for formation of the murine 
intestinal brush border [259]. CDHR2, through work on cancer cell lines, has been 
hypothesized to act as a molecular switch for contact inhibition of epithelial cells [260]. TJP1 
is a tight junction adaptor protein. ARPC1A is a subunit of the human Arp2/3 protein complex. 
AC004922.1 is an uncharacterized protein, formed from an ARPC1A and ARPC1B 
readthrough. Of the four genes (ANKRD36, CDHR2, ARPC1A, and TJP1), ANKRD36 exhibits 
the highest expression. However, all four genes are relatively lowly expressed in 
spermatozoa, with a median expression less than 25 RPKM, as ANKRD36, CDHR2, 
ARPC1A, and TJP1 have median expression values in sperm of 19.14, 7.32, 0.86, and 2.40 
RPKM, respectively. 
Of the 36 gene names up- or down-regulated in IBD, 23 of them were expressed in 
cultured human Sertoli cells [261], when requiring a threshold of at least 100 baseMean reads 
(assigned using DESeq). At this threshold, 14,843 gene names from the Ribeiro et al. dataset 
were considered expressed. Three of the 4 noted genes (ANKRD36, TJP1, and ARPC1A) in 
Table 4.3 were among the 23 Sertoli-expressed genes. This suggests that the effects of IBD 
on spermatozoa may work through Sertoli cells, rather than through absorption during 
epididymal transit. Both CDHR2 and TJP1 are associated with cell-cell interactions, further 
suggesting that IBD may alter the interactions of Sertoli cell during spermatogenesis and/or 
spermiogenesis.  
To determine if the 14 Control-enriched and 26 IBD-enriched REs were defined as 
differential in previous studies of other laboratories, the differential RE gene names and genes 





exact gene names were compared, so it is important to note that if the published gene names 
presented in the literature were updated prior to this analysis, an overlap would not be 
identified. The 40 REs’ gene names did not overlap with several previous studies that used 
colon biopsies for microarray or RNA-seq, in either human or mouse [262-270]. This is likely 
due to the vastly different transcriptomes between intestinal tissue types and male 
reproductive tissues (Figure 4.3). The few studies describing changes in peripheral blood 
[255, 258] do not provide a comprehensive list of differential genes in the publication, and so 
could not be compared to the gene names identified in the current study. Regardless, 
spermatozoa are known to have a vastly different transcriptome (compared to somatic cell 
types), and so likely would not exhibit overlaps with the peripheral blood studies. 
Differential expression analyses of Long REs in MARS study arms 
The MARS study design (Figure 4.1) allows for the detection of longitudinal changes 
occurring as a result of shifting DBP exposure. A Linear Mixed-Effects Model, when applied 
to the repeated longitudinal samples from the MARS dataset, can define the DBP-induced 
expression changes, while also taking into account any repeated samples. The LMEM model 
formulas were developed for defining the expression changes across study periods (e.g. 
Baseline, Crossover or Crossback), while considering biological and technical covariates. 
LMEM modeling across the MARS study arms revealed considerable differential expression 
(defined as empirical P-value < 0.05 and minimum absolute threshold of 10 RPKM) in each 







Figure 4.7. Volcano plots of REs altered across MARS study arms. (A) H1BH2 study arm. 
(B) B1HB2 study arm. Blue points represent REs with an empirical P-value < 0.05 and a 
minimum absolute threshold of 10 RPKM, while red points represent REs with empirical P-
value > 0.05 or a minimum absolute threshold less than 10 RPKM. 
 
The majority of all REs were exonic (321,207 REs), with intronic REs being the most 
numerous of the novel classes (near-exon: 9,730 REs; intronic: 30,853; orphan: 10,015). 
Correspondingly, the majority of REs altered by DBP were either exonic or intronic (Table 





observed transcript patterns, indicating that DBP exposure(s) affects far more than known 
transcripts. Few REs were differentially expressed in both study arms (H1BH2 arm and B1HB2 
arm), suggesting that the alternating DBP exposures affects DBP-naïve males differently from 
males chronically exposed to a high-DBP mesalamine. This arm-specific effect was also 
observed in the sperm motility and hormonal responses of the MARS individuals [69, 70, 271].  
Table 4.4. Expression patterns of REs altered across MARS study arms. (A) Total RE 
count for the given expression pattern. Expression patterns are presented to the left of the 
table, with blue lines indicating significant slopes and grey lines indicating non-significant 







Differential REs were then classified into specific response patterns, defining REs 
which either changed explicitly with high-DBP exposure, i.e., acute response REs that 
changed from baseline to crossover, followed by an opposite recovery response in REs that 
changed from crossover to crossback, and REs that increased or decreased across all study 
visits. Both study arms had relatively few REs altered concomitantly with DBP exposure 
across both transitions (1.7% and 5% in the B1HB2 arm and H1BH2 arm, respectively). 
Unexpectedly, the majority of differential REs in either study arm were significantly altered in 
a single comparison (i.e., baseline to crossover - acute response or crossover to crossback - 
Recovery). Semen analysis of the MARS subjects described in Nassan et al [69], showed a 
continuous decline in sperm motility due to a carry-over effect of high-DBP exposure in the 
B1HB2 arm. In accord, as indicated in Table 4.5, several exons of sperm-motility associated 
genes (ATP1A4, WDR66, TEKT2, TEKT5, DRC7, CFAP44, DDX4, DNAJA1) were 
downregulated in the B1HB2 arm, during the initial high-DBP insult, consistent with the B1HB2 
arm’s observed decline in sperm motility [69]. In contrast, in the H1BH2 arm, semen 
parameters (including sperm motility) did not change across the study visits and few sperm-
motility associated genes were linked with differential exonic REs in the H1BH2 arm. Notably, 
a small number of B1HB2 arm REs that were not directly associated with motility continuously 
increased (6 REs) or decreased (8 REs) across the study visits. The H1BH2 arm REs did not 
follow a continuous pattern. All 6 continuously increasing REs were novel, with 5 intronic REs 
(AC012531.3, WDR20, AC007993.2, RAE1, GUSBP1) and one near-exon RE (NPIPB10P). 
In comparison, nearly all 8 continuously decreasing REs were also novel, with 5 intronic REs 
(TMEM104, AC068594.1, AC016590.1, XRN1, FER), one near-exon RE (AC107958.2), one 
orphan RE, and a single exonic RE (PRSS21). Interestingly, PRSS21 (Serine Protease 21) is 
a cell-surface anchored serine protease present within elongating spermatids that may also 





Table 4.5. DBP-altered exonic REs overlapping genes associated with sperm motility. 
All murine genes in MGI database with the associated Gene Ontology term “sperm motility” 
(GO:0097722, http://www.informatics.jax.org/go/term/GO:0097722) were downloaded and 
transformed into the HGNC (human) gene symbol using custom R code and the BiomaRt 
package. The gene symbols associated with the differential exonic REs, partitioned according 
to expression change, were then overlapped with the list of HGNC gene symbols. All displayed 
gene names represent the gene symbol overlaps. 
 
B1HB2 arm 
B1 to H transition; 
Increased levels 
B1 to H transition; 
Decreased levels  
H to B2 transition; 
Increased levels  
H to B2 transition; 
Decreased levels  
CATSPERD ATP1A4 WDR66 CATSPERD 
TTLL1 WDR66 GAPDHS DNAH1 


















H1 to B transition; 
Increased levels 
H1 to B transition; 
Decreased levels 
B to H2 transition; 
Increased levels 
B to H2 transition; 
Decreased levels 
CELF3 IFT88 IFT88 TEKT5 
ATP1A4  DNAI1 UBE2B 
 
Biological Response to DBP exposure 
The biological impact of DBP on REs was assessed through Gene Ontology (GO) 
enrichment. The gene names associated with differential exonic, novel near-exon, or novel 
intronic REs in the expression patterns of interest were compiled to resolve GO categories 
associated with both novel REs and exonic REs. Table 4.6 summarizes the primary affected 
signaling and literature-based pathways. Few of the top GO pathways were shared between 
the two study arms, suggesting that shifts in DBP levels differentially affect DBP-naïve males 
compared to chronically exposed males. Within the B1HB2 arm, acutely downregulated REs 
were associated with “RAN-GAP cycling”, “Focal adhesion kinase signaling”, and “Ras 
GTPase binding”. Focal adhesion kinase signaling facilitates integrin-mediated signal 





RAN-GAP cycling, which is a critical component of nucleo-cytoplasmic transport, likely is 
involved in epigenetic regulation during spermatogenesis, via movement of regulatory RNAs 
[275]. During mammalian spermiogenesis, Ran GTPase may mediate kinesin localization, 
which is needed for producing the unusual spermatid form [276, 277]. Interestingly, REs 
upregulated and downregulated in recovery of the B1HB2 arm were enriched for NGF signaling 
and EGFR signaling. NGF protein is found throughout male reproductive tissues [272, 278-
280], including mammalian spermatozoa [281], and outside of the suspected regulatory roles 
in Sertoli cells [282], likely facilitates sperm motility [202, 283]. A disruption of the NGF 
signaling-mediated motility in the B1HB2 arm is thus in agreement with previously noted 
decreased motility [69] after administration of a high-DBP mesalamine to high-DBP-naïve 
participants. EGFR plays a regulatory role in mammalian spermatogenesis, mediating Sertoli-
germ cell crosstalk [284], non-classical testosterone signaling [285], and may  mediate the 






Table 4.6. Gene ontology enrichment summary of differential MARS REs. The gene 
names associated with differential exonic, novel near-exon, or novel intronic REs were 
compiled and used as input to Genomatix’s GeneRanker function. The signaling pathways 
and literature-based pathways were summarized and grouped into common ontological 
themes.  
 Acute change Recovery 
Study 
arm Upregulated REs   Upregulated REs   
B1HB2 
Amino acid metabolism NGF signaling 
TNF-alpha EGFR signaling 
14-3-3 protein signaling RAN signaling 
  
Downregulated REs  Downregulated REs  
RAN cycling NGF signaling 
Focal adhesion kinase signaling EGFR signaling 




Upregulated REs      Upregulated REs      
Arf6 trafficking Lipid metabolism 
Chromatin organization Calmodulin 
Organelle organization 
Organelle biogenesis and 
maintenance 
  
Downregulated REs   Downregulated REs  
Cell cycle Cyclin D3 




Coregulation of Androgen receptor 
activity 
 
Within the H1BH2 arm, acute response REs were associated with organellar and 
chromatin organization, which are requisite for extreme cellular and nuclear remodeling during 
spermatogenesis. The corresponding downregulated acute and recovery REs were enriched 
for “Coregulation of Androgen receptor activity”, which is coherent with previous mammalian 
literature indicating the importance of testosterone in phthalate-induced testicular dysgenesis 





endocrine disruptor exposure, the MARS study suggests that responding to in vivo adult 
exposures also elicits androgen disruption, providing another inroad to this pathology. Adult 
rat models of high-DBP exposure also indicate a disruption of androgenic activity [287, 288]. 
Recovery in the H1BH2 arm suggests an involvement of “lipid metabolism” and “calmodulin”. 
In the male, Leydig cells take up lipids for testosterone production [289], perhaps indicating a 
shift in steroidogenesis. Calmodulin, a calcium-binding protein activated in the presence of 
calcium, was previously known to be involved in mammalian sperm motility [290-292]. 
The above GO analysis suggests that specific signaling pathways, such as NGF 
signaling, EGFR signaling, RAN cycling, and Androgen receptor signaling, may be altered 
due to DBP exposures. To complement the above, Ingenuity Pathway Analysis (IPA) was 
applied to the differential exonic REs to resolve the enrichment of signaling pathways, as well 






Figure 4.8. IPA pathways of REs altered across MARS study arms. (A) Pathway 
enrichment for H1BH2 study comparisons. (B) Pathway enrichment for B1HB2 study 
comparisons. Enriched pathways are ordered according to the relative significance, with most 
significantly enriched pathways displayed on the left. Pathways highlighted in orange hues 
and blue hues indicate predicted pathway activation or repression, respectively, with darker 
colors indicating greater confidence in the activation/repression prediction. Briefly, pathway 
activation/repression prediction is based on the correlation of inputted gene expression 
changes with the pathway’s known activity patterns.  
 
IPA signaling pathway enrichment revealed several interesting associations. Notably, 
in the H1BH2 arm, the transition from crossover (B visit) to crossback (H2 visit), which 





DNA damage response pathways. This is consistent with previous reports of DBP-induced 
spermatozoal damage and oxidative stress [67, 68]. However, the B1HB2 arm’s enriched 
pathways do not strongly implicate oxidative stress and DNA damage response. The transition 
from baseline (B1 visit) to crossover (H visit) was associated with several spermatogenesis-
related pathways, including activation of EIF2 signaling and the PPAR-alpha/RXR-alpha 
signaling. These pathways were not strongly associated with either the H1BH2 arm or in the H 
visit vs B2 visit comparison of the B1HB2 arm, suggesting that a concerted shift in the PPAR-
alpha and EIF2 pathways only occurs upon the initial high-DBP exposure. The detrimental 
effects of peroxisome proliferators, i.e., DBP, on germ cells likely acts through Sertoli cells 
[58-60, 293]. The transition from crossover (H visit) to crossback (B2 visit) yielded a strong 
activation of GP6 signaling [294, 295]. Additionally, the retinoic acid receptor (RAR) pathway, 
which is a known mediator of germ cell differentiation [296], was also enriched, and although 
no concerted activity was observed, levels of several of the altered pathway members 
(CARM1, SWI/SNF, NCOR1, PKC) were  consistent with an activation of the Retinoic acid 
nuclear receptor (RAR) and Retinoid receptor (RXR) (via binding of retinoic acid). Notably, 
several of the RAR’s altered pathway members (CARM1, SWI/SNF, NCOR1) associated with 
changes in chromatin structure [43, 297-300] have the potential to mediate epigenetic effects 
of intergenerational inheritance. 
Upstream regulators of DBP-altered genes 
In addition to pathway enrichment, IPA provided the relative enrichment and 
associated activation/repression states for the upstream regulators of differential genes. The 
enriched upstream regulators are shown in Table 4.7. The upstream regulators are not 
present in the seminal plasma proteome, from Barrachina et al. [301]. In the spermatozoal 
proteome, only Myc and MAPK9 are present [43]. All upstream regulators indicated in Table 





than 1 RPKM. Only two genes, EGLN2 and FOXM1, had a median expression value 
exceeding 1 RPKM, with values of 2.22 and 2.25, respectively (Table 4.8).  
Table 4.7. Upstream regulators from IPA. Positive Z-scores are indicated in shades of red, 
while Negative Z-scores are indicated in shades of blue. Deeper shades of the given color 
represent more extreme Z-scores. All presented Z-scores represent a statistically significant 
(p<0.05) enrichment of the regulator’s associated genes. A negative Z-score indicates that 
the actions of the upstream regulator are predicted to be repressed. 
Upstream regulators B1HB2_B1_to_H B1HB2_H_to_B2 H1BH2_H1_to_B H1BH2_B_to_H2 
MYC -3.65 N/A N/A N/A 
CST5 1.71 0.00 1.00 -0.50 
ERBB2 N/A N/A -1.00 -1.55 
EGLN 2.14 N/A N/A N/A 
REST N/A N/A -1.98 N/A 
HR N/A N/A N/A -1.41 
MAPK9 N/A N/A -1.07 N/A 
TP53 N/A N/A -1.00 N/A 
CCND1 N/A N/A N/A -1.00 
mir-10 N/A N/A N/A -0.97 
miR-122-5p (miRNAs 
w/seed GGAGUGU) N/A N/A N/A 0.45 
CDK4/6 N/A -0.45 N/A N/A 
FOXM1 N/A N/A -0.33 N/A 
 
Table 4.8. Summarized expression values of IPA’s upstream regulators. The column 
“Gene Symbol” indicates the gene name, while the columns “Median expression” and “Mean 
expression” indicates the median and mean expression value, respectively, across the MARS 
samples. 
 
Gene Symbol Median expression Mean expression 
MYC 0 0.32283 
CST5 0 0.018956 
ERBB2 0 0.001302 
EGLN1 0 0.111128 
EGLN2 0 1.423787 
EGLN3 0 0 
REST 0 0 
HR 0 0.00872 
MAPK9 0 0.041987 
TP53 0 0.083205 
CCND1 0 0.55502 
CDK6 0 0.003696 
CDK4 0 0.1018 





In the current regulatory analysis, MYC, a well known transcription factor that acts as 
a proto-oncogene, has a negative Z-score (-3.65), suggesting that the actions of Myc are 
repressed by the transition to high DBP in the B1HB2 arm. This effect does not carry over to 
any of the remaining three comparisons. Higher Myc expression is associated with increased 
cell growth [302]. In mouse, spermatogonial stem cell renewal is regulated by Myc/Mycn-
mediated glycolysis [303].  
Interestingly, Cystatin D (CST5 gene) was found to be enriched in all four 
comparisons. In the B1HB2 arm, CST5 was moderately activated in the transition to high DBP, 
and having no predicted activation or repression during the return to low DBP. In the H1BH2 
arm, CST5 was lowly activated during the transition to low DBP, and lowly repressed during 
the return to high DBP. The role of Cystatin D in spermatogenesis is unknown, and is not 
highly expressed in testis. However, CST5, as a secreted cysteine proteinase inhibitor, may 
play a protective role against proteinases [304].  
Erb-B2 Receptor Tyrosine Kinase 2 (ERBB2), commonly known as HER2, is a 
member of the epidermal growth factor (EGF) receptor family of receptor tyrosine kinases. It 
was predicted to be mildly repressed in the H1BH2 arm comparisons, suggesting a continual 
repression across the changing DBP levels.  
EGLN is a family of prolyl hydroxylase enzymes, with canonical HIFα targets, which 
act as an ancient oxygen-monitoring machinery [305]. In the B1HB2 arm, the transition to high 
DBP was concurrent with a predicted moderate activation of EGLN. REST (RE1 Silencing 
Transcription Factor), a transcriptional repressor, and HR (Lysine Demethylase And Nuclear 
Receptor Corepressor) were both predicted to be repressed in the H1BH2 arm, with REST 
enriched in the transition to low DBP and HR enriched in the return to high DBP. HR is a 
histone demethylase, which acts to demethylate mono- and dimethylated Lys-9 of histone H3. 





DNA damage response, HIF is integral to sensing and responding to hypoxia. Uncontrolled 
hypoxia can result in oxidative stress. 
Interestingly, two microRNAs, mir-10 and mir-122-5p, were enriched upstream 
regulators during the return to high DBP in the H1BH2 arm. While neither microRNA was itself 
altered by DBP exposure, shown in the following section “Small RNAs altered by DBP 
exposure”, mir-10 was predicted to be repressed, while mir-122-5p was predicted to be mildly 
activated, as shown in Table 4.7 and Figure 4.9. The mir-10a-5p, mir-10b-5p, and mir-122-
5p were all well expressed in human sperm, with median expression values of 105.5, 191.7, 
170.6 RPM, respectively. The 3p sections of mir-10 and mir-122 were poorly expressed, being 
zero RPM in nearly all samples. Reference values from SpermBase (http://spermbase.org), 
which used a different sequencing platform (Ion Proton system), also indicate that mir-10a-
5p, mir-10b-5p, and mir-122-5p are well expressed in human sperm [306]. mir-10a-5p is 
expressed at 57 RPK and 91.3 RPK in whole sperm from human and mouse, respectively. 
mir-10b-5p is expressed at 31.5 and 65.8 RPK in whole sperm from human and mouse, 
respectively. mir-122-5p is expressed at 88.2 RPK in human whole sperm, but is poorly 
expressed in mouse sperm (0.7 RPK).  
 
Figure 4.9. Downstream effectors of mir-10 and mir-122. Differential downstream 
regulators of (A) mir-10 and (B) mir-122 are shown.  
 
DBP exposure promotes expression of simple repeats  
Several classes of repetitive element associated RNAs, including simple repeats, 





of human spermatozoal RNAs [156, 245]. The effect of high-DBP exposure in spermatozoa 
for each study arm and study visit was assessed as a function of relative enrichment/depletion 
of REs that overlapped a genomic repeat. As shown in Estill et al., centrometric repeats and 
MER1A were enriched in mature human spermatozoa [245]. As expected, the centromeric 
repeat, (AATGGAATGG)n, was enriched across all MARS study arms (see Figure 4.10A), 
with no distinct differences across the study arms. This centromeric enrichment was primarily 
due to novel orphan REs. Interestingly, the abundance of differential REs overlapping the 
(AATGGAATGG)n repeat decreased from the B1 visit to the H visit. As shown in Figure 4.10B, 
this suggests that in the B1HB2 arm, the transition to the high-DBP exposure reduces the levels 
of (AATGGAATGG)n-associated REs. Centromeric RNA has been shown to facilitate the 
localization of nucleoproteins and the chromosomal passenger complex (CPC) [307, 308]. 
Interestingly when nuclear structures are resolved, sperm centromeres are located towards 
the nuclear periphery [309]. This is consistent with the view that centromeric repeat RNA may 
represent residual transcripts that, in some manner, guide sperm differentiation and/or guide 
mitotic progression of the early human embryo.  
Simple repeats, such as GA-rich repeats and variations of TC-rich repeats (e.g. 
(TTTC)n) were highly enriched across many of the MARS sperm samples as shown in Figure 
4.10C. Interestingly, simple repeats were highly enriched in all study visits and arms, with the 
exception of the B1 visit of the B1HB2 study arm. Within the MARS study set, the B1 visit is the 
sole timepoint for which sperm samples have not been exposed to high-DBP mesalamine. All 
novel RE classes (near-exon, intronic and orphan), but not the exonic REs, exhibit this DBP-
specific pattern of repeat enrichment. Differential repeat analysis verified this DBP-specific 
pattern for several of the simple repeats (Appendix I), with the primary exceptions of GA-rich 
and A-rich repeat classes.  
These results suggest that high-DBP exposure elicits an immediate and acute 





gamete. This showed that, in addition to being enriched in spermatozoa, RE-associated 
genomic repeats are selectively modified by DBP exposure. As these repeats are 
compartmentalized in sperm [156], perhaps they also have a role in sperm chromatin 
organization. In this manner, their modification by DBP, that is known to increase DNA nicking 
[310], may specifically alter chromatin states [311].  
 
Figure 4.10. Enrichment of repetitive element expression. (A) Repeat enrichment (positive 
log10 fold change) or depletion (negative log10 fold change) of centromere-associated 
repeats. X-axis provides the repeat name, while the Y-axis indicates the relative enrichment 
(positive log10 fold change) or depletion (negative log10 fold change). (B) The number of 
differential REs that overlap centromeric repeats. X-axis provides the repeat name, while the 
Y-axis indicates the number of differential REs for each significant expression change. (C) 
Repeat enrichment (positive log10 fold change) or depletion (negative log10 fold change) of 
Simple repeats. High-DBP exposure within the past spermatogenic cycle enriches simple 





Small RNA composition of spermatozoa 
Several types of small RNAs, such as miRNAs and piRNAs, have known roles in 
regulating mRNA and transposable element-derived RNAs and levels of repetitive elements. 
piRNAs have been proposed to play a regulatory role in spermatogenesis and the mammalian 
embryo, perhaps as part of the confrontation-consolidation of the embryo. miRNAs are well-
known to regulate their target genes through mRNA degradation and translational repression. 
Therefore, miRNAs delivered to the embryo may play a regulatory role in regulating the early 
use of maternal RNAs before zygotic genome activation. Among the other small RNA species 
available in the mammalian genome (e.g. snoRNAs), tRNA fragments delivered by sperm 
have been suggested to regulate the endogenous retroelement MERVL in the murine embryo 
[71]. 
Common small RNA species of interest, such as miRNAs, piRNAs, tRNAs, tRNA 
fragments, and siRNA can be detected with small RNA libraries (miRNAs ~22 bp) [250], 
piRNA ~ 24-31 bp [251], and tRNA fragments ~28- to 34-nt [71]). Accordingly, small size-
selected RNA (sncRNA)-Seq libraries, were prepared and sequenced to assess the impact of 
DBP exposure. Figure 4.11 shows the expected lengths of several small RNA species, in 
context of an exemplar MARS small RNA sample. Several of the small RNA libraries show 
peaks around the expected miRNA, piRNA, and tRNA fragment (tRF) sizes. As an initial 
analysis to determine if small RNA species have different distributions between the two study 
arms, the read sizes were binned into approximately 5 bp segments, for a total of 6 bins. 
Figure 4.12 shows that the two study arms and their individual visits (Baseline, Crossover, 









Figure 4.11. Expected read lengths of small RNA species. The read length distribution of 
an example sample is used as background. The Y-axis provides the read counts for a given 
read length, while the X-axis indicates the read length. Expected miRNA, piRNA, and tRNA 
fragment lengths are shown in green, yellow, and blue, respectively.  
 
 
Figure 4.12. Small RNA read length comparisons. (A) Read count distributions. Y-axis 
indicates the read count for each sample, and the. (B) Read count proportions. The Y-axis 
indicates the proportion of a given sample belonging to the read length bin of interest. X-axis 
indicates the study arm and study visit. Points are colored according to the patient that the 






Several previous studies have assessed the small RNA component of mammalian 
sperm. In order to compare the small RNAs in the human sperm from the MARS study, the 
highly expressed small RNAs were assessed, as shown in Table 4.9 and Figure 4.13. The 
top 50 small RNAs were primarily tRNAs (15/50, 30%), piRNAs (13/50, 26%), rRNA (8/50, 
16%) and miRNAs (7/50, 14%). When considering all small RNAs that were highly expressed 
(using an arbitrary threshold of median RPM exceeding 50 RPM), 153 small RNAs were 
identified as highly expressed. As with the more limited “Top 50” set shown in Table 4.9, the 
highly expressed set was dominated by piRNAs (42/153, 27%), miRNAs (37/153, 24%), 
tRNAs (25/153, 16%), small nuclear RNAs (16/153, 10%), and rRNA (8/153, 5%), as shown 
in Figure 4.13. 
 
Figure 4.13. Distribution of small RNA families in highly expressed small RNAs. Highly 
expressed small RNAs were defined as having a median RPM exceeding 50 across all MARS 







Table 4.9. Top 50 small RNAs in MARS small RNA libraries. “small RNA ID” indicates the 
small RNA species, while the adjacent “Median RPM” column indicates the median expression 
value in RPM, across the MARS small RNA libraries.  
 
small RNA ID Median RPM small RNA ID Median RPM 
LSU-rRNA_Hsa 419782.8 ENSG00000283293| 
ENST00000636484 
1073.7 
SSU-rRNA_Hsa 109860.6 tRNA-Met 1012.6 
chrM 77858.1 tRNA-Met-i 1012.6 
hsa_piR_016735 20128.9 tRNA-Ser-AGY 933.3 
TRNA_GLY 16437.5 hsa_piR_019914 855.5 
5S 11970.6 hsa-let-7b-5p 755.5 
LSU-rRNA_Cel 11908.2 hsa_piR_008114 710.2 
SSU-rRNA_Dme 9280.0 hsa_piR_008113 677.8 
hsa_piR_000823 8419.9 tRNA-Leu-CTA_ 677.0 
LSU-rRNA_Dme 8214.1 hsa-miR-375 669.8 
hsa_piR_000765 6957.7 tRNA-SeC(e)-TGA 567.8 
Y4 6693.5 tRNA-Val-GTA 514.6 
hsa_piR_020326 5798.1 tRNA-Leu-CTA 507.5 
tRNA-Asp-GAY 5675.3 hsa_piR_019825 440.1 
TRNA_GLU 5505.7 hsa_piR_006046 431.5 
HY1 3908.0 hsa-miR-21-5p 428.2 
tRNA-Leu-CTY 3381.0 U4B 427.9 
7SL 3332.4 hsa-let-7a-5p 416.5 
SSU-rRNA_Cel 2705.0 tRNA-Pro-CCA 393.9 
RRNA45 2521.4 hsa-miR-26a-5p 352.8 
hsa_piR_004153 2288.6 hsa-miR-30a-5p 324.1 
LOR1I 1550.4 hsa_piR_015249 302.7 
TRNA_VAL 1411.4 tRNA-Leu-TTG 295.5 
tRNA-Lys-AAG 1279.6 hsa-miR-191-5p 288.2 
hsa_piR_017716 1090.8 hsa_piR_009294 288.0 
 
MARS small RNA populations were largely concordant with the small RNA proportions 
in human sperm indicated by Donkin et al., who found that when rRNAs were excluded, 
piRNAs, tRNAs, and miRNAs comprised a large proportion of the remaining small RNAs [46]. 
While Donkin et al. identified 37 piRNAs with a false discovery rate (FDR) below 0.1, those 
37 piRNAs do not overlap with the piRNAs identified above as being highly abundant. This 
likely reflects the different experimental paradigms (i.e phthalate exposure and bariatric 
surgery for weight management). 
Work in mice has previously shown an abundance of tRNA fragments in mature sperm 





Glutamic Acid). In human sperm, I find tRNA-GLY and tRNA-GLU to be the 1st and 3rd most 
highly abundant tRNAs, respectively, as shown in Table 4.9. As noted in Chen et al., sperm 
transfer RNA–derived small RNAs (tsRNAs) and miRNAs exhibit expression changes after 
High-Fat Diet (HFD) in a paternal mouse model, and parallel inherited metabolic disorders in 
offspring. The noted highly expressed tsRNAs in sperm (which accounted for ~70% of sperm 
tsRNAs) were derived from tRNA-GLU, tRNA-GLY, and tRNA-VAL (Glutamic Acid, Glycine, 
and Valine) [72], which correspond to the 3rd, 1st, and 5th most abundant tRNAs in the current 
study. Additional murine sperm analysis [71] indicates that tRNA fragments are accumulated 
by maturing sperm during epidydmal transit. Paternal protein restriction affects caudal sperm’s 
tRNA fragment levels and miRNA levels. Notably, tRNA-GLY, which is highly expressed in 
sperm, is more abundant in protein restricted mice. tRNA-GLY fragments delivered by sperm 
have been proposed to regulate the target genes of the MERVL endogenous retroelement in 
the murine embryo.  
Previous work on spermatozoal small RNAs (18–30 nucleotides) by the Krawetz 
laboratory, using ejaculates of three fertile individuals [313], suggested that between 20 and 
60% of the sequenced reads were donor specific, indicated extensive sample heterogeneity 
in sperm’s small RNAs. The MARS small RNAs were analyzed for expression specificity, and 
revealed that of the 12,779 small RNAs, 48% were expressed at a level exceeding 5 RPM in 
only a single sample, as shown in Figure 4.14. Overall, this suggests that a majority of the 
small RNAs measured in the MARS study will exhibit extensive sample specificity, regardless 






Figure 4.14. Heterogeneity of small RNAs. For 12779 small RNAs, the Y-axis indicates the 
count (in log10) of the small RNAs, and the X-axis indicates the count of small RNA libraries 
with an expression value exceeding 5 RPM.  
 
piRNA cluster expression 
Small RNAs have a known role in genomic imprinting and establishment of the embryo 
in plant species [314]. Given this suspected importance of piRNAs in gene regulation and 
confrontation/consolidation within the embryo, the expressed piRNAs were examined to 
determine if any particular piRNA clusters were transcribed. piRNA alignments were obtained 
from https://www.pirnadb.org/ for hg38. piRNA cluster information was obtained from the 
piRNA cluster database (http://www.smallrnagroup.uni-mainz.de/piRNAclusterDB.html), 
using the pooled generic testis dataset from Homo sapiens [183, 315]. Most piRNAs have 
alignments in relatively few parts of the genome, with a few piRNAs occurring many times 
(>100 times) in the human genome. A total of 14 piRNA clusters had two or more piRNAs 
present (median RPM > 1 RPM) in the sperm small RNAs, as shown in Appendix J. 
Interestingly, two clusters (on different chromosomes) had 6 expressed piRNAs, suggesting 
that the two clusters may be active in late  human spermatogenesis.  
Small RNAs altered by DBP exposure 
A LMEM was applied to the individual study arms to assess the impact of DBP 





across the entire arm. This approach, did not differentiate between study visits (e.g. baseline, 
crossover, and crossback), but instead treated samples as replicates of the associated high-
DBP or background-DBP conditions. This use of this approach was necessary due to small 
sample sizes of the individual study visits. Both the use of an empirical P-value and Benjamini-
Hochberg correction produced similar numbers of significant small RNAs. For concordance 
with adjustment strategy employed in the long RNAs, an empirical P-value was used for the 
small RNAs. As shown in Figure 4.15 and detailed in Appendix K, in comparison to non-DBP 
medication, the B1HB2 arm showed upregulation of 3 small RNAs in response to high-DBP 
mesalamine and downregulation of 12 small RNAs. In the H1BH2 arm, exposure to high-DBP 
mesalamine upregulated 9 small RNAs and downregulated 77 small RNAs. The difference in 
detection of differential small RNAs between study arms was likely due to the smaller sample 
size of the B1HB2 arm. CHARLIE3, a hAT-Charlie DNA transposon, and hsa_piR_019675 
were differentially regulated in both study arms. Of note, CHARLIE3 was upregulated in the 
B1HB2 arm, yet down regulated in the H1BH2 arm upon high-DBP exposure. In contrast, 
hsa_piR_019675 was down regulated in both study arms upon high-DBP exposure. Although 
the biological significance of hsa_piR_01967 is not yet known, its genomic loci overlap several 






Figure 4.15. Volcano plots of differential small RNAs. The left and right panels show the 
volcano plots for the H1BH2 arm and the B1HB2 arm, respectively. The X-axis indicates the 
log10 expression change (slope) in RPM, while the Y-axis indicates the negative log10 
empirical P-value. 
 
Regulatory roles of small RNAs  
Small RNAs, e.g., miRNAs and piRNAs, are known to be regulators of transposable 
elements and mRNA expression [317-321]. Relatively few small RNAs were modified by DBP 
exposure (Figure 4.15 and Appendix K), and do not appear to underly gene expression 
changes observed in the long RNAs. However, given the presence of both complex and 
simple genomic repeats that are compartmentalized within the sperm [156], their association 
with sncRNAs was considered. The association of sncRNAs with genomic repeats were 
assessed by correlation in each individual study arm. The use of a series of expressed small 
RNAs that are physically linked to repeat sequences within the small RNA libraries enabled 
their exact positioning. Independent of the study arm, greater than 90% of the small RNA 
Spearman correlations were positive. In comparison, within the H1BH2 arm, 6.8% (37,098 of 
548,628) and the B1HB2 arm 8.4% (18,880 of 224,115) of small RNA correlations were 





The majority of the negative small RNA pairs were concordant between both study 
arms, suggesting that their effect remains constant across exposures (Figure 4.16). For 
example, RNA pairs shared between the B1HB2 arm and H1BH2 arm include piRNA:rRNA, 
miRNA:rRNA, rRNA:snRNA, rRNA:SINE1/7SL, rRNA:tRNA, ERV1;rRNA, while the B1HB2 
arm also included ERV3:rRNA, L1:rRNA, rRNA:snoRNA, Endogenous Retrovirus:rRNA, and 
ERV2:rRNA. Interestingly, the small rRNA fragments were negatively correlated with many of 
the other small RNAs (piRNA, miRNA, snRNA, tRNA, snoRNA) and genomic repeats 
(SINE1/7SL, ERV1, ERV2, ERV3, L1, Endogenous Retrovirus). piRNAs exhibited a series of 
strongly negative correlations with Endogenous Retrovirus, L1, ERV1, and Simple repeats, 
likely reflective of a suppressive role, while miRNAs were negatively correlated with 
Endogenous Retrovirus. This is consistent with the view that piRNAs and miRNAs, either 






Figure 4.16. Top 40 positive and negative small RNA pairs. (A) The RNA pairs with the 
highest count, among the RNA pairs with a Spearman rho less than -0.2, are shown in order 
of most counts to least counts, from left to right. The proportion of each RNA pair belonging 
to given correlation range (e.g. a bin of 0.8;0.9 contains correlations with a rho greater than 
or equal to 0.8 and less than 0.9.) are stacked along the Y-axis and colored according to the 
correlation range. The RNA pairs in the top 40 negative pairs for both study arms (B1HB2 arm 
and H1BH2 arm) are indicated in red text along the X-axis. For example, piRNA;rRNA contains 
the greatest number of negative correlations in both study arms and is thus shown on the 
leftmost side of each of the figures in panel A. The dominance of negative correlations is 
displayed as a series of stacked bars in red shading. (B) The RNA pairs with the highest count, 
among the RNA pairs with a Spearman rho greater than 0.5, are shown in order of most counts 
to least counts, from left to right. The proportion of each RNA pair belonging to given 
correlation range (e.g. a bin of 0.8;0.9 contains correlations with a rho greater than or equal 
to 0.8 and less than 0.9.) are stacked along the Y-axis and colored according to the correlation 
range. The RNA pairs in the top 40 positive pairs for both study arms (B1HB2 arm and H1BH2 






The interaction of long RNA repetitive elements with small RNAs 
To assess the veracity of the above, genomic repeat associations were extended to 
the long RNA libraries, thus excluding the possibility that the interactions were merely 
observed in fragmented RNAs. As shown in Table 4.10, the majority of repetitive elements in 
human sperm were simple repeats, followed by ERV1, tRNA, and ERVL. This is in accord 
with both the repetitive elements observed in small RNA libraries (Figure 4.13C) and previous 
repeat enrichment analyses through spermatogenesis to zygotic genome activation  [156, 
245]. 
Table 4.10. Overall repeat expression in long RNA libraries. “Repeat Family” column 
indicates the repeat class. “Total” column indicates the total number of REs that overlap 
genomic repeats from the given repeat class. “Median >1 RPM” and “Median >5 RPM” 
indicate the number of REs overlapping the given genomic repeat that have a median 
expression value greater than 1 RPM or 5 RPM, respectively.  
   
B1HB2 ARM H1BH2 ARM 








SIMPLE_REPEAT 3292 578 315 582 322 
ERV1 285 27 19 26 14 
TRNA 46 15 9 16 11 
ERVL 118 6 4 6 4 
UNKNOWN 39 5 2 4 1 
ERVL-MALR 78 5 3 4 2 
ERVK 38 4 2 4 2 
DNA? 18 3 2 3 2 
HAT-CHARLIE 73 3 1 3 0 
SATELLITE 10 2 2 2 2 
RRNA 3 2 2 2 2 
HAT? 6 2 2 2 2 
SCRNA 5 2 1 2 1 
L1 129 1 1 1 1 
LTR 5 1 1 1 0 
GYPSY 17 1 0 1 0 
HAT-TIP100? 3 1 0 1 0 
MERLIN 1 1 0 1 0 
DNA 11 1 0 0 0 






The combined small RNA:long RNA correlations primarily yielded positive correlations 
(71.2% and 73.1% in the B1HB2 arm and H1BH2 arm, respectively), concordant with the small 
RNA-only correlations (small RNAs:small RNAs). As previously observed for the small RNA-
only analysis, the RNA pairs with the greatest number of negative correlations or positive 
correlations were largely shared between the two study arms. However, unlike the small RNA-
only analysis (Figure 4.16), nearly all of the top 40 negative pairs exhibited a high background 
of positive correlations, among comparatively fewer negative correlations. 
piRNAs can act as direct regulators of transposable elements [317] and miRNAs also 
have indirect roles in modulating transposons and direct roles in modulating mRNA [318-321]. 
Both miRNA and piRNA were primarily correlated to long RNA repetitive elements in a positive 
manner (Figure 4.17). However, a small portion of the miRNA pairing to Simple repeats, 
ERV1, ERVL, and tRNA were highly negative. Similarly, a small portion of the piRNA pairings 
to Simple repeats, ERV1, ERVL, ERVL-MaLR, and tRNA were highly negative. Interestingly, 
despite a similar read coverage of the rRNA locus by long and short RNA libraries, rRNA 
fragments in the long >200 bp RNA libraries were largely positively correlated with piRNA, 






Figure 4.17. miRNA, piRNA and tRNA correlations to genomic repeats in long RNA 
libraries. (A) Pairs for which a miRNA was correlated with a repeat in the long RNA samples. 
(B) Pairs for which an piRNA was correlated with a repeat in the long RNA samples. (C) Pairs 
for which an tRNA in the small RNA libraries was correlated with a repeat in the long RNA 
samples. The top 20 most numerous pairs and their given Spearman correlations are shown, 
with the pairs identically graphed in the same order for both study arms. The proportion of 
each RNA pair belonging to given correlation range (e.g. a bin of 0.8;0.9 contains correlations 
with a rho greater than or equal to 0.8 and less than 0.9.) are stacked along the Y-axis and 







Figure 4.18. rRNA correlations to repeats and small RNAs. (A) Pairs for which an rRNA 
repeat (derived from the long RNA) was correlated with an expressed small RNA are shown. 
(B) Pairs for which an rRNA repeat (derived from the small RNAs) was correlated with a repeat 
from the long RNAs are shown. The top 20 most numerous pairs and their given Spearman 
correlations are shown, with the pairs identically graphed in the same order for both study 
arms. The proportion of each RNA pair belonging to given correlation range (e.g. a bin of 
0.8;0.9 contains correlations with a rho greater than or equal to 0.8 and less than 0.9.) are 
stacked along the Y-axis and colored according to the correlation range. 
 
Concordant with piRNA and miRNA pairings, the majority of tRNA (from small RNA 





exhibiting negative correlations (Figure 4.17). Additionally, piRNA, miRNA, tRNA, and 
scaRNA, while largely positively correlated with three main ERV family members (ERV1, 
ERV2, and ERV3) [322], also exhibit a series of strong negative correlations (Figure 4.19). 
Interestingly, all ERVs have strong negative correlations with short rRNA fragments and short 
RNA simple repeats. Together, this data supports that view that tRNAs, miRNAs, and piRNAs 
are negative regulators of the observed repeat partners, and they likely act in a target-specific 







Figure 4.19. ERV correlations to small RNAs. (A-C) Pairs for which an ERV repeat (derived 
from the long RNA) was correlated with an expressed small RNA are shown. The top 20 most 
numerous pairs and their given Spearman correlations are shown, with the pairs identically 
graphed in the same order for both study arms. The proportion of each RNA pair belonging to 
given correlation range (e.g. a bin of 0.8;0.9 contains correlations with a rho greater than or 







Dynamic changes in sperm RNAs occur during spermiogenesis  
Detection of consistent associations between small RNAs and long RNA with sperm 
repetitive elements suggests a dynamic relationship. As shown in Figure 4.20, small rRNA 
fragments and large rRNA fragments exhibit opposite correlations with piRNA, miRNA, tRNAs 
and scaRNA (Figure 4.20, center). In addition, these small RNAs were primarily positively 
correlated (Figure 4.20, solid line) with simple repeats and ERVs. However, select ERV1 
repeats (HERV17-int and HERVIP10FH-int) and ERV3 repeats (MER68C, LTR47A2, 
LTR86B2, and LTR86A2) were negatively correlated (Figure 4.20, dotted line) with small 
RNAs. This suggested an opposite relationship between the select ERVs and piRNA, miRNA, 
tRNAs and scaRNAs. Similarly, simple repeats, while positively correlated with most small 
RNAs, had a series of strong negative correlations to small RNAs (Figure 4.20, dotted line 
with blue star). Specific miRNAs, highlighted by hsa-miR-4516 and hsa-miR-30a-3p and 
scaRNAs, such as scaRNA15, scaRNA 13, and scaRNA8, comprised a large proportion of 
the negative correlations to simple repeats (Figure 4.20, dotted line with blue star). Among 
the tRNAs, which are assumed to be tRNA fragments, tRNA-GLY, tRNA-VAL, tRNA-ILE, and 
tRNA-MET accounted for the greatest number of negative correlations. 
 
Figure 4.20. Relationships of sperm RNA repeats 
and small RNAs. Negative and positive correlations 
are represented as dashed lines and solid lines, 
respectively. Negative correlations that only occur in 
a specific manner are marked with a star. tRF=tRNA 











The presented interactions in Figure 4.20 are not known to be causal (either indirectly 
or directly) but are intended to illuminate the possible dynamic processes during 
spermiogenesis. Creation of a functional spermatozoa capable of fertilization requires a 
complex re-arrangement of organelles during the post-meiotic phase of spermatogenesis, 
accompanied by removal of the cytoplasmic droplet. Additionally, the spermatid nucleus 
undergoes extensive chromatin compaction of the haploid genome, replacing the majority of 
histones with protamine toroids. Due to these changes and extensive degradation of RNAs, 
including ribosomal RNAs, the ejaculated spermatid is transcriptionally and translationally 
inert. The rRNA locus exhibited a similar read coverage of the by long and short RNA libraries. 
However, given the opposite associations of long and short rRNA fragments to small RNA 
species, it is tempting to speculate that the two rRNA populations represent decreasing and 
increasing rRNA fragmentation, respectively. The paradigm in mammalian spermatozoa is 
that sperm do not contain intact rRNA, having undergone extensive fragmentation during the 
post-meiotic phase of spermatogenesis. The current analysis suggests that there is a 
spectrum of rRNA fragmentation, ranging from long (>200 bp) fragments to short (<50 bp) 
fragments. These long and short rRNA fragments were not strongly correlated (either 
negatively or positively), and so are not connected in Figure 4.20. The biological phenotype 
associated with the network is unknown. However, the dynamics are suggestive of a choice 
between destructive and non-destructive pathways during spermatogenesis, and possibly the 
quality of the ejaculated spermatozoa. This dynamic spermatozoal network may also play a 
role in the considerable transcriptomic intra- and inter-individual heterogeneity of human 
sperm. 
v. Discussion 
In both rural and urban environments, humans are exposed to cocktails of endocrine 
disruptors [323]. While environmental regulations designate maximum allowable levels of only 





models, which may not accurately reflect the human condition. The human male is known to 
mediate some intergenerational effects in offspring [17], yet the intergenerational effect of 
adult paternal exposures to common xenobiotics and endocrine disruptors, particularly in 
humans, is poorly characterized. The MARS study showed that exposure of human males to 
high levels of a single endocrine disruptor, di-butyl phthalate (DBP), was capable of reducing 
sperm motility in DBP-naïve subjects [69].  
Applying RNA-seq to the MARS samples (Figure 4.1) showed that DBP-induced 
alterations in spermatozoal RNAs were largely unique to a single study arm (either the acute 
B1HB2 or chronic H1BH2 study arm). Each biological response to increasing or decreasing 
DBP levels yielded a different altered RNA profile (Table 4.4). Interestingly, novel RE’s 
comprise a significant portion of altered REs, indicating that DBP exposure(s) affects far more 
than the previously known transcripts. The RNA profiles observed in the ejaculated 
spermatozoa reflect the final outcome of spermatogenesis, which includes both RNAs 
generated in preparation for differentiation and those acquired during epididymal maturation 
for transmission to the future embryo. Within the immunoprivileged state of the testis 
(reviewed in [324]), the spermatogenic effect of high-DBP mesalamine is likely communicated 
through Sertoli cells that support the germline during differentiation, or through the epididymis 
during transit, when the sperm first become exposed to other fluids.  
Mammalian models have previously indicated that phthalate exposure may be acting 
on reproductive tissues through processes that include PPAR-dependent mechanisms [58-
60], inducing oxidative damage [67, 68]. In the current study, several spermatogenesis-related 
pathways, including activation of EIF2 signaling and the PPAR-alpha/RXR-alpha signaling, 
were strongly associated with the transition from baseline (B1 visit) to crossover (H visit) 
(Figure 4.8B). This suggests that a concerted shift in the Peroxisome Proliferator-Activated 
Receptor alpha (PPAR-alpha) and Eukaryotic Initiation Factor 2 (EIF2) pathways occurs at 





temporary respite of a single spermatogenic cycle on non-DBP medication, the return to high-
DBP mesalamine activated oxidative stress and DNA damage response pathways, perhaps 
signaling the beginning of the repair process (Figure 4.8A). The ontological association of 
androgen receptor coregulation in the H1BH2 arm of the MARS study also suggests that 
responses to in vivo adult exposures elicits androgen disruption, which has previously been 
implicated in phthalate-induced testicular dysgenesis syndrome. Notably, subjects in the 
H1BH2 arm have been chronically exposed to high-DBP mesalamine, some for several years, 
prior to the MARS study and are assumed to have reached a phthalate-induced expression 
plateau in response to the high-DBP levels. The temporary (1 spermatogenic cycle) 
withdrawal from high-DBP mesalamine then precedes the additional and significant stress 
imparted onto the germline upon re-introduction of high-DBP mesalamine. 
Among the genomic repetitive elements shown to be enriched in spermatozoa, TC-
rich tetramers form a larger contribution to the sperm RNA when an individual has experienced 
a high-DBP exposure in the previous spermatogenic cycle (Figure 4.10). The time required 
to fully recover is not known and may well be far longer than the single crossback cycle 
observed in the B1HB2 arm of the current study. Nevertheless, the study indicates that any 
recent high-DBP exposure increases the abundance of simple repeats in human 
spermatozoa. The biological function of these recurring simple repeats in spermatogenesis, 
fertilization and early embryo development has yet to be defined [245]. However, they are 
compartmentalized in sperm [156], perhaps reflective of a role in sperm chromatin 
organization. Phthalate’s noted ability to increase DNA nicking [310] and thus spermatozoal 
DNA fragmentation [67, 68] in a specific manner [311] may alter the specialized compact 
chromatin environment in spermatozoa. The physiological effect(s) of the cocktail of 
background exposure to endocrine disruptors in humans, particularly in somatic tissue, is 





(mediated by sperm RNA content and sperm epigenome), ubiquitous human exposure to 
phthalates and other known endocrine disruptors remains a concern. 
The MARS study also provided the opportunity to assess the spermatozoal impact of 
mild Inflammatory Bowel Disease (IBD). IBD, defined as Ulcerative colitis and Crohn’s 
disease, is a common condition, with a prevalence of approximately 1 per 500 people [325]. 
The current study compared males with non-flaring, mild IBD treated daily with mesalamine 
to a control cohort of fertile males from idiopathic infertile couples. As expected, mild IBD, or 
chronic mesalamine use, had minimal impact on spermatozoal contents (Figure 4.6). 
The transcriptomic dynamics across human spermatogenesis is complex [175, 245, 
326]. Mechanisms driving transitions across sperm differentiation have been largely inferred 
from mammalian model systems [327, 328]. The final stages of sperm differentiation, 
spermiogenesis, is noted for extensive modification of chromatin structure, organelle 
distribution, and changes in RNA composition [35, 36, 245]. However, the role of RNAs in 
promoting these modifications has only recently begun to be addressed [156, 329]. Previous 
studies on chromatin structure have suggested a role for genomic repeats in establishing and 
maintaining chromatin. The MARS dataset demonstrated an spermatozoal enrichment of 
transcribed repetitive elements, including simple repeats, ERV1, tRNA, and ERVL, which may 
play a role in establishing the human spermatid. The relationship between transcribed repeats 
(such as simple repeats and endogenous retroviruses), ribosomal RNAs, and small non-
coding RNAs in ejaculated sperm was also uncovered. The identification of small cajal body-
specific RNAs (scaRNAs), involved in small nuclear ribonucleoprotein (snRNP) biogenesis, 
highlights the importance of RNA processing and localization in spermatogenesis. 
The high-level network presented in Figure 4.20 provides a snapshot of the networks 
involved in successful spermiogenesis, selective spermatid apoptosis [154, 330, 331], or 
maturation during epididymal transit [71, 332-334]. The morphological and transcriptomic 





due to choices along this network. This was exemplified by the RNA dynamics in 
spermiogenesis of DBP-naïve subjects, adjusting their response in accord with position along 
the network, i.e., spermatozoa recently exposed to high-DBP are enriched in simple repeats.  
At present, the MARS study shows that exposure of human males to high levels of a 
single endocrine disruptor, di-butyl phthalate (DBP), can alter spermatozoal RNAs and 
expression of genomic repeats in sperm. Furthermore, an individual’s history of high-DBP 
exposure influences their reproductive response to changes in DBP levels. The time period 
required to fully recover from a high-DBP exposure, while currently undetermined, was 
suggested in this study to be longer than a single spermatogenic cycle (approximately 90 
days). Future in vitro and in vivo experiments relevant to adult phthalate exposures are 
required to identify the mechanisms and pinpoint the biological processes at work in the 
reproductive and endocrine systems of phthalate-exposed adults. Observational studies of 
offspring from DBP-exposed fathers will provide a path to determine the extent of the impact 







CONCLUSIONS AND FUTURE DIRECTIONS 
Developmental Origins of Health and Disease (DOHaD) proposes that 
preconceptional, prenatal and childhood exposures affect health outcomes later in life. The 
use of animal models has shone light on the importance of maternal health and gestational 
influence on offspring health. Notably, environmental exposures, such as exogenous 
endocrine disruptors, can be influential during key periods of susceptibility in fetal 
development [338-341]. However, the male influence in DOHaD has only begun to be 
appreciated. In this final chapter, I review the discoveries made regarding the pre-
conceptional environment of human embryos, and contents of the male germline.  
i. Assisted Reproductive Technologies 
The circumstances surrounding a successful human birth are complex. The initial 
events involve the fertilization of a matured oocyte by a presumably high-quality spermatozoa, 
followed by embryonic cell division and finally implantation [342]. Advanced Assisted 
Reproductive Technologies, such as IVF, ICSI, cryopreservation, controversial nuclear 
transfer and Mitochondrial transfer techniques, manipulate the pre-implantation embryo [343-
345]. While such infertility treatments offer hope to individuals struggling to conceive, the 
treatments may also have unintended consequences for the offspring due to an altered pre-
conceptional and pre-implantation environment. With the exception of intentional embryonic 
gene editing [346], the effect(s) of ART on offspring are expected to be primarily epigenetic in 
nature. A variety of epigenetic mechanisms, such as DNA methylation, histone modifications, 
and chromatin structure, are potentially altered by ART [82, 89, 91, 97].  
DNA methylation, the addition of a methyl group to DNA, is typically examined in 
context of 5-methylcytosine (5-mC). In Chapter 2, I examined the influence of several ART 
processes, including embryo cryopreservation, on the 5-mC profiles of the child soon after 





naturally, or through the use of intrauterine insemination (IUI), or in vitro fertilization (IVF) 
using Fresh or Cryopreserved (Frozen) embryo transfer, were compared. Except for the 
naturally conceived infants, all newborns used in the study were born to parents experiencing 
some degree of infertility, which required IUI or IVF/ICSI to resolve. Naturally conceived 
infants were shown to have a dramatically different methylation profile compared to those born 
through IUI or ICSI. Therefore, this research suggests that the underlying infertility of the 
parents influences the child’s methylation. However, outside of ensuring that the samples 
were from full-term newborns, this work did not consider maternal characteristics, such as 
race, age, and socio-economic status, due to a lack of maternal and demographic information. 
In particular, the natural conception group was drawn from an urban, primarily African-
American population, while the assisted conception group was drawn from patients 
undergoing fertility treatment in a suburban clinic. Such maternal characteristics can bias 
results and should be considered when modeling datasets from in future newborn cohorts. 
However, if the current interpretation is accurate, this would lead to the striking conclusion 
that successful treatment of infertile individuals, even by relatively non-invasive measures, 
produces a cohort of children with an epigenome different from those born to fertile individuals. 
Human infertility is a common condition, affecting approximately 12% of couples of 
childbearing age in the United States [30], which has a variety of causes. Therefore, 
examination of the newborn’s epigenome in context of the infertility diagnosis (e.g. male factor, 
specific female factor) will be essential for characterizing this future population of children. 
A second interesting observation was the striking similarity of IUI and IVF-Frozen 
embryo transfer infants (Figure 2.2). This suggested that epigenetic aberrations in the IVF 
conceptions may be abrogated using embryo cryopreservation. Notably, these results are in 
accord with the observed reduction in birth defects using ART protocols that employ 
cryopreserved embryos [89]. Taken together, these studies implicate a resetting mechanism 





embryos are likely to be naturally cycling, whereas patients undergoing fresh embryo transfer 
(excluding the use of gestational surrogates) recently experienced unusual hormonal and 
physical stresses in preparation for oocyte extraction. Due to a number of social and economic 
factors, embryo and oocyte cryopreservation are increasingly being utilized by infertility clinics 
[347]. The above research indicates that this trend towards cryopreservation may be 
beneficial to the offspring and help ameliorate any epigenetic aberrations introduced by the 
use of IVF/ICSI.  
Periconceptual nutrition, in the context of unassisted conception, is known to alter 
epigenomes of offspring at specific loci termed metastable epialleles (MEs). With the current 
cohorts, I tested the hypothesis that ME loci were sensitive to early nutritional exposure in the 
context of IVF culture conditions. IVF culture conditions and parental infertility showed 
consistently altered methylation at certain MEs. This was the first study to reveal an impact of 
ART or fertility status on MEs and suggests a lasting epigenetic effect of IVF nutrition on the 
developing embryo. However, it is important to note that the current study was limited to loci 
targeted by the 450K array, and further limited by the ChAMP approach, which did not assess 
methylation changes of loci with fewer than two probes. The implementation of the larger EPIC 
array MethylationEPIC BeadChip array, which covers over 850,000 CpG sites and provides 
greater coverage of distal regulatory elements, or bisulphite sequencing, which can provide 
whole genome coverage, would be more informative in future cohorts. Additionally, while the 
current cohort had limited patient data, a large matched cohort with detailed records of 
maternal and gestational variables, employing more expansive DNA methylation detection 
methods, would serve well to verify the observed sites and identify additional epimutations 
that may be caused by ART. 
ii. Sperm RNA 
The RNA profiles of human sperm, as well as how RNA profiles change after endocrine 





specialized cell type, with a unique cell structure [35] and transcriptome [154]. Mature 
spermatozoa are transcriptionally and translationally inactive, with a high degree of RNA 
fragmentation to ensure silence and expunge the majority of the cytoplasm [35]. For the 
majority of the known transcriptome, the considerable heterogeneity and transcriptome 
fragmentation in spermatozoa renders common gene expression approaches inaccurate. 
Additionally, recent studies have observed a series of RNAs arising from intronic and 
intergenic loci, which are not enumerated in the annotated human transcriptome [154, 163].  
To fully address these intronic and intergenic RNAs, the RNA Element (RE) discovery 
algorithm (REDa) was developed [245]. REDa is a tool for the discovery of transcribed, 
unannotated sequence elements from RNA-seq libraries, and was applied to a spectrum of 
tissues and cells representing germline, embryonic, and somatic tissues, shown in Figure 3.3. 
In all examined tissues, previously unannotated RNAs were identified, with transcription of 
such RNAs throughout the autosomes and sex chromosomes. Interestingly, the post-meiotic 
stages of spermatogenesis (Round spermatids and ejaculated sperm) contain large numbers 
of novel (intergenic and intronic) REs (Figure 3.7). While the function of these novel RNAs in 
spermatogenesis is not known, murine spermatozoa have shown preferential localization of 
RNAs [156]. Identification of the cellular location of the human sperm RNAs, both from known 
transcripts and novel REs, across the post-meiotic stage of spermatogenesis, would be a first 
step towards understanding the potential function of sperm RNAs. 
It has been proposed and shown in vitro that human sperm deliver a collection of RNAs 
upon fertilization [154, 160, 211, 212]. The series of human RNA-seq profiles from sperm, 
oocyte, and embryo allowed for the identification of REs that were transmitted to the human 
oocyte solely by sperm. As expected, the majority of zygotic RNAs were shown to be derived 
from the oocyte. However, up to 289 sperm REs were identified as a majority contributed by 
paternal transmittance, with an FDR of ~3.4%, and 75 REs essentially provided by the sperm, 





in the embryo was not examined in the current work, such RNAs may play a regulatory role 
in the embryo. Of particular interest are any full length RNAs, as these are potentially 
translated in the embryo [154]. Micro-injection of known paternally delivered RNAs, in the 
context of murine or human embryos, would serve to determine if such RNAs can tune embryo 
development. 
Novel REs (intronic, near-exon, and orphan REs) often correspond to the same 
regions as genomic repeats. Given this association, the population of REs was used to 
determine the enrichment of genomic repeats in various cell types. This approach has the 
advantage of knowing the exact location and proxy expression (via RE expression) of the 
genomic repeat. Certain retrotransposons are of known interest in the early human embryo, 
such as ERVL [188, 348], SINE-VNTR-Alu (SVA) elements, and LTR12 (LTRs of HERV9) 
[349]. The current study also demonstrated transcriptional enrichment of ERVL (MLT2A1 and 
MER73) and SVA (SVA-D) during human embryogenesis. Repeat transcription during 
spermatogenesis was also observed, with an enrichment of simple centromeric repeats, 
MER1A (DNA transposon), HERVE, HSAT1 (Satellite) [350], and LTR71B (member of the 
ERV1 family) [322] during spermatogenesis. The classes of enriched repeats appears to be 
vastly different between spermatogenesis and embryogenesis, with an additional switch 
during embryonic genome activation, when REs associated with MLT2A1 and SVA-D are 
transcribed. It is important to note that the observed repeat enrichment in round spermatids 
and spermatozoa may be indicative of a targeted retention of certain RNAs during the RNA 
degradation and cytoplasmic expulsion of spermatozoa, rather than active transcription of the 
given repeat. This distinction cannot be determined with the current data structure, but 
requires measurement of the spermatozoal RNAs in context of a consistent exogenous control 
RNA. An alternative approach would be to perform target counts with an array platform that 
does not require sample amplification, such as nanoString [351]. It is currently unknown if 





the early embryo. Microinjection of these RNAs into the mammalian embryo, followed by 
examination of the embryonic epigenome and growth characteristics, would improve 
understanding of these RNAs. 
Humans are ubiquitously exposed to endocrine disruptors (EDs), such as phthalates. 
However, the influence and underlying mechanisms of the cocktail of commonplace ED 
exposures on reproduction in humans, particularly in adult males, is poorly understood. While 
such exposures can easily be examined in animal models, there are practical issues to 
observing the causative mechanisms of reproductive effects in humans. However, as 
ejaculated sperm is an accessible cell type, examination of sperm RNAs may assist in 
addressing the reproductive effects of EDs in human males. In addition to being potential 
mediators of transgenerational inheritance, sperm RNAs may act as markers of environmental 
perturbations or disease [163, 254]. Using the MARS study [69], changes in sperm RNAs 
across longitudinal DBP exposure can be assessed to identify DBP-induced reproductive 
changes. Additionally, the availability of MARS samples, which originate from individuals 
suffering from mild IBD, provided the opportunity to identify IBD-induced changes in 
spermatozoa. IBD-induced spermatozoal alterations were thus identified by comparing control 
sperm samples to the B1HB2 arm samples, which represent men initiating the MARS study on 
a DBP-naïve condition. This work showed few sperm RNA changes due to mild IBD. Future 
cohorts should also include individuals with moderate to severe IBD, while controlling for 
medication use. Overall, these results are reassuring for IBD-afflicted males.  
By applying a LMEM to the MARS long RNA samples, the patterns of REs across 
shifting DBP levels (High or Background) were generated. Surprisingly, few REs were altered 
strictly with DBP levels (top two patterns of Table 4.4A). Instead the majority of differential 
REs were altered in solely the Acute phase (Baseline to Crossover) or the Recovery phase 
(Crossover to Crossback). This occurred regardless of the study arm, suggestive of an 





provided the opportunity to identify ontological terms and signaling pathways altered by DBP. 
The DBP-naïve cohort (B1HB2 arm) was associated with translation, PPAR/ RXR-alpha 
signaling, and a strong activation of GP6 signaling. PPARs are known to act as xenobiotic 
sensors, and can interact with phthalates, resulting in PPAR activation [58-60]. The other 
enriched pathways, notably GP6 signaling, have not previously been directly implicated with 
DBP in literature. GP6 is a classical receptor for collagen, involved in platelet aggregation and 
thrombus formation, but also is known to be enriched in human testis [352]. As a gradual 
reduction in collagen binding by sperm during uterine transit has previously been suggested 
to enable sperm capacitation [294, 295], GP6 signaling may play a role in sperm capacitation. 
In contrast, the H1BH2 arm, implicates several pathways classically associated with 
experimental phthalate exposures and phthalate-induced testicular dysgenesis syndrome, 
such as oxidative stress, DNA damage response pathways, and androgen receptor 
regulation. This suggested that re-introduction of DBP-containing medication after a single 
spermatogenic cycle at background DBP level may harm the germline. The use of normalized 
RNA expression to predict DBP-induced activation or repression of signaling pathways 
provides a starting point for targeted proteomic analyses. However, verification of protein 
expression and the presence of known protein modifications involved in signaling pathway 
modulation is needed.  
In addition to the gene ontologies and signaling pathways associated with the 
differential REs, examination of repeat-associated REs suggested that high-DBP exposure 
influenced repeat transcription. TC-rich simple repeats are upregulated by recent (1 
spermatogenic cycle) high DBP exposure, and centromere-associated repeats appear to be 
downregulated by high DBP in DBP-naïve individuals. The current approach has the 
advantages of precisely placing expression of genomic repeats, by using RE expression as a 
proxy for repeat expression. However, this assumes that the overlapping RE is an accurate 





DBP exposure(s) should be replicated using the read coverage of the individual repeat loci. 
Simple repeats have previously been implicated in spermatozoal nuclear matrix-associated 
regions [230], while centromeric RNAs may play a role in establishing stage specific 
chromosomal structure and position throughout spermatogenesis [229, 230]. Altogether, this 
data suggests that DBP likely alters germline chromatin structure during spermatogenesis. 
While testing this hypothesis is outside the scope of this thesis, re-examination of the MARS 
cohort or future cohorts for chromatin accessibility and histone marks (e.g. ChIP-seq) would 
provide a further understanding of DBP-induced chromatin modifications. 
Small RNAs have been implicated as likely mediators of paternal transmission. Using 
a subset of the MARS samples, small RNA-seq libraries were generated to identify the 
changes induced by human in vivo DBP exposure. Compared to the numerous DBP-regulated 
REs in the long RNAs, relatively few small RNAs were identified as being altered by DBP 
(Figure 4.15), in either study arm. However, a single piRNA, hsa_piR_01967, was 
downregulated in both study arms upon high-DBP exposure. Despite the limited power of the 
present small RNA analysis, this work suggests that DBP does impact small RNAs. The 
physiological importance of the altered small RNAs in testis and the spermatogenic cycle is 
not yet known. However, taken together, the long RNA and short RNA fractions of the MARS 
samples suggest that DBP may alter various cellular mechanisms and signaling pathways 
during post-meiotic spermatogenesis. 
The male and female germline are known to have abundant expression of small 
regulatory RNAs, such as piRNAs. Concordantly, abundant piRNAs were observed in the 
MARS dataset. However, the regulatory relationships of RNAs during spermatogenesis is not 
well known. Previous studies imply a role of small RNAs in repeat suppression, with piRNAs 
acting as direct regulators of transposable elements [317] and miRNAs having an indirect role 
[318-321]. However, the relationship of the small RNAs to the larger coding RNAs and RNAs 





datasets, the availability of small RNAs and proxy genomic repeat expression permitted the 
construction of the relationship between the two RNA categories. As shown in Figure 4.20, 
consistent associations between small RNAs and long RNA with sperm repetitive elements 
suggests a dynamic relationship. In particular, small rRNA fragments and large rRNA 
fragments exhibit opposite correlations with piRNA, miRNA, tRNAs and scaRNA. Select ERV1 
and ERV3 elements were also negatively correlated (Figure 4.20, dotted line) with small 
RNAs, suggesting a contrary relationship. Similarly, simple repeats, while positively correlated 
with most small RNAs, had a series of strong negative correlations to select small RNAs. 
Notably, the network suggests opposite relationships of long and short rRNA fragments to 
small regulatory RNAs. Spermatozoa are known to have extensively degraded ribosomal 
RNA, and both long and short rRNA fragments have similar coverage of the consensus rRNA 
loci. It is tempting to thus hypothesize that the small regulatory RNAs may be acting to cause 
rRNA fragmentation. This hypothesis will require extensive work to prove (1) binding of the 
small RNAs to the target rRNA locus and (2) causative fragmentation of rRNA. Regardless, 
the network dynamic is suggestive of a choice between destructive and non-destructive 
pathways during spermatogenesis, and possibly the quality of the ejaculated spermatozoa. 
iii. Conclusion 
The conception and uterine establishment of a human embryo is influenced by a 
variety of factors, including the quality of the male and female germline. In Chapter 2, I outlined 
the importance of the peri-conceptional environment in the context of assisted reproductive 
technologies, namely, IVF/ICSI and cryopreservation. The sub-fertility of the parents and the 
use of embryo cryopreservation alters methylation in the newborn’s blood cells. Additionally, 
while metastable epialleles (MEs) have been previously associated with methyl donor 
supplementation (in mouse) and seasonal diet changes (in human), this is the first work to 





The involvement of the male germline in DoHAD has mostly been shown in mouse 
and rat models. The tools to identify sperm RNAs, which likely are mediators of generational 
transmission were developed and human spermatozoa were examined in the context of a 
common endocrine disruptor. Using ejaculates from men longitudinally exposed to DBP, both 
long and small RNAs were found to be altered by phthalate. Many of the differential long 
RNAs, examined in context of RNA elements, were novel, non-exonic RNAs. These 
exploratory works provide a set of RNAs and repeat classes to examine in future studies of 






Appendix A : DNA quality scores for Newborn bloodspots. A260/A230 and A260/A280 







10006_B 0.08 2.5 10798_B 0.08 2.74 
10010_A 0.13 2.58 10821_C 0.09 2.03 
10046_B 0.09 2.61 10829_C 0.1 2.52 
10055_C 0.1 2.65 10831_C 0.11 2.21 
10058_A 0.1 3.18 10843_B 0.11 2.21 
10101_B 0.15 2.07 10846_B 0.12 2.28 
10117_B 0.1 2.64 10863_A 0.15 2.97 
10133_B 0.08 2.84 10869_B 0.14 1.77 
10136_C 0.1 2.49 10882_B 0.09 2.58 
10141_C 0.09 2.83 10890_C 0.1 2.32 
10156_B 0.09 1.92 10894_C 0.08 2.42 
10208_C 0.07 2.53 10932_B 0.07 2.75 
10225_A 0.14 2.52 10947_C 0.09 2.79 
10231_B 0.11 1.85 11002_B 0.07 2.77 
10255_A 0.1 2.84 11016_B 0.09 2.44 
10291_A 0.14 2.55 11029_B 0.08 2.68 
10292_C 0.09 2.6 11034_B 0.07 2.77 
10344_B 0.1 2.33 11048_C 0.09 2.99 
10346_B 0.08 2.32 11066_A 0.13 2.41 
10347_C 0.17 2.32 11067_A 0.11 2.1 
10350_B 0.11 2 11127_C 0.11 2.67 
10359_C 0.12 2.27 11165_C 0.16 2.35 
10374_A 0.09 2.92 11177_C 0.06 2.62 
10389_C 0.11 2.43 11283_B 0.11 2.62 
10402_B 0.13 1.91 11340_C 0.09 2.68 
10432_B 0.12 2.03 11359_B 0.11 2.1 
10434_B 0.11 2.09 11368_C 0.18 1.77 
10443_C 0.13 2.27 11378_B 0.1 4.99 
10447_C 0.08 2.9 11381_C 0.08 2.5 
10453_C 0.11 2.79 11387_B 0.08 3.66 
10460_C 0.07 2.94 11414_A 0.08 1.99 
10511_C 0.12 2.52 11420_B 0.09 2.82 
10512_A 0.11 2.79 11452_C 0.09 1.82 
10555_C 0.1 2.94 11458_B 0.12 2.19 
10558_B 0.12 2.49 11465_C 0.12 1.97 
10587_C 0.09 2.76 11508_A 0.14 2.21 





10612_C 0.07 3.61 11541_B 0.06 3.44 
10649_C 0.12 2.61 11580_C 0.1 2.59 
10653_A 0.1 2.43 11598_B 0.1 2.82 
10667_C 0.09 2.93 11600_C 0.14 2.19 
10695_C 0.1 2.36 11624_B 0.12 2.37 
10697_B 0.09 3.39 11629_B 0.15 3.4 
10706_B 0.11 2.05 11651_B 0.12 2.22 
10716_A 0.13 2.35 11691_A 0.1 2.72 
10729_C 0.1 2.42 11981_A 0.11 2.25 







Appendix B: Enhancers overlapping differentially methylated regions. Chromosomal 
locations of enhancers are provided.  
FH vs IUI FZ 
vs 
IUI 































































































































































































































































144948782   
chr21:38630405-
38630786 








   
  
chr2:394418-394640 
   
  
chr4:3374732-3375130 
   
  
chr4:640356-640557 
   
  
chr5:1103805-1104368 
   
  
chr5:1107341-1108073 








   
  
chr5:669501-669935 
































   
  
chr8:1847894-1848163 























Appendix C. Regulators with consistent methylation changes between genders of 
multiple conception groups. Regulators with consistent methylation changes between 
genders of two or more conception groups are shown. Methylation changes for each regulator 
in the supporting conception groups are indicated as beta-value changes. Genes associated 
with the given regulator are named and described in the columns titled “Associated Gene” and 
“Protein function”. 
  













7;0.05 4 CYP1A1 
A member of the cytochrome P450 
superfamily, monooxygenases which 
catalyze many reactions involved in drug 
metabolism and synthesis of cholesterol, 











A protein that forms bridges between 
cytoskeletal elements, MACF1 impacts 
microtubule dynamics and associated 


















1 3 IHX8 
A LIM homeobox transcription factor that 
plays a role in tooth morphogenesis, 




















A secretory protein which promotes matrix 
assembly and may play a role in non-








open reading frame 
50 (C7orf50) 
A predicted intracellular protein with 












































protein 7 (GRB7) 
A growth factor receptor-binding protein 
with roles in integrin signaling and cell 







2 Testis expressed 
14 (TEX14) 
A protein highly expressed in testis and 
required for the formation of intercellular 












A transcription factor that binds viral and 







2 Hypoxia inducible 
lipid droplet-





















2 Theg spermatid 
protein (THEG) 
A protein  expressed in the haploid germ 












A histone deacetylase involved in 
transcriptional regulation through MEF2C 











crystallin, alpha A 
(CRYAA) 
CRYAA is a (HSP20) family  molecular 
chaperone with autokinase activity, which 
may be involved in intracellular 
architecture. This protein is preferentially 







-0.07 3 PTPRN2 
Protein tyrosine phosphatase (PTP), of 
the receptor-type PTPs. PTPRN is a 
major autoantigen associated with insulin-










and Novel lincRNA 
(RP11-503G7.2) 
and mucin 8 
(MUC8) 
MUC8 is expressed in epithelial cells of 
the human airway, although the function 




















GALNT9 and related enzymes initiate O-
linked oligosaccharide biosynthesis 
through transfer of N-acetyl-D-







Appendix D. Enhancers with consistent bloodspot methylation changes. Enhancers 
highlighted in blue are consistently altered between all three assisted conditions and natural 
conception. Statistically significant methylation changes observed in conception comparisons 
between NAT and IUI, FH, or FZ, are given in units of beta-values, with changes in male and 
female comparisons shown in blue and red, respectively. Genes associated with the given 






















May play roles in 
cytoskeleton structure 
and cell polarity through 
protein binding [371].  
Evolutionarily conserved region is 
located in the intron of FRMD4A 
and promoter region of an 
alternative FRMD4A isoform. 
Region contains many transcription 
factor binding sites. Site exhibits 
high degree of chromatin 


















nucleotide binding and 
may play a role in cancer 
risk [372]. 
Site is located approximately 13 kb 
and 3 kb from start site of 
C10orf114 and stop site of 
SKIDA1, respectively. Site exhibits 
high degree of chromatin 










kinase inhibitor 1C 
(p57, Kip2) 
(CDKN1C), Solute 
carrier family 22, 
member 18 
(SLC22A18), and 
Solute carrier family 





CDKN1C inhibits several 
G1 cyclin/Cdk complexes 
and may be a tumor 
suppressor. SLC22A18 
acts as an organic cation 
transporter and plays a 
role in drug transport 
[373, 374].  
Site is located in the intron of 
SLC22A18AS, is directly upstream 
of the promoter  for SLC22A18, 
and is approximately 13 kb 
upstream of the transcriptional start 
site for CDKN1C. Site exhibits high 
degree of chromatin accessibility, 











protein 2 (BAIAP2) 
An adaptor protein which 
aids in the conduction of 
signals from membrane 
bound G-proteins to 
cytoplasmic effector 
proteins. BAIAP2 may 
play a role in 
axonigenesis and insulin 
signaling in the nervous 
system [375].  
Enhancer is located in the intron of 
BAIAP2, adjacent to many 
transcription factor binding sites. 
Site exhibits high degree of 
chromatin accessibility, as 




















GNAL, a stimulatory G 
protein alpha subunit, 
modulates signal 
transduction within the 
olfactory neuroepithelium 
and basal ganglia. 
CHMP1B , a component 
of the ESCRT-III 
complex, is likely 
involved in multivesicular 
bodies (MVBs) formation 
[376, 377]. 
Site is located in the intron of 
GNAL and is in the promoter 
region of CHMP1B. Site exhibits 
high degree of chromatin 










peptidase like 2B 
(SPPL2B), LSM7 




SPPL2B encodes an 
intramembrane-cleaving 
aspartic protease (I-
CLiP) involved in ITM2B 
and TNF processing. 
LSM7 is an Sm-like 
protein which likely  
participates in splicing 
through interaction with 
U6 snRNA [378, 379].  
Site is located in the intron of 
SPPL2B and is approximately 4 kb  
upstream of the LSM7 
transcriptional start site. Site 
exhibits high degree of chromatin 





















containing peroxidase is 
involved in extracellular 
matrix formation. 
Involved in ocular 
development and may 
have a systemic role in 
peroxidase metabolism. 
[380, 381] 
Site is located in the intron of 
AC144450.1, and is approximately 
25 kb, 15 kb, and 26 kb away from 
AC141930.2, AC144450.2, and 
PXDN, respectively. Site exhibits 
high degree of chromatin 















A receptor for kynurenic 
acid, GPR35 is involved 
in intracellular signaling. 
AQP12B, as a member 
of the aquaporin family, 
forms a pore to facilitate 
transport of water and 
solutes across cell 
membranes [382, 383].  
Site is located approximately 15 kb 
and 30 kb from GPR35 and 
AQP12B, respectively. Site exhibits 
moderate chromatin accessibility, 









    
Site is located at least 85 kb away 
from any annotated gene. Site 
exhibits moderate chromatin 












Crystallin, alpha A 
(CRYAA) 
CRYAA is a (HSP20) 
family  molecular 
chaperone with 
autokinase activity, which 
may be involved in 
intracellular architecture. 
This protein is 
preferentially expressed 
in the lens. [367] 
Site is located ~ 5kb and 15 kb 
away from AP001631.10 and 
CRYAA, respectively. Site exhibits 
high degree of chromatin 










protein signaling 12 
(RGS12) 
Involved in signal 
transduction, RGS12 
acts inhibits signal 
transduction and thus 
acts as a transcriptional 
repressor [384]. 
Site is located in intron of RGS12. 
Site exhibits a high degree of 
chromatin accessibility, as 












A member of the plakin 
family, EPPK1 may 
regulate and maintain 
keratin intermediate 
filament networks [385].  
Site is located in the unspliced 5' 
UTR of EPPK1. Site exhibits a high 
degree of chromatin accessibility, 










Neuron navigator 1 
(NAV1) 
A member of the neuron 
navigator family which 
may play a role in axon 
guidance [386] 
Site is located in the first intron of 
NAV1. Site exhibits a high degree 
of chromatin accessibility, as 













catalyze many reactions 
involved in drug 
metabolism and 
synthesis of cholesterol, 
steroids and other lipids 
[353]. 
Site is located in the promoter of 
CYP1A1. Site exhibits a high 
degree of chromatin accessibility, 













Protein involved in 
polymerization of tubulin 
and maintainence of the 
microtubule network 
[387]. 
Site is located in the first intron of 
TPPP. Site exhibits a moderate 
degree of chromatin accessibility, 








Appendix E: RE discovery computational methods (REDa) 
Processing bam files 
The RE discovery algorithm is designed to be run entirely in R, with the user providing aligned 
reads in BAM file format. To conserve memory, the BAM files are first converted to bigWig 
format. The user is expected to use the helper function “generatebw” to generate both the 
required bigWigs as well as the text file containing the number of aligned reads per sample. 
However, the required bigWigs can also be generated by converting BAM files to bedgraph 
format, using the bedtools tool genomeCoverageBed, with the parameters “-split –bg”, and 
subsequently bigwig format, using the bedGraphToBigWig program (available from the UCSC 
Genome Browser utilities).  
Collapsing redundant exons  
Gene isoforms and transcripts often share overlapping exons and UTRs. In the RE discovery 
tool, overlapping annotated regions (here described as exons, regardless of the coding 
potential) on the same strand are collapsed into a single loci, designated as “exonic”. This 
singular representation of multi-exonic transcripts is not conducive to isoform discovery, but 
works well for fragmented RNAs, as is seen in spermatozoa or formalin-fixed paraffin 
embedded (FFPE) tissues. The “prepareExons” function collapses exons using the “bedR” 
package. 
Discovering expressed regions 
The initial step in discovering expressed regions of the genome is performed in the “findRE” 
function. The user needs to provide their genome of interest in BSgenome format, and a gene 
annotation file in GTF format. Although the current study performed RE discovery on the hg38 
build of the human genome, the algorithm is adaptable for different species and genome 
builds. There is no restriction on the format of chromosome names used in the genome. 
However, later annotation steps are coded to be used with ensembl gene annotations 
available through the R package ‘biomaRt’, and thus it is recommended that the GTF file uses 
ensembl gene IDs (please see https://www.gencodegenes.org/releases/current.html for 
examples). The genome is first processed by binning into 10 bp regions. Coverage across 
each 10 bp bin is calculated and bins overlapping an annotated region in the GTF file (here 
described as exons, regardless of the coding potential) are removed from consideration. The 
remaining genomic bins are compared to the designated library size-normalized threshold mu 
(µ), with those bins equal to or exceeding the coverage required in µ retained as a novel RNA 
element (RE). This threshold µ, for a theoretical RNA-seq library with 3 million reads, would 
require a mean coverage of 7.5 reads for a given 10 bp bin in order to label the bin as 
expressed. REs within 100 bp of one another are merged into a single new RE. It is important 
to note that the default parameters used by the “findRE” function retain expressed regions if 
they are present in at least one sample. REs defined across each sample are subsequently 
merged with the “combineRE” function, in which the REs from each iteration are concatenated 
into a single GRanges object. The concatenated object is then reduced, merging overlapping 






Once the newly discovered REs are generated, they need to be annotated according to their 
genomic position, which is achieved in the “annotateRE” function. Intronic regions are defined 
according to the user-supplied GTF file, followed by identifying novel REs that overlap an 
intron. The distance between any non-intronic novel REs  and exons is then calculated and 
used to define non-intronic novel REs as near-exon (less than 10kb from an exon) or orphan 
(greater than or equal to 10 kb from an exon).  
In the human genome, poorly annotated genes have occasionally been observed to have 
transcription beyond their designated borders. In an optional step, performed with the 
“extendExon” function, near-exon REs within a default 20 bp of an exon are examined. The 
read coverage across near-exon REs, in 10 bp increments, are compared to the average read 
coverage of the adjacent exon. If the read coverage in the near-exon RE is increased or 
decreased by less than 50% of the average read coverage of the adjacent exon, the novel RE 
is merged with the adjacent exon. This process is repeated until no more 10 bp bins of the 
near-exon RE remain, or the near-exon RE coverage changes by more than 50% of the 
average read coverage of the adjacent exon. 
In order to provide the user with the common gene symbol of each ensembl gene ID, the 
function “annotateFinal” is provided. The “biomaRt” package is used to transform the ensembl 
gene ID into the common gene symbol. The output is a complete bed file of exonic and novel 
REs, along with the common gene symbol(s) and ensembl gene id(s) of the REs. This bed 






Appendix F: RNA-seq samples applied to REDa (RE discovery). This table provides the 
unique sample name (Sample.name) for each RNA-seq library, as well as the corresponding 
tissue type and RNA-preparation type (Tissue, Tissue.simple, RNA.type and Pool). The 
publication or GEO dataset from which the sample was drawn is provided in "Publication" 
column. 






































































































































































































































































































































































































































































































































































































































































liver.female.6yo Liver Aplus 20
16 
pool GEO Accession: GSM2072373 
SRR3192418 Gingera
s 
liver.male.32yo Liver Aplus 20
16 
pool GEO Accession: GSM2072372 
SRR3192440 Gingera
s 
liver.fetal Liver Aplus 20
16 
pool GEO Accession: GSM2072387 
SRR4422587 Gingera
s 
Testis Testis Aplus 20
16 
pool GEO Accession: GSM2343115 
SRR4422588 Gingera
s 
Testis Testis Aplus 20
16 
pool GEO Accession: GSM2343115 
SRR4421667 Gingera
s 
Testis Testis Aplus 20
16 
pool GEO Accession: GSM2343589 
SRR4421668 Gingera
s 
Testis Testis Aplus 20
16 
pool GEO Accession: GSM2343589 
SRR3192439 Gingera
s 
liver.fetal Liver Aplus 20
16 
pool GEO Accession: GSM2072386 














































pool doi: 10.1242/dev.152413  































pool doi: 10.1242/dev.152413  











Appendix G: Location of novel REs exceeding 1 kb in length. A total of 138 novel REs 
exceed one kilobase in length. The chromosomal location (in hg38 coordinates) of the RE is 
provided in the first three columns, “Chromosome”, “Start position”, and “End position”. The 
length of the RE, in base pairs, is provided in column “RE length”. For intronic and near-exon 
REs, the associated gene names are provided in column “Gene symbol”. The designation of 
an RE as near-exon, intronic, or novel is given in column “RE class”. 
 
Chromosome Start position End position RE length Gene symbol RE class 
chr9 133019427 133021126 1700 EEF1A1P5 NOVEL_10KB_EXON 
chr5 4867045 4868064 1020 AC026415.1 NOVEL_INTRONIC 
chr1 1595371 1596770 1400 FNDC10 NOVEL_10KB_EXON 
chr1 25907041 25908250 1210 STMN1 NOVEL_10KB_EXON 
chr1 37859741 37862430 2690 INPP5B NOVEL_10KB_EXON 
chr1 40860961 40862366 1406 CITED4 NOVEL_10KB_EXON 
chr1 180190981 180192010 1030 QSOX1 NOVEL_INTRONIC 
chr2 19351349 19352410 1062 OSR1 NOVEL_10KB_EXON 
chr2 44167539 44168859 1321 AC019129.2 NOVEL_10KB_EXON 
chr2 132270379 132271658 1280 CDC27P1 NOVEL_10KB_EXON 
chr3 50258368 50259819 1452 GNAI2 NOVEL_10KB_EXON 
chr4 15002500 15004335 1836 CPEB2 NOVEL_10KB_EXON 
chr4 118630440 118634189 3750 AC110079.1 NOVEL_10KB_EXON 
chr5 177456545 177458707 2163 DBN1 NOVEL_10KB_EXON 
chr6 2966400 2972205 5806 SERPINB6 NOVEL_10KB_EXON 
chr7 905617 906626 1010 ADAP1 NOVEL_INTRONIC 
chr7 65838216 65839335 1120 AC093582.1 NOVEL_10KB_EXON 
chr7 65840796 65842065 1270 AC093582.1 NOVEL_10KB_EXON 
chr9 136107687 136109081 1395 AL138781.1 NOVEL_10KB_EXON 
chr10 26645650 26646779 1130 AL390961.1 NOVEL_10KB_EXON 
chr14 70230224 70232587 2364 AL160191.3 NOVEL_10KB_EXON 
chr14 106286318 106287657 1340 HOMER2P2 NOVEL_10KB_EXON 
chr17 7881186 7882765 1580 NAA38 NOVEL_INTRONIC 
chr19 4227969 4229118 1150 EBI3 NOVEL_10KB_EXON 
chr22 23892523 23893922 1400 AP000350.4 NOVEL_INTRONIC 
chr22 30967066 30968552 1487 MORC2 NOVEL_10KB_EXON 
chr22 41994621 41998652 4032 SEPT3 NOVEL_10KB_EXON 
chr1 38129381 38130522 1142 AL139158.3 NOVEL_10KB_EXON 
chr1 149924351 149925820 1470 SF3B4 NOVEL_INTRONIC 
chr1 154952201 154953600 1400 PBXIP1 NOVEL_INTRONIC 
chr2 112062629 112063728 1100 TMEM87B NOVEL_INTRONIC 
chr3 168845049 168846468 1420 NA NOVEL_ORPHAN 
chr6 36863796 36865095 1300 PPIL1 NOVEL_INTRONIC 
chr7 30157438 30162876 5439 MTURN,AC007036.3 NOVEL_10KB_EXON 
chr8 99944163 99946062 1900 NA NOVEL_ORPHAN 
chr9 34667387 34668426 1040 AL162231.2 NOVEL_INTRONIC 
chr9 35103667 35105374 1708 FAM214B NOVEL_10KB_EXON 
chr11 70121258 70122757 1500 ANO1 NOVEL_INTRONIC 
chr12 2855495 2856944 1450 ITFG2 NOVEL_INTRONIC 
chr15 22767380 22770269 2890 AC138649.1 NOVEL_INTRONIC 
chr16 22115491 22116500 1010 VWA3A NOVEL_INTRONIC 
chr19 4618609 4619678 1070 AC011498.5 NOVEL_10KB_EXON 
chr19 50497439 50500158 2720 EMC10 NOVEL_10KB_EXON 
chr20 48501613 48516852 15240 RNU7-144P NOVEL_10KB_EXON 
chr1 2604371 2605540 1170 MMEL1 NOVEL_INTRONIC 





chr1 222471921 222473380 1460 CICP13 NOVEL_10KB_EXON 
chr1 222473491 222475320 1830 AL513314.2 NOVEL_10KB_EXON 
chr1 222476031 222477304 1274 AL513314.2 NOVEL_10KB_EXON 
chr6 23854156 23855645 1490 AL139093.1 NOVEL_10KB_EXON 
chr7 149587 152547 2961 AC093627.4 NOVEL_10KB_EXON 
chr7 942327 943466 1140 ADAP1 NOVEL_INTRONIC 
chr7 51390017 51391366 1350 AC012441.1 NOVEL_10KB_EXON 
chr7 51391797 51393186 1390 AC012441.1 NOVEL_10KB_EXON 
chr7 63930996 63932015 1020 SLC25A1P3 NOVEL_10KB_EXON 
chr7 112618816 112620645 1830 AC002463.1 NOVEL_10KB_EXON 
chr10 132887000 132888069 1070 CFAP46 NOVEL_INTRONIC 
chr16 1672491 1673510 1020 CRAMP1 NOVEL_INTRONIC 
chr16 2528236 2531510 3275 AMDHD2 NOVEL_10KB_EXON 
chr17 3385930 3386955 1026 AC087498.1 NOVEL_10KB_EXON 
chr20 50958623 50963931 5309 MOCS3 NOVEL_10KB_EXON 
chr1 24086831 24087900 1070 MYOM3 NOVEL_INTRONIC 
chr1 154206511 154207648 1138 C1orf43 NOVEL_10KB_EXON 
chr2 45309399 45311588 2190 LINC01121 NOVEL_INTRONIC 
chr2 165665809 165667138 1330 CSRNP3 NOVEL_INTRONIC 
chr2 216857249 216858478 1230 AC007563.2 NOVEL_INTRONIC 
chr3 169821889 169822941 1053 LRRIQ4 NOVEL_10KB_EXON 
chr3 195941779 195945588 3810 AC124944.3 NOVEL_INTRONIC 
chr3 196001229 196005068 3840 AC024937.2 NOVEL_10KB_EXON 
chr3 197640019 197642188 2170 AC024560.3 NOVEL_10KB_EXON 
chr4 10083250 10084379 1130 WDR1 NOVEL_INTRONIC 
chr4 119405650 119407129 1480 GTF2IP12 NOVEL_10KB_EXON 
chr4 119407310 119409332 2023 GTF2IP12 NOVEL_10KB_EXON 
chr4 183850820 183852569 1750 STOX2 NOVEL_INTRONIC 
chr4 189846080 189847239 1160 FRG1-DT NOVEL_INTRONIC 
chr5 1620305 1624854 4550 AC026412.1 NOVEL_INTRONIC 
chr5 7299375 7301459 2085 AC091951.1 NOVEL_10KB_EXON 
chr5 70487825 70491084 3260 AC146944.3 NOVEL_10KB_EXON 
chr5 70509795 70511814 2020 AC146944.1 NOVEL_10KB_EXON 
chr5 70774825 70778714 3890 AC139272.1 NOVEL_INTRONIC 
chr6 166899956 166902745 2790 RPS6KA2 NOVEL_INTRONIC 
chr7 32591137 32592176 1040 DPY19L1P1 NOVEL_INTRONIC 
chr7 37847147 37848366 1220 EPDR1 NOVEL_INTRONIC 
chr7 57216146 57218355 2210 AC099654.1 NOVEL_INTRONIC 
chr7 57219716 57221165 1450 AC099654.1 NOVEL_INTRONIC 
chr7 132561286 132564405 3120 PLXNA4 NOVEL_INTRONIC 
chr7 143579446 143580725 1280 AC073264.2 NOVEL_10KB_EXON 
chr7 143748736 143750055 1320 RNU6-267P NOVEL_10KB_EXON 
chr8 27011147 27012422 1276 AC067904.1 NOVEL_10KB_EXON 
chr8 42451183 42452682 1500 SLC20A2 NOVEL_INTRONIC 
chr8 54049383 54050712 1330 LYPLA1 NOVEL_INTRONIC 
chr9 68971447 68972466 1020 PIP5K1B NOVEL_INTRONIC 
chr9 88129307 88132710 3404 SPATA31C2 NOVEL_10KB_EXON 
chr10 671190 672949 1760 DIP2C NOVEL_INTRONIC 
chr10 46129883 46131429 1547 AGAP7P NOVEL_10KB_EXON 
chr10 46357239 46358769 1531 AGAP14P NOVEL_10KB_EXON 
chr10 131385470 131386809 1340 NA NOVEL_ORPHAN 
chr11 119397667 119398776 1110 USP2-AS1 NOVEL_INTRONIC 
chr12 97988365 97989664 1300 MIR4303 NOVEL_10KB_EXON 
chr13 40481146 40483205 2060 LINC00598 NOVEL_INTRONIC 
chr13 111317126 111318245 1120 TEX29 NOVEL_INTRONIC 





chr16 90166011 90167060 1050 FAM157C NOVEL_INTRONIC 
chr17 68148996 68150055 1060 LRRC37A16P NOVEL_10KB_EXON 
chr17 81580005 81581034 1030 NPLOC4 NOVEL_INTRONIC 
chr18 73325334 73326733 1400 LINC02582 NOVEL_INTRONIC 
chr19 23322559 23323958 1400 ZNF91 NOVEL_INTRONIC 
chr19 23465429 23469978 4550 AC074140.1 NOVEL_10KB_EXON 
chr19 23878309 23882468 4160 AC139769.2 NOVEL_10KB_EXON 
chr19 24179389 24181548 2160 NA NOVEL_ORPHAN 
chr19 29015399 29016728 1330 LINC01532 NOVEL_10KB_EXON 
chr19 46918489 46922356 3868 ARHGAP35 NOVEL_10KB_EXON 
chr19 50039299 50040528 1230 ZNF473 NOVEL_INTRONIC 
chr20 1817803 1819042 1240 AL121760.1 NOVEL_10KB_EXON 
chr20 5483953 5485022 1070 AL121757.1 NOVEL_10KB_EXON 
chr20 47833573 47834972 1400 RNU7-173P NOVEL_10KB_EXON 
chr20 47894373 47897142 2770 RNU7-92P NOVEL_10KB_EXON 
chr20 47897423 47898942 1520 RNU7-92P NOVEL_10KB_EXON 
chr20 48122623 48126802 4180 NA NOVEL_ORPHAN 
chr20 48473243 48475192 1950 AL049541.1 NOVEL_10KB_EXON 
chr20 48499743 48501212 1470 RNU7-144P NOVEL_10KB_EXON 
chr21 28993116 28994175 1060 LTN1 NOVEL_10KB_EXON 
chrX 527285 528594 1310 FABP5P13 NOVEL_10KB_EXON 
chrX 622205 623384 1180 SHOX NOVEL_10KB_EXON 
chrX 625535 627004 1470 SHOX NOVEL_INTRONIC 
chrX 942355 943544 1190 NA NOVEL_ORPHAN 
chrX 1910245 1911684 1440 NA NOVEL_ORPHAN 
chr2 241808169 241809368 1200 AC131097.3 NOVEL_10KB_EXON 
chr15 64951720 64952949 1230 ANKDD1A NOVEL_INTRONIC 
chr3 195644509 195646888 2380 AC233280.2 NOVEL_10KB_EXON 
chr21 8228686 8230745 2060 FP671120.1 NOVEL_10KB_EXON 
chr21 8455846 8457845 2000 NA NOVEL_ORPHAN 
chrY 527180 528589 1410 FABP5P13 NOVEL_10KB_EXON 
chrY 622200 623389 1190 SHOX NOVEL_10KB_EXON 
chrY 625540 627009 1470 SHOX NOVEL_INTRONIC 
chrY 942350 943549 1200 NA NOVEL_ORPHAN 
chrY 1910130 1911589 1460 NA NOVEL_ORPHAN 








Appendix H: Specifications for quantitative quality control of MARS samples. 
 
Step 1: If the sample has less than 20% of the aligned reads belonging to the human genome 
and less than 2 million autosomal reads (duplicates included), then the sample is assigned as 
“Category 1: Low Genomic”. Otherwise, the sample continues to step 2. 
Step 2: If the sample has greater than 75% of the aligned reads belonging to the human 
genome and one of the two following conditions: Read duplication rate less than 10% or less 
than 5% of aligned reads belonging to ribosomal RNA, then the sample is assigned as 
“Category 2: High intergenic reads”. Otherwise, the sample continues to step 3. 
Step 3: If the sample has a % of aligned reads belonging to the human genome between 20% 
and 40%, and greater than 4% of the aligned reads belonging to the bacteria or viruses, then 
the sample is assigned as “Category 3: High bacterial and viral reads”. Otherwise, the sample 
continues to step 4.  
Step 4: If the sample has a % of aligned reads belonging to the human genome between 20% 
and 40%, and greater than 50% of the aligned reads belonging to the ERCC spike-in, then 
the sample is assigned as “Category 4: High spike-in reads”. Otherwise, the sample continues 
to step 5. 
Step 5: If the sample has a % of aligned reads belonging to the human genome between 20% 
and 40%, and greater than 40% of the reads remaining unmapped, then the sample is 
assigned as “Category 5: High unmapped reads”. Otherwise, the sample has passed quality 
control and is determined to be of satisfactory quality. 
 
The R function for the above process is shown below:  
 
makelab <- function(x){ ##where x is a row number, corresponding to a particular sample 
  a <- ar{ar$sample==x,} 
  if(a$genomic_prop<0.2 & a$autosome<2000000){ 
    b <- "Cond1_lowgenomic"} 
  else if(a$genomic_prop>0.75 & (a$duplicates_prop < 0.1 | a$rRNA_prop < 0.05)){ 
    b <- "Cond2_grassy"}  
  else if(a$genomic_prop>=0.2 & a$genomic_prop<=0.4 & a$bactviral_prop>0.04){ 
    b <- "Cond3_highbactviral"}  
  else if(a$genomic_prop>=0.2 & a$genomic_prop<=0.4 & a$ercc_prop>0.5){ 
    b <- "Cond4_highercc"} 
  else if(a$genomic_prop>=0.2 & a$genomic_prop<=0.4 & a$unmapped_prop>0.4){ 
    b <- "Cond5_highunmapped"}  
  else { 
    b <- "OK" 
    } 








Appendix I: Differential expression of sperm-enriched genomic repeats. The number of 
differential REs that overlap a given repeat are indicated for (A) Simple repeats, (B) Complex 
repeats, and (C) Centromeric repeats. X-axis provides the repeat name, while the Y-axis 







Appendix J. piRNA clusters with multiple piRNAs expressed in human sperm. The 
cluster location and name are indicated in the columns “Chromosome”, “Start”, “End”, “Cluster 
width”, and “Cluster_name”. “Cluster expression in Testis” provides the expression details 
from the pooled generic testis dataset, from which the clusters were generated. The column 
“Count of expressed piRNAs” indicates the number of piRNAs present in human sperm 
(median RPM > 1 RPM) belonging to the given cluster. 
 
Chromosome Start End Cluster 
Width 
Cluster name Cluster expression in Testis Count of 
expressed 
piRNAs 
chr19 16011114 16044967 33854 cluster_168 normal_testis_generic|10711.0258613575|mono:plus|168 6 
chr3 12848046 12879013 30968 cluster_234 normal_testis_generic|1513.99429755676|mono:minus|234 6 
chr1 179582014 179593814 11801 cluster_21 normal_testis_generic|1903.72089572736|mono:minus|21 3 
chr10 28786000 28797031 11032 cluster_27 normal_testis_generic|7153.61881881805|mono:minus|27 3 
chr15 51246002 51308028 62027 cluster_99 normal_testis_generic|14407.8869660576|mono:minus|99 3 
chr15 96761025 96790009 28985 cluster_111 normal_testis_generic|3644.61909348552|mono:minus|111 3 
chr4 119403036 119414007 10972 cluster_248 normal_testis_generic|218.559754300489|mono:minus|248 3 
chr9 81910020 81933023 23004 cluster_330 normal_testis_generic|1269.70452451239|mono:minus|330 3 
chr10 79680067 79719007 38941 cluster_40 normal_testis_generic|535.912720047788|mono:minus|40 2 
chr11 45666000 45730027 64028 cluster_51 normal_testis_generic|23143.2207101714|mono:minus|51 2 
chr11 75003029 75014999 11971 cluster_56 normal_testis_generic|1048.76550357495|mono:plus|56 2 
chr6 33863011 33925970 62960 cluster_271 normal_testis_generic|34453.9318019432|bi:minus-plus (split 
between 33892867 and 33892867)|271 
2 
chr9 113101011 113122392 21382 cluster_340 normal_testis_generic|11059.4403415613|bi:minus-plus (split 
between 113112111 and 113112118)|340 
2 







Appendix K. Small RNAs altered by DBP. Cells highlighted in lime green exhibit the same 
expression trend in both study arms, while those highlighted in light orange exhibit opposite 
expression trends. 







High-DBP < Non-DBP 
L1M2_5 hsa_piR_016677 7SL ALRb hsa_piR_008397 
AluYg6 hsa_piR_016742 GOLEM AluSq hsa_piR_009228 
CHARLIE3 hsa-miR-192-5p hsa-miR-339-5p AluSq10 hsa_piR_013247 
  hsa_piR_019675 hsa_piR_005076 AluYf1 hsa_piR_016582 
  hsa-miR-200a-3p hsa_piR_010010 AluYk12 hsa_piR_016584 
  tRNA-Gln-CAA hsa_piR_011482 CHARLIE3 hsa_piR_016804 
  hsa-miR-186-5p hsa_piR_017724 
ENSG00000199313|ENST000
00362443 hsa_piR_017550 
  hsa-miR-27b-3p MER28 
ENSG00000222094|ENST000
00410162 hsa_piR_017591 
  CHARLIE10 TRNA_GLU 
ENSG00000252461|ENST000
00516652 hsa_piR_017781 
  MER54A   
ENSG00000252677|ENST000
00516868 hsa_piR_017990 
  hsa-miR-499a-5p   HERV16 hsa_piR_017996 
  hsa_piR_016735   HERV-Fc1 hsa_piR_018717 
      HERVK3I hsa_piR_018790 
      hsa-let-7d-3p hsa_piR_019675 
      hsa-miR-142-5p hsa_piR_020497 
      hsa-miR-151b hsa_piR_021041 
      hsa-miR-28-3p hsa_piR_021722 
      hsa-miR-320a hsa_piR_022107 
      hsa-miR-3656 hsa_piR_023221 
      hsa-miR-423-5p hsa_piR_023224 
      hsa-miR-486-5p hsa_piR_023415 
      hsa-miR-508-5p L1M3C_5 
      hsa-miR-574-5p L1MB7 
      hsa-miR-891a-5p L1MC3 
      hsa_piR_000753 L1P4d_5end 
      hsa_piR_001809 LTR10C 
      hsa_piR_003116 LTR16A 
      hsa_piR_003180 LTR1F1 
      hsa_piR_003220 LTR30 
      hsa_piR_003257 LTR66 
      hsa_piR_004427 MER54 
      hsa_piR_004880 MER66_I 
      hsa_piR_005278 MER72 
      hsa_piR_005371 MLT1D 
      hsa_piR_005675 MST_I 
      hsa_piR_005767 SVA_A 
      hsa_piR_006426 THE1D 
      hsa_piR_006434 tRNA-Ala-GCA 
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mechanisms. Although the paternal component in humans is poorly understood, both 
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of intrauterine insemination (IUI), or in vitro fertilization (IVF) using Fresh or Cryopreserved 
(Frozen) embryo transfer, were compared. In addition to a reduction of epigenetic aberrations 
in the IVF conceptions using cryopreservation, metastable epialleles also exhibited altered 
methylation with fertility status. ART, embryo nutrition, and fertility status are thus suggested 
to have a lasting epigenetic effect of on the developing embryo. While the paternal contribution 
to the human embryo is uncertain, sperm deliver a collection of proteins and RNA to the 
zygote. To identify the entire cadre of intergenic spermatozoal RNAs, RNA Element (RE) 
discovery algorithm (REDa) was developed and applied to a spectrum of germline, embryonic, 





and yielded previously unidentified human RNAs. Human spermatogenesis was found to 
exhibit extensive intergenic transcription and pervasive repetitive sequence expression. By 
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